query	target	qheader	theader	fident	alnlen	mismatch	qstart	qend	tstart	tend	evalue	bits
LOKIASV2_3899_ESMFold_N-A	4n57-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4n57-assembly1.cif.gz_A Crystal structure of aminoglycoside phosphotransferase APH(2'')-IVa ADP complex	0.196	299	236	9	307	1	294	3.553E-18	648
LOKIASV2_3899_ESMFold_N-A	4dfb-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	4dfb-assembly2.cif.gz_B Crystal structure of aminoglycoside phosphotransferase aph(2")-id/aph(2")-iva in complex with kanamycin	0.185	300	240	8	307	1	295	6.627E-18	648
LOKIASV2_3899_ESMFold_N-A	4dfb-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4dfb-assembly1.cif.gz_A Crystal structure of aminoglycoside phosphotransferase aph(2")-id/aph(2")-iva in complex with kanamycin	0.194	300	235	8	307	1	293	1.444E-17	638
LOKIASV2_3899_ESMFold_N-A	6ctz-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6ctz-assembly1.cif.gz_A Structure of the GDP and kanamycin complex of APH(2")-IIia	0.190	298	236	15	312	3	294	1.153E-16	629
LOKIASV2_3899_ESMFold_N-A	3tdv-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	3tdv-assembly2.cif.gz_B Structure of the GDP complex of wild-type aminoglycoside 2'-phosphotransferase-IIIa	0.190	302	239	11	312	1	296	2.647E-16	629
LOKIASV2_3899_ESMFold_N-A	3n4v-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	3n4v-assembly2.cif.gz_B apo APH(2")-IVa form III	0.192	300	238	8	307	1	295	2.188E-17	627
LOKIASV2_3899_ESMFold_N-A	3tdw-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3tdw-assembly1.cif.gz_A The GDP complex of the aminoglycoside 2'-phosphotransfere-IIIa F108L mutant	0.190	303	240	12	314	1	297	3.258E-16	624
LOKIASV2_3899_ESMFold_N-A	4dtb-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	4dtb-assembly2.cif.gz_B Crystal Structure of F95Y Aminoglycoside-2''-Phosphotransferase Type IVa in Complex with Guanosine	0.192	300	238	8	307	1	295	3.874E-17	621
LOKIASV2_3899_ESMFold_N-A	4dta-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4dta-assembly1.cif.gz_A Crystal Structure of F95M Aminoglycoside-2''-Phosphotransferase Type IVa in Complex with Adenosine	0.192	300	238	8	307	1	295	1.419E-16	599
LOKIASV2_3899_ESMFold_N-A	5iqg-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5iqg-assembly1.cif.gz_A Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GDP, Magnesium, and Gentamicin C1	0.218	298	222	14	311	5	289	5.199E-16	586
LOKIASV2_3899_ESMFold_N-A	6c5u-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6c5u-assembly1.cif.gz_A Aminoglycoside Phosphotransferase (2'')-Ia in complex with GMPPNP, Magnesium, and Ribostamycin, Alternate form	0.224	298	220	14	311	7	290	8.739E-16	570
LOKIASV2_3899_ESMFold_N-A	6cey-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6cey-assembly1.cif.gz_A Aminoglycoside Phosphotransferase (2'')-Ia in complex with GMPPNP, Magnesium, and Lividomycin moieties	0.214	301	225	12	312	1	287	3.040E-15	560
LOKIASV2_3899_ESMFold_N-A	4ork-assembly4.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	4ork-assembly4.cif.gz_D Crystal Structure of the Phosphotransferase Domain of the Bifunctional Aminoglycoside Resistance Enzyme AAC(6')-Ie-APH(2'')-Ia	0.224	298	223	14	311	5	292	9.696E-16	559
LOKIASV2_3899_ESMFold_N-A	4ork-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	4ork-assembly2.cif.gz_B Crystal Structure of the Phosphotransferase Domain of the Bifunctional Aminoglycoside Resistance Enzyme AAC(6')-Ie-APH(2'')-Ia	0.220	299	224	14	312	8	295	3.093E-16	559
LOKIASV2_3899_ESMFold_N-A	4ork-assembly3.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	4ork-assembly3.cif.gz_C Crystal Structure of the Phosphotransferase Domain of the Bifunctional Aminoglycoside Resistance Enzyme AAC(6')-Ie-APH(2'')-Ia	0.214	299	226	14	312	5	292	7.479E-16	558
LOKIASV2_3899_ESMFold_N-A	5iqc-assembly3.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	5iqc-assembly3.cif.gz_C Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GMPPNP, Magnesium, and Gentamicin C1	0.231	298	222	14	311	5	294	1.193E-15	558
LOKIASV2_3899_ESMFold_N-A	6cgg-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6cgg-assembly1.cif.gz_A Aminoglycoside Phosphotransferase (2'')-Ia in complex with GMPPNP, Magnesium, and Arbekacin	0.224	298	223	14	311	6	293	3.372E-15	550
LOKIASV2_3899_ESMFold_N-A	6ch4-assembly3.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	6ch4-assembly3.cif.gz_C Aminoglycoside Phosphotransferase (2'')-Ia S376N mutant in complex with GMPPNP and Magnesium	0.218	298	226	14	311	5	294	4.851E-15	550
LOKIASV2_3899_ESMFold_N-A	5iqb-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5iqb-assembly1.cif.gz_A Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GMPPNP, Magnesium, and Kanamycin A	0.220	299	224	14	312	4	291	3.202E-15	546
LOKIASV2_3899_ESMFold_N-A	5iqe-assembly3.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	5iqe-assembly3.cif.gz_C Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GMPPNP, Magnesium, and Neomycin B	0.221	298	221	14	311	5	289	3.552E-15	545
LOKIASV2_3899_ESMFold_N-A	5iqh-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5iqh-assembly1.cif.gz_A Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) S214A mutant in complex with GMPPNP and Magnesium	0.207	299	228	14	312	6	293	1.547E-15	542
LOKIASV2_3899_ESMFold_N-A	5iqc-assembly4.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	5iqc-assembly4.cif.gz_D Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GMPPNP, Magnesium, and Gentamicin C1	0.222	298	218	14	311	9	289	3.202E-15	540
LOKIASV2_3899_ESMFold_N-A	5iqi-assembly3.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	5iqi-assembly3.cif.gz_C Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) Y237F mutant in complex with GMPPNP and Magnesium	0.212	298	228	14	311	5	294	2.469E-15	540
LOKIASV2_3899_ESMFold_N-A	5iqd-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	5iqd-assembly2.cif.gz_B Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GMPPNP, Magnesium, and Ribostamycin	0.221	298	224	14	311	9	296	3.040E-15	532
LOKIASV2_3899_ESMFold_N-A	5iqh-assembly3.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	5iqh-assembly3.cif.gz_C Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) S214A mutant in complex with GMPPNP and Magnesium	0.205	299	224	14	312	5	287	5.109E-15	528
LOKIASV2_3899_ESMFold_N-A	5iqf-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	5iqf-assembly2.cif.gz_B Aminoglycoside Phosphotransferase (2'')-Ia (CTD of APH(6')-Ie/APH(2'')-Ia) in complex with GDP and Magnesium	0.227	299	221	14	312	9	295	4.372E-15	528
LOKIASV2_3899_ESMFold_N-A	6cav-assembly3.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	6cav-assembly3.cif.gz_C Aminoglycoside Phosphotransferase (2'')-Ia in complex with GMPPNP, Magnesium, and Dibekacin	0.214	299	222	13	311	1	284	8.588E-15	527
LOKIASV2_3899_ESMFold_N-A	6cav-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6cav-assembly2.cif.gz_B Aminoglycoside Phosphotransferase (2'')-Ia in complex with GMPPNP, Magnesium, and Dibekacin	0.214	298	225	14	311	5	291	5.971E-15	523
LOKIASV2_3899_ESMFold_N-A	5iqc-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	5iqc-assembly2.cif.gz_B Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GMPPNP, Magnesium, and Gentamicin C1	0.212	305	231	7	311	4	297	4.151E-15	523
LOKIASV2_3899_ESMFold_N-A	5iqe-assembly4.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	5iqe-assembly4.cif.gz_D Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GMPPNP, Magnesium, and Neomycin B	0.200	299	226	14	312	9	291	4.372E-15	522
LOKIASV2_3899_ESMFold_N-A	6cgd-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6cgd-assembly2.cif.gz_B Aminoglycoside Phosphotransferase (2'')-Ia in complex with GMPPNP, Magnesium, and Amikacin	0.214	298	224	14	311	9	294	6.289E-15	522
LOKIASV2_3899_ESMFold_N-A	5iqg-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	5iqg-assembly2.cif.gz_B Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GDP, Magnesium, and Gentamicin C1	0.214	299	221	14	312	8	289	6.624E-15	520
LOKIASV2_3899_ESMFold_N-A	5iqi-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	5iqi-assembly2.cif.gz_B Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) Y237F mutant in complex with GMPPNP and Magnesium	0.202	299	227	14	312	9	293	4.151E-15	520
LOKIASV2_3899_ESMFold_N-A	4dca-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4dca-assembly1.cif.gz_A Crystal structure of aminoglycoside phosphotransferase APH(2'')-Ib, ADP-bound	0.190	295	233	12	306	1	289	2.601E-15	517
LOKIASV2_3899_ESMFold_N-A	6ch4-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6ch4-assembly2.cif.gz_B Aminoglycoside Phosphotransferase (2'')-Ia S376N mutant in complex with GMPPNP and Magnesium	0.221	298	222	14	311	9	294	9.528E-15	517
LOKIASV2_3899_ESMFold_N-A	3ham-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3ham-assembly1.cif.gz_A Structure of the gentamicin-APH(2")-IIa complex	0.180	301	237	8	308	1	290	2.113E-15	517
LOKIASV2_3899_ESMFold_N-A	6cgg-assembly4.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	6cgg-assembly4.cif.gz_D Aminoglycoside Phosphotransferase (2'')-Ia in complex with GMPPNP, Magnesium, and Arbekacin	0.234	295	214	14	308	7	286	2.304E-14	513
LOKIASV2_3899_ESMFold_N-A	6cav-assembly4.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	6cav-assembly4.cif.gz_D Aminoglycoside Phosphotransferase (2'')-Ia in complex with GMPPNP, Magnesium, and Dibekacin	0.224	295	214	14	308	5	281	4.767E-14	505
LOKIASV2_3899_ESMFold_N-A	5iqb-assembly4.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	5iqb-assembly4.cif.gz_D Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GMPPNP, Magnesium, and Kanamycin A	0.224	295	216	14	308	8	286	2.556E-14	504
LOKIASV2_3899_ESMFold_N-A	5iqh-assembly4.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	5iqh-assembly4.cif.gz_D Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) S214A mutant in complex with GMPPNP and Magnesium	0.202	298	227	14	311	5	290	1.602E-14	504
LOKIASV2_3899_ESMFold_N-A	3hav-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3hav-assembly1.cif.gz_A Structure of the streptomycin-ATP-APH(2")-IIa ternary complex	0.186	303	237	9	311	1	292	7.349E-15	500
LOKIASV2_3899_ESMFold_N-A	5iqi-assembly4.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	5iqi-assembly4.cif.gz_D Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) Y237F mutant in complex with GMPPNP and Magnesium	0.224	299	218	14	312	9	290	5.021E-14	491
LOKIASV2_3899_ESMFold_N-A	6ch4-assembly4.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	6ch4-assembly4.cif.gz_D Aminoglycoside Phosphotransferase (2'')-Ia S376N mutant in complex with GMPPNP and Magnesium	0.211	295	216	14	308	5	279	1.839E-13	458
LOKIASV2_3899_ESMFold_N-A	3hav-assembly3.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	3hav-assembly3.cif.gz_C Structure of the streptomycin-ATP-APH(2")-IIa ternary complex	0.194	294	222	8	301	1	276	6.857E-14	450
LOKIASV2_3899_ESMFold_N-A	3hav-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	3hav-assembly2.cif.gz_B Structure of the streptomycin-ATP-APH(2")-IIa ternary complex	0.188	286	222	8	293	1	275	1.494E-13	450
LOKIASV2_3899_ESMFold_N-A	7f0f-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7f0f-assembly1.cif.gz_A Crystal structure of capreomycin phosphotransferase in complex with CMN IIB	0.168	294	230	12	305	1	277	1.193E-12	414
LOKIASV2_3899_ESMFold_N-A	5ih0-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5ih0-assembly1.cif.gz_A Macrolide 2'-phosphotransferase type II Y92M mutant - complex with GDP and erythromycin	0.159	297	247	13	307	1	297	1.871E-11	386
LOKIASV2_3899_ESMFold_N-A	5uxb-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	5uxb-assembly2.cif.gz_B Crystal structure of macrolide 2'-phosphotransferase MphH from Brachybacterium faecium, apoenzyme	0.144	293	247	15	307	2	291	4.295E-11	375
LOKIASV2_3899_ESMFold_N-A	4fev-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4fev-assembly1.cif.gz_A Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor pyrazolopyrimidine PP1	0.173	274	212	6	279	3	259	2.468E-12	367
LOKIASV2_3899_ESMFold_N-A	4fex-assembly3.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	4fex-assembly3.cif.gz_C Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor tyrphostin AG1478	0.187	273	203	8	280	5	255	6.622E-12	365
LOKIASV2_3899_ESMFold_N-A	4gkh-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	4gkh-assembly2.cif.gz_B Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor 1-NA-PP1	0.174	274	208	6	279	12	264	2.468E-12	365
LOKIASV2_3899_ESMFold_N-A	4gkh-assembly17.cif.gz_I	LOKIASV2_3899_ESMFold_N-A	4gkh-assembly17.cif.gz_I Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor 1-NA-PP1	0.176	274	210	6	279	7	262	3.371E-12	364
LOKIASV2_3899_ESMFold_N-A	4gki-assembly6.cif.gz_F	LOKIASV2_3899_ESMFold_N-A	4gki-assembly6.cif.gz_F Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor 1-NM-PP1	0.174	274	207	6	279	6	257	6.622E-12	352
LOKIASV2_3899_ESMFold_N-A	4few-assembly7.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	4few-assembly7.cif.gz_B Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor pyrazolopyrimidine PP2	0.188	252	194	28	279	13	252	1.686E-11	350
LOKIASV2_3899_ESMFold_N-A	4fev-assembly9.cif.gz_F	LOKIASV2_3899_ESMFold_N-A	4fev-assembly9.cif.gz_F Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor pyrazolopyrimidine PP1	0.197	254	194	26	279	7	248	3.675E-11	349
LOKIASV2_3899_ESMFold_N-A	4few-assembly9.cif.gz_F	LOKIASV2_3899_ESMFold_N-A	4few-assembly9.cif.gz_F Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor pyrazolopyrimidine PP2	0.186	254	199	26	279	17	262	1.370E-11	347
LOKIASV2_3899_ESMFold_N-A	4feu-assembly6.cif.gz_F	LOKIASV2_3899_ESMFold_N-A	4feu-assembly6.cif.gz_F Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor anthrapyrazolone SP600125	0.186	252	195	28	279	2	241	7.604E-11	343
LOKIASV2_3899_ESMFold_N-A	4few-assembly8.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	4few-assembly8.cif.gz_D Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor pyrazolopyrimidine PP2	0.167	280	217	1	280	1	262	1.113E-11	343
LOKIASV2_3899_ESMFold_N-A	4gkh-assembly10.cif.gz_J	LOKIASV2_3899_ESMFold_N-A	4gkh-assembly10.cif.gz_J Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor 1-NA-PP1	0.178	274	206	6	279	12	263	1.686E-11	342
LOKIASV2_3899_ESMFold_N-A	4fex-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	4fex-assembly2.cif.gz_B Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor tyrphostin AG1478	0.199	254	194	26	279	15	257	3.871E-11	341
LOKIASV2_3899_ESMFold_N-A	4ej7-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	4ej7-assembly2.cif.gz_B Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, ATP-bound	0.200	255	194	26	280	16	259	3.489E-11	336
LOKIASV2_3899_ESMFold_N-A	4gkh-assembly18.cif.gz_K	LOKIASV2_3899_ESMFold_N-A	4gkh-assembly18.cif.gz_K Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor 1-NA-PP1	0.175	274	209	6	279	12	265	2.555E-11	336
LOKIASV2_3899_ESMFold_N-A	4fev-assembly7.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	4fev-assembly7.cif.gz_B Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor pyrazolopyrimidine PP1	0.188	252	194	28	279	11	250	8.010E-11	332
LOKIASV2_3899_ESMFold_N-A	6fuc-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6fuc-assembly1.cif.gz_A Structure of aminoglycoside phosphotransferase APH(3'')-Id from Streptomyces rimosus ATCC10970	0.172	266	219	15	280	3	268	4.524E-11	327
LOKIASV2_3899_ESMFold_N-A	4feu-assembly3.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	4feu-assembly3.cif.gz_C Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor anthrapyrazolone SP600125	0.181	272	206	8	279	7	258	1.346E-10	322
LOKIASV2_3899_ESMFold_N-A	1nd4-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	1nd4-assembly1.cif.gz_B Crystal structure of aminoglycoside-3'-phosphotransferase-IIa	0.178	259	202	22	280	5	251	1.418E-10	321
LOKIASV2_3899_ESMFold_N-A	6fux-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6fux-assembly1.cif.gz_A Structure of aminoglycoside phosphotransferase APH(3'')-Id from Streptomyces rimosus ATCC10970 in complex with ADP and streptomycin	0.175	266	216	15	280	3	265	3.091E-10	314
LOKIASV2_3899_ESMFold_N-A	4feu-assembly4.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	4feu-assembly4.cif.gz_D Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor anthrapyrazolone SP600125	0.191	249	192	31	279	1	238	6.736E-10	311
LOKIASV2_3899_ESMFold_N-A	4feu-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	4feu-assembly2.cif.gz_B Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor anthrapyrazolone SP600125	0.188	274	201	6	279	12	259	3.612E-10	307
LOKIASV2_3899_ESMFold_N-A	3w0m-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3w0m-assembly1.cif.gz_A Crystal structure of a thermostable mutant of aminoglycoside phosphotransferase APH(4)-Ia, apo form	0.136	291	246	20	310	1	286	5.106E-09	299
LOKIASV2_3899_ESMFold_N-A	1l8t-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	1l8t-assembly1.cif.gz_A Crystal Structure Of 3',5"-Aminoglycoside Phosphotransferase Type IIIa ADP Kanamycin A Complex	0.146	271	220	9	279	1	259	2.884E-09	274
LOKIASV2_3899_ESMFold_N-A	4h05-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4h05-assembly1.cif.gz_A Crystal structure of aminoglycoside-3'-phosphotransferase of type VIII	0.168	268	221	13	280	4	270	7.735E-09	267
LOKIASV2_3899_ESMFold_N-A	6iy9-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6iy9-assembly2.cif.gz_B Crystal structure of aminoglycoside 7"-phoshotransferase-Ia (APH(7")-Ia/HYG) from Streptomyces hygroscopicus complexed with hygromycin B	0.159	299	248	5	303	7	302	1.003E-08	254
LOKIASV2_3899_ESMFold_N-A	2bkk-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	2bkk-assembly1.cif.gz_A Crystal structure of Aminoglycoside Phosphotransferase APH(3')-IIIa in complex with the inhibitor AR_3a	0.147	271	206	9	279	1	243	7.602E-08	244
LOKIASV2_3899_ESMFold_N-A	2qg7-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	2qg7-assembly1.cif.gz_A Plasmodium vivax ethanolamine kinase Pv091845	0.150	326	253	12	310	34	359	2.554E-08	227
LOKIASV2_3899_ESMFold_N-A	4ocv-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4ocv-assembly1.cif.gz_A N-acetylhexosamine 1-phosphate kinase_ATCC15697 in complex with GlcNAc and AMPPNP	0.134	339	260	15	315	3	341	2.933E-07	221
LOKIASV2_3899_ESMFold_N-A	4wh3-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4wh3-assembly1.cif.gz_A N-acetylhexosamine 1-kinase in complex with ATP	0.118	340	265	14	315	2	341	2.933E-07	206
LOKIASV2_3899_ESMFold_N-A	6sv5-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6sv5-assembly1.cif.gz_A Amicoumacin kinase AmiN in complex with ATP	0.125	310	263	11	312	8	317	1.132E-06	185
LOKIASV2_3899_ESMFold_N-A	2olc-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	2olc-assembly1.cif.gz_B Crystal structure of 5-methylthioribose kinase in complex with ADP-2Ho	0.133	310	261	9	310	4	313	5.762E-07	179
LOKIASV2_3899_ESMFold_N-A	6sul-assembly2.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	6sul-assembly2.cif.gz_D Amicoumacin kinase AmiN in complex with AMP-PNP, Mg2+ and Ami	0.131	309	262	11	312	9	317	8.579E-06	161
LOKIASV2_3899_ESMFold_N-A	3ppz-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3ppz-assembly1.cif.gz_A Crystal structure of CTR1 kinase domain in complex with staurosporine	0.121	284	222	30	313	12	265	8.880E-05	125
LOKIASV2_3899_ESMFold_N-A	5s82-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5s82-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with XS035128c	0.129	258	163	27	284	4	191	1.093E-04	119
LOKIASV2_3899_ESMFold_N-A	6b2q-assembly2.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	6b2q-assembly2.cif.gz_C Dual Inhibition of the Essential Protein Kinases A and B in Mycobacterium tuberculosis	0.125	265	219	27	291	8	258	7.866E-04	111
LOKIASV2_3899_ESMFold_N-A	7up4-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7up4-assembly1.cif.gz_A Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound pyrrolopyrimidine compound 20 (co-crystal)	0.100	270	206	25	294	4	233	4.929E-04	111
LOKIASV2_3899_ESMFold_N-A	6oyt-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6oyt-assembly1.cif.gz_A ASK1 kinase domain in complex with GS-4997	0.141	253	171	26	278	2	201	1.322E-03	105
LOKIASV2_3899_ESMFold_N-A	7up8-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7up8-assembly1.cif.gz_A Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound pyrrolopyrimidine compound 27 (co-crystal)	0.108	255	191	25	279	4	218	1.074E-03	105
LOKIASV2_3899_ESMFold_N-A	6vvg-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6vvg-assembly1.cif.gz_B Structure of the Cydia pomonella Granulovirus kinase, PK-1	0.112	294	214	14	307	2	243	9.192E-04	104
LOKIASV2_3899_ESMFold_N-A	7up7-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	7up7-assembly2.cif.gz_B Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound with literature RSK2 inhibitor indazole cyanoacrylamide compound 26 (soak)	0.096	291	249	25	315	3	278	9.192E-04	104
LOKIASV2_3899_ESMFold_N-A	7a52-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	7a52-assembly2.cif.gz_B Structure of DYRK1A in complex with compound 6	0.136	251	186	28	278	16	231	1.074E-03	104
LOKIASV2_3899_ESMFold_N-A	8sap-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	8sap-assembly2.cif.gz_B Crystal structure of class III lanthipeptide synthetase ThurKC	0.132	300	229	11	310	188	452	7.599E-05	104
LOKIASV2_3899_ESMFold_N-A	7uiq-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	7uiq-assembly2.cif.gz_B Cocrystal structure of human CaMKII-alpha (CAMK2A)kinase domain and Tiam1	0.113	263	210	27	289	3	240	1.322E-03	103
LOKIASV2_3899_ESMFold_N-A	8guw-assembly1.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	8guw-assembly1.cif.gz_C Structure of Aurora Kinase A in complex with activator peptide	0.128	303	233	8	310	1	268	1.093E-04	103
LOKIASV2_3899_ESMFold_N-A	1v0o-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	1v0o-assembly1.cif.gz_A Structure of P. falciparum PfPK5-Indirubin-5-sulphonate ligand complex	0.116	255	180	29	283	1	205	8.285E-04	103
LOKIASV2_3899_ESMFold_N-A	3d2k-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3d2k-assembly1.cif.gz_A Crystal structure of mouse Aurora A (Asn186->Gly, Lys240->Arg, Met302->Leu) in complex with [7-(2-{2-[3-(3-chloro-phenyl)-ureido]-thiazol-5-yl}-ethylamino)-pyrazolo[4,3-d]pyrimidin-1-yl]-acetic acid	0.127	260	188	30	289	6	221	1.192E-03	102
LOKIASV2_3899_ESMFold_N-A	5wnj-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5wnj-assembly1.cif.gz_A Crystal structure of murine receptor-interacting protein kinase 4 (Ripk4) D143N in complex with lestaurtinib	0.106	277	224	27	303	10	261	1.545E-03	102
LOKIASV2_3899_ESMFold_N-A	7up7-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7up7-assembly1.cif.gz_A Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound with literature RSK2 inhibitor indazole cyanoacrylamide compound 26 (soak)	0.108	255	193	25	279	4	220	9.192E-04	102
LOKIASV2_3899_ESMFold_N-A	6v6a-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6v6a-assembly1.cif.gz_A Inhibitory scaffolding of the ancient MAPK, ERK7	0.129	288	230	25	312	5	269	4.679E-04	102
LOKIASV2_3899_ESMFold_N-A	5wvd-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5wvd-assembly1.cif.gz_A Structure of Mnk1 in complex with DS12881479	0.112	250	199	26	275	4	228	2.222E-03	101
LOKIASV2_3899_ESMFold_N-A	3qgy-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	3qgy-assembly2.cif.gz_B Crystal structure of ITK inhibitor complex	0.101	274	213	28	301	6	243	2.341E-03	101
LOKIASV2_3899_ESMFold_N-A	3p86-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3p86-assembly1.cif.gz_A Crystal structure of CTR1 kinase domain mutant D676N in complex with staurosporine	0.103	284	215	30	313	8	248	1.074E-03	101
LOKIASV2_3899_ESMFold_N-A	4ysm-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	4ysm-assembly2.cif.gz_B Calcium-Dependent Protein Kinase from Eimeria tenella	0.127	284	230	27	310	19	282	2.262E-04	101
LOKIASV2_3899_ESMFold_N-A	5hu3-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5hu3-assembly1.cif.gz_A Drosophila CaMKII-D136N in complex with a phosphorylated fragment of the Eag potassium channel and Mg2+/ADP	0.104	284	232	24	307	2	261	2.222E-03	100
LOKIASV2_3899_ESMFold_N-A	2qoc-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	2qoc-assembly1.cif.gz_A Human EphA3 kinase domain, phosphorylated, AMP-PNP bound structure	0.103	292	231	26	317	5	262	4.004E-04	100
LOKIASV2_3899_ESMFold_N-A	6ilz-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6ilz-assembly1.cif.gz_A Crystal structure of PKCiota in complex with inhibitor	0.115	284	234	29	312	2	266	4.218E-04	100
LOKIASV2_3899_ESMFold_N-A	3qgw-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	3qgw-assembly2.cif.gz_B Crystal Structure of ITK kinase bound to an inhibitor	0.090	281	212	28	308	4	237	1.806E-03	99
LOKIASV2_3899_ESMFold_N-A	1ol6-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	1ol6-assembly1.cif.gz_A Structure of unphosphorylated D274N mutant of Aurora-A	0.120	260	190	30	289	6	222	1.192E-03	99
LOKIASV2_3899_ESMFold_N-A	6oyt-assembly2.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	6oyt-assembly2.cif.gz_D ASK1 kinase domain in complex with GS-4997	0.145	254	196	26	279	2	231	8.727E-04	99
LOKIASV2_3899_ESMFold_N-A	5uhn-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	5uhn-assembly2.cif.gz_B Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 harboring a N549H/E565A Double Gain-of-Function Mutation	0.097	282	232	28	309	11	268	2.597E-03	99
LOKIASV2_3899_ESMFold_N-A	6ya8-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6ya8-assembly1.cif.gz_A Cdc7-Dbf4 bound to ADP-BeF3	0.130	256	155	14	269	4	182	3.547E-03	99
LOKIASV2_3899_ESMFold_N-A	7up6-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7up6-assembly1.cif.gz_A Crystal structure of C-terminal domain of MSK1 in complex with in covalently bound literature RSK2 inhibitor pyrrolopyrimidine cyanoacrylamide compound 25 (co-crystal)	0.112	255	191	25	279	3	218	2.597E-03	97
LOKIASV2_3899_ESMFold_N-A	6ruu-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6ruu-assembly1.cif.gz_A Pseudokinase domain of human IRAK3	0.136	302	244	11	312	1	283	9.192E-04	97
LOKIASV2_3899_ESMFold_N-A	2vz6-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	2vz6-assembly2.cif.gz_B Structure of human calcium calmodulin dependent protein kinase type II alpha (CAMK2A) in complex with Indirubin E804	0.104	254	218	26	279	3	246	1.627E-03	97
LOKIASV2_3899_ESMFold_N-A	5de2-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	5de2-assembly2.cif.gz_B Structural mechanism of Nek7 activation by Nek9-induced dimerisation	0.117	265	205	25	289	5	237	1.627E-03	96
LOKIASV2_3899_ESMFold_N-A	3ma6-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	3ma6-assembly2.cif.gz_B Crystal structure of kinase domain of TgCDPK1 in presence of 3BrB-PP1	0.108	285	235	26	310	2	265	1.192E-03	96
LOKIASV2_3899_ESMFold_N-A	3orx-assembly5.cif.gz_E	LOKIASV2_3899_ESMFold_N-A	3orx-assembly5.cif.gz_E PDK1 mutant bound to allosteric disulfide fragment inhibitor 1F8	0.134	260	195	30	289	7	232	1.074E-03	96
LOKIASV2_3899_ESMFold_N-A	7jus-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	7jus-assembly1.cif.gz_B Crystal Structure of KSR2:MEK1 in complex with AMP-PNP, and allosteric MEK inhibitor Cobimetinib	0.165	114	94	28	141	13	126	5.660E-03	96
LOKIASV2_3899_ESMFold_N-A	6eir-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6eir-assembly2.cif.gz_B DYRK1A in complex with XMD15-27-2	0.128	252	188	28	279	25	241	3.367E-03	96
LOKIASV2_3899_ESMFold_N-A	3uzs-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3uzs-assembly1.cif.gz_A Structure of the C13.28 RNA Aptamer Bound to the G Protein-Coupled Receptor Kinase 2-Heterotrimeric G Protein Beta 1 and Gamma 2 Subunit Complex	0.139	269	208	12	280	139	381	9.192E-04	96
LOKIASV2_3899_ESMFold_N-A	8sap-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	8sap-assembly1.cif.gz_A Crystal structure of class III lanthipeptide synthetase ThurKC	0.137	305	232	7	311	175	444	9.353E-05	96
LOKIASV2_3899_ESMFold_N-A	8sam-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	8sam-assembly1.cif.gz_A Crystal structure of class III lanthipeptide synthetase LP-GS-ThurKC in complex with ATP	0.134	299	232	12	310	202	470	1.151E-04	96
LOKIASV2_3899_ESMFold_N-A	7uir-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	7uir-assembly2.cif.gz_B Cocrystal structure of human CaMKII-alpha (CAMK2A)kinase domain and Tiam1 in complex with ATP	0.114	258	186	27	284	4	214	2.222E-03	95
LOKIASV2_3899_ESMFold_N-A	7umb-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	7umb-assembly1.cif.gz_B NanoBRET tracer Tram-bo bound to a KSR2-MEK1 complex	0.165	114	94	28	141	13	126	6.614E-03	95
LOKIASV2_3899_ESMFold_N-A	6bab-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6bab-assembly1.cif.gz_A The structure of human CamKII with bound inhibitor	0.110	262	214	28	289	2	243	3.547E-03	95
LOKIASV2_3899_ESMFold_N-A	6ya7-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6ya7-assembly1.cif.gz_A Cdc7-Dbf4 bound to an Mcm2-S40 derived bivalent substrate	0.117	259	161	12	270	1	183	5.962E-03	95
LOKIASV2_3899_ESMFold_N-A	3zxt-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	3zxt-assembly1.cif.gz_B Dimeric structure of DAPK-1 catalytic domain in complex with AMPPCP- Mg	0.112	263	203	27	289	4	233	5.660E-03	94
LOKIASV2_3899_ESMFold_N-A	2hel-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	2hel-assembly1.cif.gz_A Crystal structure of a mutant EphA4 kinase domain (Y742A)	0.106	310	225	8	317	1	253	1.074E-03	94
LOKIASV2_3899_ESMFold_N-A	4krd-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4krd-assembly1.cif.gz_A Crystal Structure of Pho85-Pcl10 Complex	0.123	254	186	27	280	3	215	1.467E-03	94
LOKIASV2_3899_ESMFold_N-A	5izj-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5izj-assembly1.cif.gz_A Complex of PKA with the bisubstrate protein kinase inhibitor ARC-1411	0.118	273	209	12	284	1	238	5.468E-04	94
LOKIASV2_3899_ESMFold_N-A	2h34-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	2h34-assembly2.cif.gz_B Apoenzyme crystal structure of the tuberculosis serine/threonine kinase, PknE	0.169	115	93	29	141	4	118	1.234E-02	93
LOKIASV2_3899_ESMFold_N-A	7b8w-assembly3.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	7b8w-assembly3.cif.gz_C Structure of LIMK1 Kinase domain with allosteric inhibitor TH-470	0.105	276	236	30	305	10	274	1.131E-03	93
LOKIASV2_3899_ESMFold_N-A	5lpy-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5lpy-assembly1.cif.gz_A Crystal structure of the BRI1 kinase domain (865-1160) in complex with ATP from Arabidopsis thaliana	0.117	302	227	9	310	3	260	1.322E-03	93
LOKIASV2_3899_ESMFold_N-A	4jdk-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4jdk-assembly1.cif.gz_A Crystal structure of Serine/threonine-protein kinase PAK 4 F461V mutant in complex with Paktide S peptide substrate	0.090	269	207	12	280	1	229	1.467E-03	93
LOKIASV2_3899_ESMFold_N-A	2r0i-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	2r0i-assembly2.cif.gz_B Crystal structure of a kinase MARK2/Par-1 mutant	0.124	263	188	30	292	6	221	1.192E-03	93
LOKIASV2_3899_ESMFold_N-A	6so4-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6so4-assembly1.cif.gz_A Fragment RZ132 in complex with MAP kinase p38-alpha	0.143	124	100	28	145	18	141	5.102E-03	93
LOKIASV2_3899_ESMFold_N-A	5tkd-assembly3.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	5tkd-assembly3.cif.gz_B CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH 6-[(3,5-DIMETHYLPHE NYL)AMINO]-8- (METHYLAMINO)IMIDAZO[1,2-B]PYRIDAZINE-3-CARBO XAMIDE	0.118	269	207	31	299	11	246	2.003E-03	92
LOKIASV2_3899_ESMFold_N-A	5up3-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5up3-assembly1.cif.gz_A Structure-Based Design of ASK1 Inhibitors as Potential First-in-Class Agents for Heart Failure	0.105	261	211	29	289	1	237	1.545E-03	92
LOKIASV2_3899_ESMFold_N-A	3kul-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3kul-assembly1.cif.gz_A Kinase domain of human ephrin type-A receptor 8 (EPHA8)	0.098	291	235	27	317	6	266	2.466E-03	92
LOKIASV2_3899_ESMFold_N-A	3zfx-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3zfx-assembly1.cif.gz_A Crystal structure of EphB1	0.101	287	227	26	312	5	258	3.197E-03	92
LOKIASV2_3899_ESMFold_N-A	5n1m-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5n1m-assembly1.cif.gz_A cAMP-dependent Protein Kinase A from Cricetulus griseus in complex with fragment like molecule (5-chloro-2-methoxyphenyl)methanamine	0.114	266	226	14	279	19	274	7.468E-04	92
LOKIASV2_3899_ESMFold_N-A	6oyt-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6oyt-assembly2.cif.gz_B ASK1 kinase domain in complex with GS-4997	0.129	249	187	31	279	3	218	2.003E-03	91
LOKIASV2_3899_ESMFold_N-A	2clq-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	2clq-assembly2.cif.gz_B Structure of mitogen-activated protein kinase kinase kinase 5	0.111	288	193	29	316	1	218	8.285E-04	91
LOKIASV2_3899_ESMFold_N-A	6bl8-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6bl8-assembly1.cif.gz_A Predicting the Conformational Variability of Abl Tyrosine Kinase Using Molecular Dynamics Simulations and Markov State Models	0.118	269	227	30	298	10	267	2.736E-03	91
LOKIASV2_3899_ESMFold_N-A	1xo2-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	1xo2-assembly1.cif.gz_B Crystal structure of a human cyclin-dependent kinase 6 complex with a flavonol inhibitor, fisetin	0.100	211	140	31	241	2	157	5.962E-03	91
LOKIASV2_3899_ESMFold_N-A	3tl8-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3tl8-assembly1.cif.gz_A The AvrPtoB-BAK1 complex reveals two structurally similar kinaseinteracting domains in a single type III effector	0.119	292	248	21	302	11	302	1.255E-03	91
LOKIASV2_3899_ESMFold_N-A	3oz6-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	3oz6-assembly1.cif.gz_B Crystal structure of MapK from Cryptosporidium Parvum, cgd2_1960	0.118	288	214	25	312	5	248	3.367E-03	91
LOKIASV2_3899_ESMFold_N-A	8sam-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	8sam-assembly2.cif.gz_B Crystal structure of class III lanthipeptide synthetase LP-GS-ThurKC in complex with ATP	0.132	299	233	12	310	201	469	2.784E-04	91
LOKIASV2_3899_ESMFold_N-A	5vio-assembly4.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	5vio-assembly4.cif.gz_D Crystal structure of ASK1 kinase domain with a potent inhibitor (analog 13)	0.131	212	137	29	240	1	159	2.736E-03	90
LOKIASV2_3899_ESMFold_N-A	7b8w-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7b8w-assembly1.cif.gz_A Structure of LIMK1 Kinase domain with allosteric inhibitor TH-470	0.124	262	158	30	291	10	190	2.341E-03	90
LOKIASV2_3899_ESMFold_N-A	5hvj-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5hvj-assembly1.cif.gz_A Crystal structure of LIMK1 D460N mutant in complex with AMP-PNP	0.135	267	161	25	291	8	194	1.902E-03	90
LOKIASV2_3899_ESMFold_N-A	4f9c-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4f9c-assembly1.cif.gz_A Human CDC7 kinase in complex with DBF4 and XL413	0.126	276	181	14	289	2	209	4.598E-03	90
LOKIASV2_3899_ESMFold_N-A	4f9b-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4f9b-assembly1.cif.gz_A Human CDC7 kinase in complex with DBF4 and PHA767491	0.122	277	191	12	288	1	218	4.844E-03	90
LOKIASV2_3899_ESMFold_N-A	4azt-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4azt-assembly1.cif.gz_A Co-crystal structure of WbdD and kinase inhibitor LY294002.	0.118	251	170	29	279	217	410	5.962E-03	90
LOKIASV2_3899_ESMFold_N-A	5u6y-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	5u6y-assembly1.cif.gz_B Pseudo-atomic model of the CaMKIIa holoenzyme.	0.114	251	213	29	279	1	241	2.003E-03	90
LOKIASV2_3899_ESMFold_N-A	6cjw-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6cjw-assembly1.cif.gz_A Crystal Structure of Mnk2-D228G in Complex With Inhibitor	0.147	114	96	29	141	14	127	9.033E-03	89
LOKIASV2_3899_ESMFold_N-A	3kul-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	3kul-assembly2.cif.gz_B Kinase domain of human ephrin type-A receptor 8 (EPHA8)	0.105	291	238	27	317	6	272	1.902E-03	89
LOKIASV2_3899_ESMFold_N-A	7ukz-assembly6.cif.gz_F	LOKIASV2_3899_ESMFold_N-A	7ukz-assembly6.cif.gz_F CDK11 in complex with small molecule inhibitor OTS964	0.127	251	182	30	280	3	212	1.131E-03	89
LOKIASV2_3899_ESMFold_N-A	5n1o-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5n1o-assembly1.cif.gz_A cAMP-dependent Protein Kinase A from Cricetulus griseus in complex with fragment like molecule 2-chloro-4-(chloromethyl)-5-hydroxyphenyl)ethan-1-one	0.128	279	220	14	292	10	262	1.714E-03	89
LOKIASV2_3899_ESMFold_N-A	6ya6-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6ya6-assembly1.cif.gz_A Minimal construct of Cdc7-Dbf4 bound to XL413	0.126	256	156	14	269	4	183	9.514E-03	89
LOKIASV2_3899_ESMFold_N-A	5r9w-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5r9w-assembly1.cif.gz_A PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13598a in complex with MAP kinase p38-alpha	0.148	127	100	28	145	18	144	1.171E-02	89
LOKIASV2_3899_ESMFold_N-A	5v19-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5v19-assembly1.cif.gz_A Structure-based drug design of novel ASK1 inhibitors using a fully integrated lead optimization strategy	0.127	286	173	31	316	12	210	1.192E-03	88
LOKIASV2_3899_ESMFold_N-A	4bic-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4bic-assembly1.cif.gz_A Crystal Structures of Ask1-inhibitor Complexes	0.136	264	206	29	292	1	239	3.547E-03	88
LOKIASV2_3899_ESMFold_N-A	3bhy-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3bhy-assembly1.cif.gz_A Crystal structure of human death associated protein kinase 3 (DAPK3) in complex with a beta-carboline ligand	0.106	292	237	26	317	2	267	5.962E-03	88
LOKIASV2_3899_ESMFold_N-A	7juz-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7juz-assembly1.cif.gz_A Crystal Structure of KSR1:MEK1 in complex with AMP-PNP, and allosteric MEK inhibitor Selumetinib	0.138	274	223	28	301	11	270	1.902E-03	88
LOKIASV2_3899_ESMFold_N-A	7up8-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	7up8-assembly2.cif.gz_B Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound pyrrolopyrimidine compound 27 (co-crystal)	0.097	290	240	27	316	14	280	5.102E-03	88
LOKIASV2_3899_ESMFold_N-A	6ilz-assembly2.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	6ilz-assembly2.cif.gz_C Crystal structure of PKCiota in complex with inhibitor	0.106	251	203	29	279	2	229	4.598E-03	88
LOKIASV2_3899_ESMFold_N-A	6s14-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6s14-assembly1.cif.gz_A Crystal Structure of DYRK1A with small molecule inhibitor	0.127	276	206	3	278	2	238	2.597E-03	88
LOKIASV2_3899_ESMFold_N-A	7ejv-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7ejv-assembly1.cif.gz_A The co-crystal structure of DYRK2 with YK-2-69	0.143	250	182	29	278	71	283	5.962E-03	88
LOKIASV2_3899_ESMFold_N-A	6oyt-assembly1.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	6oyt-assembly1.cif.gz_C ASK1 kinase domain in complex with GS-4997	0.150	249	183	31	279	2	217	2.222E-03	87
LOKIASV2_3899_ESMFold_N-A	4pp9-assembly3.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	4pp9-assembly3.cif.gz_B ITK kinase domain with compound 1 (N-[1-(3-CYANOBENZYL)-1H-PYRAZOL-4-YL]-2H-INDAZOLE-3-CARBOXAMIDE)	0.115	277	204	32	308	11	241	6.280E-03	87
LOKIASV2_3899_ESMFold_N-A	4bie-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4bie-assembly1.cif.gz_A Crystal Structures of Ask1-inhibitor Complexes	0.125	251	206	29	279	1	236	2.341E-03	87
LOKIASV2_3899_ESMFold_N-A	4agu-assembly3.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	4agu-assembly3.cif.gz_C CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN	0.109	256	180	28	283	1	203	5.660E-03	87
LOKIASV2_3899_ESMFold_N-A	1uu7-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	1uu7-assembly1.cif.gz_A Structure of human PDK1 kinase domain in complex with BIM-2	0.135	260	199	30	289	10	240	2.222E-03	87
LOKIASV2_3899_ESMFold_N-A	5vlo-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5vlo-assembly1.cif.gz_A The structure of human CamKII with bound inhibitor	0.107	263	213	27	289	4	243	6.967E-03	87
LOKIASV2_3899_ESMFold_N-A	4ian-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	4ian-assembly1.cif.gz_B Crystal Structure of apo Human PRPF4B kinase domain	0.116	256	193	28	283	10	228	1.192E-03	87
LOKIASV2_3899_ESMFold_N-A	4ifc-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4ifc-assembly1.cif.gz_A Crystal Structure of ADP-bound Human PRPF4B kinase domain	0.119	256	192	28	283	18	236	5.760E-04	87
LOKIASV2_3899_ESMFold_N-A	3vuk-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3vuk-assembly1.cif.gz_A Crystal structure of a cysteine-deficient mutant M5 in MAP kinase JNK1	0.109	256	189	28	283	18	230	6.614E-03	87
LOKIASV2_3899_ESMFold_N-A	3k2l-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3k2l-assembly1.cif.gz_A Crystal Structure of dual-specificity tyrosine phosphorylation regulated kinase 2 (DYRK2)	0.132	250	184	29	278	85	297	1.112E-02	87
LOKIASV2_3899_ESMFold_N-A	3mwu-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3mwu-assembly1.cif.gz_A Activated Calcium-Dependent Protein Kinase 1 from Cryptosporidium parvum (CpCDPK1) in complex with bumped kinase inhibitor RM-1-95	0.145	281	202	27	307	8	244	2.003E-03	87
LOKIASV2_3899_ESMFold_N-A	6e2m-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6e2m-assembly1.cif.gz_B ASK1 kinase domain complex with inhibitor	0.141	249	185	31	279	12	227	2.003E-03	86
LOKIASV2_3899_ESMFold_N-A	4d2s-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4d2s-assembly1.cif.gz_A Human TTK in complex with a Dyrk1B inhibitor	0.088	250	196	30	279	13	228	1.627E-03	86
LOKIASV2_3899_ESMFold_N-A	5uox-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	5uox-assembly2.cif.gz_B Structure-Based Design of ASK1 Inhibitors as Potential First-in-Class Agents for Heart Failure	0.124	264	202	29	292	1	232	4.145E-03	86
LOKIASV2_3899_ESMFold_N-A	3zfx-assembly6.cif.gz_F	LOKIASV2_3899_ESMFold_N-A	3zfx-assembly6.cif.gz_F Crystal structure of EphB1	0.108	287	215	26	312	4	245	4.598E-03	86
LOKIASV2_3899_ESMFold_N-A	6oyw-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6oyw-assembly2.cif.gz_B ASK1 kinase domain in complex with Compound 11	0.128	262	194	31	292	12	235	7.866E-04	86
LOKIASV2_3899_ESMFold_N-A	4agu-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	4agu-assembly2.cif.gz_B CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN	0.113	255	177	29	283	1	200	6.614E-03	86
LOKIASV2_3899_ESMFold_N-A	6bab-assembly3.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	6bab-assembly3.cif.gz_C The structure of human CamKII with bound inhibitor	0.105	261	211	29	289	1	237	6.614E-03	86
LOKIASV2_3899_ESMFold_N-A	5uiu-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5uiu-assembly1.cif.gz_A Crystal structure of IRAK4 in complex with compound 30	0.112	294	250	17	310	6	288	2.881E-03	86
LOKIASV2_3899_ESMFold_N-A	5xvf-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5xvf-assembly1.cif.gz_A Crystal Structure of PAK4 in complex with inhibitor CZH062	0.095	279	230	11	289	1	255	3.367E-03	86
LOKIASV2_3899_ESMFold_N-A	7dh9-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7dh9-assembly1.cif.gz_A The co-crystal structure of DYRK2 with a small molecule inhibitor 7	0.125	250	186	29	278	7	219	5.660E-03	86
LOKIASV2_3899_ESMFold_N-A	7e11-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7e11-assembly1.cif.gz_A Crystal structure of PKAc-PLN R9C complex	0.119	280	226	13	292	3	259	1.902E-03	86
LOKIASV2_3899_ESMFold_N-A	5ztn-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	5ztn-assembly1.cif.gz_B The crystal structure of human DYRK2 in complex with Curcumin	0.140	250	182	29	278	89	301	4.844E-03	86
LOKIASV2_3899_ESMFold_N-A	7jij-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7jij-assembly1.cif.gz_A ATP-bound AMP-activated protein kinase	0.111	262	205	28	289	4	235	1.020E-03	86
LOKIASV2_3899_ESMFold_N-A	3zfx-assembly3.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	3zfx-assembly3.cif.gz_C Crystal structure of EphB1	0.108	287	212	26	312	2	240	7.730E-03	85
LOKIASV2_3899_ESMFold_N-A	2h6d-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	2h6d-assembly1.cif.gz_A Protein Kinase Domain of the Human 5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK alpha-2 chain)	0.120	262	192	28	289	5	223	4.145E-03	85
LOKIASV2_3899_ESMFold_N-A	7kx6-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7kx6-assembly1.cif.gz_A Crystal structure of DCLK1-KD in complex with XMD8-85	0.112	266	208	24	289	4	238	4.598E-03	85
LOKIASV2_3899_ESMFold_N-A	3zew-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3zew-assembly1.cif.gz_A Crystal structure of EphB4 in complex with staurosporine	0.092	290	236	26	315	3	263	1.902E-03	85
LOKIASV2_3899_ESMFold_N-A	6brj-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6brj-assembly1.cif.gz_A DDR1 bound to VX-680	0.131	249	184	30	278	6	218	4.844E-03	85
LOKIASV2_3899_ESMFold_N-A	1v0o-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	1v0o-assembly2.cif.gz_B Structure of P. falciparum PfPK5-Indirubin-5-sulphonate ligand complex	0.101	255	182	29	283	1	203	5.102E-03	85
LOKIASV2_3899_ESMFold_N-A	2ac3-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	2ac3-assembly1.cif.gz_A Structure of human Mnk2 Kinase Domain	0.137	287	226	26	312	10	272	2.110E-03	85
LOKIASV2_3899_ESMFold_N-A	5hvj-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	5hvj-assembly2.cif.gz_B Crystal structure of LIMK1 D460N mutant in complex with AMP-PNP	0.133	262	157	30	291	10	191	3.935E-03	85
LOKIASV2_3899_ESMFold_N-A	5lpw-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5lpw-assembly1.cif.gz_A Crystal structure of the apo-BRI1 kinase domain (865-1160)	0.133	232	140	9	240	4	165	1.234E-02	85
LOKIASV2_3899_ESMFold_N-A	3e87-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	3e87-assembly2.cif.gz_B Crystal structures of the kinase domain of AKT2 in complex with ATP-competitive inhibitors	0.118	276	239	28	303	5	276	1.393E-03	85
LOKIASV2_3899_ESMFold_N-A	6k0j-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6k0j-assembly1.cif.gz_A The co-crystal structure of DYRK2 with a small molecule inhibitor	0.135	250	183	29	278	10	222	5.102E-03	85
LOKIASV2_3899_ESMFold_N-A	5tbe-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5tbe-assembly1.cif.gz_A Human p38alpha MAP Kinase in Complex with Dibenzosuberone Compound 2	0.142	272	191	30	301	20	243	1.806E-03	85
LOKIASV2_3899_ESMFold_N-A	2vag-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	2vag-assembly1.cif.gz_A Crystal structure of di-phosphorylated human CLK1 in complex with a novel substituted indole inhibitor	0.108	124	103	27	142	12	135	2.074E-02	85
LOKIASV2_3899_ESMFold_N-A	6hdr-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6hdr-assembly1.cif.gz_A Human DYRK2 bound to Curcumin	0.134	250	184	29	278	94	306	1.369E-02	85
LOKIASV2_3899_ESMFold_N-A	8tb6-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	8tb6-assembly2.cif.gz_B TYK2 JH2 bound to Compound14	0.122	277	212	31	307	12	253	3.935E-03	84
LOKIASV2_3899_ESMFold_N-A	4bid-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	4bid-assembly2.cif.gz_B Crystal Structures of Ask1-inhibitor Complexes	0.115	288	191	29	316	1	217	2.736E-03	84
LOKIASV2_3899_ESMFold_N-A	7n9g-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	7n9g-assembly2.cif.gz_B Crystal structure of the Abl 1b Kinase domain in complex with Dasatinib and Imatinib	0.109	267	225	30	296	10	263	5.374E-03	84
LOKIASV2_3899_ESMFold_N-A	2j90-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	2j90-assembly1.cif.gz_A Crystal structure of human ZIP kinase in complex with a tetracyclic pyridone inhibitor (Pyridone 6)	0.120	264	209	26	289	5	243	9.514E-03	84
LOKIASV2_3899_ESMFold_N-A	6qau-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6qau-assembly2.cif.gz_B Crystal structure of ULK2 in complexed with MRT67307	0.131	247	199	33	279	14	243	7.730E-03	84
LOKIASV2_3899_ESMFold_N-A	5xff-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5xff-assembly1.cif.gz_A Crystal structure of LY2874455 in complex of FGFR4 gatekeeper mutation (V550L)	0.115	282	226	27	308	12	267	4.366E-03	84
LOKIASV2_3899_ESMFold_N-A	3s95-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	3s95-assembly2.cif.gz_B Crystal structure of the human LIMK1 kinase domain in complex with staurosporine	0.139	262	159	30	291	12	197	7.730E-03	84
LOKIASV2_3899_ESMFold_N-A	7ake-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7ake-assembly1.cif.gz_A Structure of DYRK1A in complex with compound 58	0.141	251	183	28	278	17	230	4.145E-03	84
LOKIASV2_3899_ESMFold_N-A	3p4k-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3p4k-assembly1.cif.gz_A The third conformation of p38a MAP kinase observed in phosphorylated p38a and in solution	0.134	253	172	31	283	23	222	6.614E-03	84
LOKIASV2_3899_ESMFold_N-A	6ytw-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6ytw-assembly2.cif.gz_B CLK3 bound with benzothiazole Tg003 (Cpd 2)	0.122	133	108	29	152	22	154	3.671E-02	84
LOKIASV2_3899_ESMFold_N-A	4y5q-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4y5q-assembly1.cif.gz_A Activated Calcium-Dependent Protein Kinase 1 from Cryptosporidium parvum (CpCDPK1) in complex with AMP	0.129	264	207	26	289	7	245	3.736E-03	84
LOKIASV2_3899_ESMFold_N-A	5m53-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5m53-assembly1.cif.gz_A Nek2 bound to arylaminopurine inhibitor 11	0.127	242	172	29	270	1	198	1.171E-02	83
LOKIASV2_3899_ESMFold_N-A	7chn-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7chn-assembly1.cif.gz_A Crystal structure of TTK kinase domain in complex with compound 9	0.087	252	208	28	279	14	242	1.902E-03	83
LOKIASV2_3899_ESMFold_N-A	2iw8-assembly2.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	2iw8-assembly2.cif.gz_C STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A F82H-L83V-H84D MUTANT WITH AN O6-CYCLOHEXYLMETHYLGUANINE INHIBITOR	0.130	281	217	27	307	2	251	7.730E-03	83
LOKIASV2_3899_ESMFold_N-A	7quf-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7quf-assembly1.cif.gz_A The STK17A (DRAK1) Kinase Domain Bound to CK156	0.100	280	231	27	306	9	266	1.442E-02	83
LOKIASV2_3899_ESMFold_N-A	7b8w-assembly4.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	7b8w-assembly4.cif.gz_D Structure of LIMK1 Kinase domain with allosteric inhibitor TH-470	0.118	277	229	29	305	11	271	3.935E-03	83
LOKIASV2_3899_ESMFold_N-A	6egd-assembly1.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	6egd-assembly1.cif.gz_D Crystal structure of the unphosphorylated IRAK4 kinase domain Bound to a type I inhibitor	0.121	287	221	24	310	24	275	2.736E-03	83
LOKIASV2_3899_ESMFold_N-A	2y7j-assembly1.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	2y7j-assembly1.cif.gz_C Structure of human phosphorylase kinase, gamma 2	0.093	274	235	16	289	4	263	7.730E-03	83
LOKIASV2_3899_ESMFold_N-A	5lpv-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5lpv-assembly1.cif.gz_A Crystal structure of the BRI1 kinase domain (865-1160) in complex with AMPPNP and Mn from Arabidopsis thaliana	0.137	232	138	9	240	3	163	1.599E-02	83
LOKIASV2_3899_ESMFold_N-A	3bhh-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	3bhh-assembly2.cif.gz_B Crystal structure of human calcium/calmodulin-dependent protein kinase IIB isoform 1 (CAMK2B)	0.111	280	227	27	306	2	257	7.338E-03	83
LOKIASV2_3899_ESMFold_N-A	5hvk-assembly2.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	5hvk-assembly2.cif.gz_C Crystal structure of LIMK1 mutant D460N in complex with full-length cofilin-1	0.129	265	167	25	289	9	201	5.374E-03	83
LOKIASV2_3899_ESMFold_N-A	7ukz-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7ukz-assembly1.cif.gz_A CDK11 in complex with small molecule inhibitor OTS964	0.131	253	183	28	280	1	212	5.962E-03	83
LOKIASV2_3899_ESMFold_N-A	6gvx-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6gvx-assembly2.cif.gz_B Crystal structure of Maternal Embryonic Leucine Zipper Kinase (MELK) in complex with dorsomorphin (Compound C)	0.134	271	197	9	279	1	228	6.614E-03	83
LOKIASV2_3899_ESMFold_N-A	5o90-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5o90-assembly1.cif.gz_A Crystal structure of a P38alpha T185G mutant in complex with TAB1 peptide.	0.117	256	182	28	283	18	224	2.341E-03	83
LOKIASV2_3899_ESMFold_N-A	3lhj-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3lhj-assembly1.cif.gz_A Crystal Structure of p38a Mitogen-Activated Protein Kinase in Complex with a Pyrazolopyridinone Inhibitor.	0.117	215	129	28	242	18	164	4.598E-03	83
LOKIASV2_3899_ESMFold_N-A	6sot-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6sot-assembly1.cif.gz_A Fragment N11290a in complex with MAP kinase p38-alpha	0.136	123	101	28	145	18	140	1.299E-02	83
LOKIASV2_3899_ESMFold_N-A	5ezv-assembly2.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	5ezv-assembly2.cif.gz_C X-ray crystal structure of AMP-activated protein kinase alpha-2/alpha-1 RIM chimaera (alpha-2(1-347)/alpha-1(349-401)/alpha-2(397-end) beta-1 gamma-1) co-crystallized with C2 (5-(5-hydroxyl-isoxazol-3-yl)-furan-2-phosphonic acid)	0.108	211	131	30	240	8	155	9.514E-03	83
LOKIASV2_3899_ESMFold_N-A	3qgy-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3qgy-assembly1.cif.gz_A Crystal structure of ITK inhibitor complex	0.086	289	218	28	316	7	246	1.002E-02	82
LOKIASV2_3899_ESMFold_N-A	7vjl-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	7vjl-assembly2.cif.gz_B The crystal structure of FGFR4 kinase domain in complex with N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-(2,2,2-trifluoroacetyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide	0.112	285	224	28	312	13	265	6.614E-03	82
LOKIASV2_3899_ESMFold_N-A	6jlr-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6jlr-assembly1.cif.gz_A Crystal structure of wild type MNK2 in complex with inhibitor	0.143	264	200	29	292	14	247	5.962E-03	82
LOKIASV2_3899_ESMFold_N-A	5ia4-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5ia4-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with foretinib (XL880)	0.110	288	231	29	316	10	269	1.056E-02	82
LOKIASV2_3899_ESMFold_N-A	7du9-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	7du9-assembly1.cif.gz_B Crystal structure of human Proto-oncogene tyrosine-protein kinase receptor Ret in complex with Pralsetinib	0.100	290	238	18	307	2	266	5.660E-03	82
LOKIASV2_3899_ESMFold_N-A	3udb-assembly7.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3udb-assembly7.cif.gz_A Crystal structure of SnRK2.6	0.147	119	101	26	144	6	124	1.171E-02	82
LOKIASV2_3899_ESMFold_N-A	3kk9-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3kk9-assembly1.cif.gz_A CaMKII Substrate Complex B	0.100	263	217	27	289	4	245	9.514E-03	82
LOKIASV2_3899_ESMFold_N-A	5lpb-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5lpb-assembly1.cif.gz_A Crystal structure of the BRI1 kinase domain (865-1160) in complex with ADP from Arabidopsis thaliana	0.132	232	140	9	240	3	164	1.442E-02	82
LOKIASV2_3899_ESMFold_N-A	4rmz-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	4rmz-assembly2.cif.gz_B Crystal Structure of IRAK-4	0.127	287	242	17	303	6	283	5.374E-03	82
LOKIASV2_3899_ESMFold_N-A	6f3d-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6f3d-assembly2.cif.gz_B IRAK4 IN COMPLEX WITH inhibitor	0.108	294	247	17	310	7	284	8.142E-03	82
LOKIASV2_3899_ESMFold_N-A	2wnt-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	2wnt-assembly1.cif.gz_B Crystal Structure of the Human Ribosomal protein S6 kinase	0.135	253	200	27	279	1	232	5.660E-03	82
LOKIASV2_3899_ESMFold_N-A	3hgk-assembly3.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	3hgk-assembly3.cif.gz_C crystal structure of effect protein AvrptoB complexed with kinase Pto	0.153	262	164	28	289	8	202	7.338E-03	82
LOKIASV2_3899_ESMFold_N-A	4eok-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4eok-assembly1.cif.gz_A Thr 160 phosphorylated CDK2 H84S, Q85M, K89D - human cyclin A3 complex with the inhibitor NU6102	0.120	256	187	28	283	3	215	6.614E-03	82
LOKIASV2_3899_ESMFold_N-A	4eop-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4eop-assembly1.cif.gz_A Thr 160 phosphorylated CDK2 Q131E - human cyclin A3 complex with the inhibitor RO3306	0.148	118	98	27	142	4	121	2.423E-02	82
LOKIASV2_3899_ESMFold_N-A	4nw6-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4nw6-assembly1.cif.gz_A Rsk2 N-terminal kinase in complex with 2-amino-7-substituted benzoxazole compound 27	0.120	265	208	26	290	14	250	5.102E-03	82
LOKIASV2_3899_ESMFold_N-A	4e6c-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4e6c-assembly1.cif.gz_A p38a-perifosine Complex	0.138	256	170	28	283	19	216	5.102E-03	82
LOKIASV2_3899_ESMFold_N-A	2y8o-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	2y8o-assembly1.cif.gz_A Crystal structure of human p38alpha complexed with a MAPK docking peptide	0.131	256	177	28	283	19	223	2.341E-03	82
LOKIASV2_3899_ESMFold_N-A	4l7f-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4l7f-assembly1.cif.gz_A Co-crystal Structure of JNK1 and AX13587	0.109	253	176	31	283	24	222	6.967E-03	82
LOKIASV2_3899_ESMFold_N-A	4kio-assembly3.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	4kio-assembly3.cif.gz_C Kinase domain mutant of human Itk in complex with a covalently-binding inhibitor	0.098	277	209	32	308	12	244	9.033E-03	81
LOKIASV2_3899_ESMFold_N-A	4o0u-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4o0u-assembly1.cif.gz_A Crystal structures of human kinase Aurora A	0.107	281	220	30	310	8	254	1.806E-03	81
LOKIASV2_3899_ESMFold_N-A	6qat-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6qat-assembly1.cif.gz_A Crystal structure of ULK2 in complexed with hesperadin	0.124	252	203	28	279	5	237	1.171E-02	81
LOKIASV2_3899_ESMFold_N-A	6cpy-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6cpy-assembly2.cif.gz_B Structure of apo GRMZM2G135359 pseudokinase	0.120	307	223	11	317	8	261	5.102E-03	81
LOKIASV2_3899_ESMFold_N-A	8our-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	8our-assembly1.cif.gz_A CRYSTAL STRUCTURE OF DLK IN COMPLEX WITH COMPOUND 16	0.119	282	217	31	312	10	256	5.102E-03	81
LOKIASV2_3899_ESMFold_N-A	4xli-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	4xli-assembly2.cif.gz_B Crystal structure of Abl2/Arg kinase in complex with dasatinib	0.101	285	226	30	314	10	261	1.442E-02	81
LOKIASV2_3899_ESMFold_N-A	5ia5-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5ia5-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with golvatinib (E7050)	0.138	119	100	25	141	6	124	2.983E-02	81
LOKIASV2_3899_ESMFold_N-A	3qd0-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3qd0-assembly1.cif.gz_A Phosphoinositide-Dependent Kinase-1 (PDK1) kinase domain with (2R,5S)-1-[2-Amino-6-(3-amino-1H-indazol-6-yl)-4-pyrimidinyl]-6-methyl-N-phenyl-3-piperidinecarboxamide	0.135	260	193	30	289	10	233	4.366E-03	81
LOKIASV2_3899_ESMFold_N-A	4agu-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4agu-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN	0.113	256	178	28	283	1	202	1.299E-02	81
LOKIASV2_3899_ESMFold_N-A	8ho6-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	8ho6-assembly1.cif.gz_A ScRIPK WT	0.122	269	225	34	302	22	278	3.367E-03	81
LOKIASV2_3899_ESMFold_N-A	2biy-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	2biy-assembly1.cif.gz_A Structure of PDK1-S241A mutant kinase domain	0.133	260	204	30	289	11	246	3.035E-03	81
LOKIASV2_3899_ESMFold_N-A	7ukz-assembly4.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	7ukz-assembly4.cif.gz_D CDK11 in complex with small molecule inhibitor OTS964	0.135	252	180	29	280	1	209	6.280E-03	81
LOKIASV2_3899_ESMFold_N-A	6ilz-assembly4.cif.gz_G	LOKIASV2_3899_ESMFold_N-A	6ilz-assembly4.cif.gz_G Crystal structure of PKCiota in complex with inhibitor	0.105	251	204	29	279	2	230	5.102E-03	81
LOKIASV2_3899_ESMFold_N-A	2onl-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	2onl-assembly1.cif.gz_A Crystal Structure of the p38a-MAPKAP kinase 2 Heterodimer	0.142	252	173	30	281	21	223	1.112E-02	81
LOKIASV2_3899_ESMFold_N-A	5n32-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5n32-assembly1.cif.gz_A cAMP-dependent Protein Kinase A from Cricetulus griseus in complex with fragment like molecule 4-chlorobenzyl carbamimidothioate	0.122	279	222	14	292	17	270	3.736E-03	81
LOKIASV2_3899_ESMFold_N-A	5he1-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5he1-assembly1.cif.gz_A Human GRK2 in complex with Gbetagamma subunits and CCG224062	0.127	280	232	13	279	122	401	6.280E-03	81
LOKIASV2_3899_ESMFold_N-A	4bf2-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4bf2-assembly1.cif.gz_A Crystal Structures of Ask1-inhibitor Complexes	0.129	249	201	31	279	2	233	5.962E-03	80
LOKIASV2_3899_ESMFold_N-A	2clq-assembly1.cif.gz_A-2	LOKIASV2_3899_ESMFold_N-A	2clq-assembly1.cif.gz_A-2 Structure of mitogen-activated protein kinase kinase kinase 5	0.128	281	191	29	309	1	220	1.020E-03	80
LOKIASV2_3899_ESMFold_N-A	2g2i-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	2g2i-assembly1.cif.gz_A A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domain	0.094	264	227	32	295	14	265	6.614E-03	80
LOKIASV2_3899_ESMFold_N-A	5nxd-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	5nxd-assembly2.cif.gz_B LIM Domain Kinase 2 (LIMK2) In Complex With TH-300	0.118	285	213	29	313	1	243	4.598E-03	80
LOKIASV2_3899_ESMFold_N-A	4qqc-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4qqc-assembly1.cif.gz_A Crystal Structure of FGF Receptor (FGFR) 4 Kinase Domain in Complex with FIIN-2, an Irreversible Tyrosine Kinase Inhibitor Capable of Overcoming FGFR Kinase Gate-Keeper Mutations	0.113	282	221	27	308	22	271	8.576E-03	80
LOKIASV2_3899_ESMFold_N-A	5lpz-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5lpz-assembly1.cif.gz_A Crystal structure of the BRI1 kinase domain (865-1196) in complex with ADP from Arabidopsis thaliana	0.122	295	246	9	303	4	284	1.002E-02	80
LOKIASV2_3899_ESMFold_N-A	7up5-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	7up5-assembly2.cif.gz_B Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound pyrrolopyrimidine compound 23 (co-crystal)	0.089	291	255	25	315	4	284	1.545E-03	80
LOKIASV2_3899_ESMFold_N-A	5hez-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5hez-assembly1.cif.gz_A JAK2 kinase (JH1 domain) mutant P1057A in complex with TG101209	0.096	284	252	30	313	8	287	8.142E-03	80
LOKIASV2_3899_ESMFold_N-A	7ukz-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	7ukz-assembly2.cif.gz_B CDK11 in complex with small molecule inhibitor OTS964	0.126	251	184	30	280	3	213	1.627E-03	80
LOKIASV2_3899_ESMFold_N-A	7ukz-assembly5.cif.gz_E	LOKIASV2_3899_ESMFold_N-A	7ukz-assembly5.cif.gz_E CDK11 in complex with small molecule inhibitor OTS964	0.130	253	184	28	280	2	214	3.197E-03	80
LOKIASV2_3899_ESMFold_N-A	4eol-assembly2.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	4eol-assembly2.cif.gz_C Thr 160 phosphorylated CDK2 H84S, Q85M, K89D - human cyclin A3 complex with the inhibitor RO3306	0.118	251	187	30	280	7	219	1.112E-02	80
LOKIASV2_3899_ESMFold_N-A	1wmk-assembly4.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	1wmk-assembly4.cif.gz_B Human death-associated kinase DRP-1, mutant S308D d40	0.116	209	134	30	238	12	164	1.869E-02	80
LOKIASV2_3899_ESMFold_N-A	6l21-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6l21-assembly1.cif.gz_A Crystal structure of CK2a1 H160A with hematein	0.110	259	195	30	288	38	257	1.599E-02	80
LOKIASV2_3899_ESMFold_N-A	2okr-assembly2.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	2okr-assembly2.cif.gz_D Crystal Structure of the P38a-MAPKAP kinase 2 Heterodimer	0.141	253	171	31	283	22	221	6.614E-03	80
LOKIASV2_3899_ESMFold_N-A	6z2v-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6z2v-assembly1.cif.gz_A CLK3 A319V mutant bound with beta-carboline KH-CARB13 (Cpd 3)	0.093	249	201	29	277	22	244	1.056E-02	80
LOKIASV2_3899_ESMFold_N-A	5r96-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5r96-assembly1.cif.gz_A PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment KCL095 in complex with MAP kinase p38-alpha	0.140	127	101	28	145	18	144	2.074E-02	80
LOKIASV2_3899_ESMFold_N-A	3pvu-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3pvu-assembly1.cif.gz_A Bovine GRK2 in complex with Gbetagamma subunits and a selective kinase inhibitor (CMPD101)	0.118	289	220	4	292	150	399	6.967E-03	80
LOKIASV2_3899_ESMFold_N-A	4csv-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4csv-assembly1.cif.gz_A Tyrosine kinase AS - a common ancestor of Src and Abl bound to Gleevec	0.113	248	168	30	277	9	198	1.685E-02	79
LOKIASV2_3899_ESMFold_N-A	2xne-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	2xne-assembly1.cif.gz_A Structure of Aurora-A bound to an imidazopyrazine inhibitor	0.110	281	211	30	310	7	244	1.112E-02	79
LOKIASV2_3899_ESMFold_N-A	6c83-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6c83-assembly1.cif.gz_B Structure of Aurora A (122-403) bound to inhibitory Monobody Mb2 and AMPPCP	0.106	250	193	30	279	7	223	8.576E-03	79
LOKIASV2_3899_ESMFold_N-A	4bid-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4bid-assembly1.cif.gz_A Crystal Structures of Ask1-inhibitor Complexes	0.130	264	203	29	292	1	234	1.002E-02	79
LOKIASV2_3899_ESMFold_N-A	8tb5-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	8tb5-assembly1.cif.gz_A TYK2 JH2 bound to Compound7	0.177	111	89	32	140	10	120	2.184E-02	79
LOKIASV2_3899_ESMFold_N-A	2hz4-assembly3.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	2hz4-assembly3.cif.gz_C Abl kinase domain unligated and in complex with tetrahydrostaurosporine	0.089	267	227	32	298	9	258	1.599E-02	79
LOKIASV2_3899_ESMFold_N-A	7kxw-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	7kxw-assembly2.cif.gz_B Crystal structure of DCLK1-KD in complex with DCLK1-IN-1	0.122	265	205	25	289	4	238	8.142E-03	79
LOKIASV2_3899_ESMFold_N-A	5v19-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	5v19-assembly2.cif.gz_B Structure-based drug design of novel ASK1 inhibitors using a fully integrated lead optimization strategy	0.118	281	191	29	309	1	217	5.102E-03	79
LOKIASV2_3899_ESMFold_N-A	6vre-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6vre-assembly2.cif.gz_B Structure of ASK1 bound to BIO-1772961	0.110	289	194	28	316	1	219	4.844E-03	79
LOKIASV2_3899_ESMFold_N-A	3fdn-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3fdn-assembly1.cif.gz_A Structure-based drug design of novel Aurora kinase A inhibitors: Structure basis for potency and specificity	0.117	251	177	30	280	8	209	1.234E-02	79
LOKIASV2_3899_ESMFold_N-A	6eas-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6eas-assembly1.cif.gz_A Co-crystal of pseudokinase DRIK1 (drought responsive inactive kinase 1) bound to ENMD-2076	0.120	312	227	6	317	4	262	2.736E-03	79
LOKIASV2_3899_ESMFold_N-A	6mnh-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6mnh-assembly1.cif.gz_A ULK1 Unc-51 like autophagy activating kinase in complex with inhibitor BTC	0.131	248	176	29	276	6	208	5.962E-03	79
LOKIASV2_3899_ESMFold_N-A	3kf4-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	3kf4-assembly2.cif.gz_B Structural analysis of DFG-in and DFG-out dual Src-Abl inhibitors sharing a common vinyl purine template	0.108	267	227	32	298	14	268	1.518E-02	79
LOKIASV2_3899_ESMFold_N-A	7ats-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7ats-assembly1.cif.gz_A The LIMK1 Kinase Domain Bound To LIJTF500127	0.119	281	231	25	305	9	271	6.967E-03	79
LOKIASV2_3899_ESMFold_N-A	6fer-assembly6.cif.gz_F	LOKIASV2_3899_ESMFold_N-A	6fer-assembly6.cif.gz_F Crystal Structure of human DDR2 kinase in complex with 2-[4,5-difluoro-2-oxo-1'-(1H-pyrazolo[3,4-b]pyridine-5-carbonyl)spiro[indole-3,4'-piperidine]-1-yl]-N-(2,2,2-trifluoroethyl)acetamide	0.168	139	109	27	158	8	146	1.869E-02	79
LOKIASV2_3899_ESMFold_N-A	3orz-assembly3.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	3orz-assembly3.cif.gz_C PDK1 mutant bound to allosteric disulfide fragment activator 2A2	0.136	260	195	30	289	9	235	9.033E-03	79
LOKIASV2_3899_ESMFold_N-A	4l00-assembly3.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	4l00-assembly3.cif.gz_B Crystal structure of the apo Jak1 pseudokinase domain	0.134	129	106	18	140	5	133	1.234E-02	79
LOKIASV2_3899_ESMFold_N-A	6bab-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6bab-assembly2.cif.gz_B The structure of human CamKII with bound inhibitor	0.118	251	208	29	279	1	237	9.514E-03	79
LOKIASV2_3899_ESMFold_N-A	3bhh-assembly3.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	3bhh-assembly3.cif.gz_C Crystal structure of human calcium/calmodulin-dependent protein kinase IIB isoform 1 (CAMK2B)	0.106	258	208	32	289	5	238	1.112E-02	79
LOKIASV2_3899_ESMFold_N-A	2pwl-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	2pwl-assembly1.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic N549H Mutation Responsible for Crouzon Syndrome.	0.100	282	245	28	309	12	284	6.614E-03	79
LOKIASV2_3899_ESMFold_N-A	7up4-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	7up4-assembly2.cif.gz_B Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound pyrrolopyrimidine compound 20 (co-crystal)	0.103	281	241	27	307	14	283	6.967E-03	79
LOKIASV2_3899_ESMFold_N-A	2hak-assembly4.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	2hak-assembly4.cif.gz_D Catalytic and ubiqutin-associated domains of MARK1/PAR-1	0.109	263	198	30	292	7	229	4.366E-03	79
LOKIASV2_3899_ESMFold_N-A	4f9a-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4f9a-assembly1.cif.gz_A Human CDC7 kinase in complex with DBF4 and nucleotide	0.119	277	189	12	288	1	215	1.685E-02	79
LOKIASV2_3899_ESMFold_N-A	6una-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6una-assembly2.cif.gz_B Crystal structure of inactive p38gamma	0.108	253	179	31	283	21	222	1.518E-02	79
LOKIASV2_3899_ESMFold_N-A	2onl-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	2onl-assembly2.cif.gz_B Crystal Structure of the p38a-MAPKAP kinase 2 Heterodimer	0.138	254	175	30	283	21	224	1.056E-02	79
LOKIASV2_3899_ESMFold_N-A	1lew-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	1lew-assembly1.cif.gz_A CRYSTAL STRUCTURE OF MAP KINASE P38 COMPLEXED TO THE DOCKING SITE ON ITS NUCLEAR SUBSTRATE MEF2A	0.139	254	176	30	283	20	224	4.366E-03	79
LOKIASV2_3899_ESMFold_N-A	5r94-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5r94-assembly1.cif.gz_A PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment KCL081 in complex with MAP kinase p38-alpha	0.141	125	101	28	145	19	143	1.774E-02	79
LOKIASV2_3899_ESMFold_N-A	4ewq-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4ewq-assembly1.cif.gz_A Human p38 alpha MAPK in complex with a pyridazine based inhibitor	0.136	253	181	31	283	22	231	9.033E-03	79
LOKIASV2_3899_ESMFold_N-A	7ejv-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	7ejv-assembly1.cif.gz_B The co-crystal structure of DYRK2 with YK-2-69	0.136	250	183	29	278	69	281	3.736E-03	79
LOKIASV2_3899_ESMFold_N-A	4azs-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4azs-assembly1.cif.gz_A High resolution (2.2 A) crystal structure of WbdD.	0.120	251	174	29	279	217	415	2.423E-02	79
LOKIASV2_3899_ESMFold_N-A	4yga-assembly3.cif.gz_E	LOKIASV2_3899_ESMFold_N-A	4yga-assembly3.cif.gz_E CDPK1, from Toxoplasma gondii, bound to inhibitory VHH-1B7	0.107	281	225	27	307	4	256	3.547E-03	79
LOKIASV2_3899_ESMFold_N-A	3krw-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3krw-assembly1.cif.gz_A Human GRK2 in complex with Gbetgamma subunits and balanol (soak)	0.121	299	262	12	310	136	434	9.033E-03	79
LOKIASV2_3899_ESMFold_N-A	5uor-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5uor-assembly1.cif.gz_A Structure-Based Design of ASK1 Inhibitors as Potential First-in-Class Agents for Heart Failure	0.124	245	169	31	275	12	205	1.545E-03	78
LOKIASV2_3899_ESMFold_N-A	7k7q-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	7k7q-assembly1.cif.gz_B CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH COMPOUND-12 AKA:6-[(cyclopropanecarbonyl)amino]-4-({3-[6-(dimethylcarbamoyl)pyridazin-3-yl]-2-methoxyphenyl}amino)-N-methylpyridazine-3-carboxamide	0.148	286	176	32	317	10	217	3.935E-03	78
LOKIASV2_3899_ESMFold_N-A	3zon-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3zon-assembly1.cif.gz_A Human TYK2 pseudokinase domain bound to a kinase inhibitor	0.143	287	183	31	317	15	228	3.547E-03	78
LOKIASV2_3899_ESMFold_N-A	2xyn-assembly3.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	2xyn-assembly3.cif.gz_C HUMAN ABL2 IN COMPLEX WITH AURORA KINASE INHIBITOR VX-680	0.101	283	227	32	314	8	261	1.599E-02	78
LOKIASV2_3899_ESMFold_N-A	5nxc-assembly1.cif.gz_L	LOKIASV2_3899_ESMFold_N-A	5nxc-assembly1.cif.gz_L LIM Domain Kinase 1 (LIMK1) In Complex With PF-00477736	0.115	276	230	30	305	12	272	1.442E-02	78
LOKIASV2_3899_ESMFold_N-A	1fpu-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	1fpu-assembly1.cif.gz_A CRYSTAL STRUCTURE OF ABL KINASE DOMAIN IN COMPLEX WITH A SMALL MOLECULE INHIBITOR	0.108	311	244	1	311	1	274	8.576E-03	78
LOKIASV2_3899_ESMFold_N-A	7up5-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7up5-assembly1.cif.gz_A Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound pyrrolopyrimidine compound 23 (co-crystal)	0.105	255	193	25	279	4	220	1.467E-03	78
LOKIASV2_3899_ESMFold_N-A	3h9o-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3h9o-assembly1.cif.gz_A Phosphoinositide-dependent protein kinase 1 (PDK-1) in complex with compound 9	0.140	260	194	30	289	8	234	5.660E-03	78
LOKIASV2_3899_ESMFold_N-A	4tpt-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4tpt-assembly1.cif.gz_A Crystal Structure of the Human LIMK2 Kinase Domain In Complex With a Non-ATP Competitive Inhibitor	0.116	283	210	31	313	15	252	4.598E-03	78
LOKIASV2_3899_ESMFold_N-A	7c2v-assembly1.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	7c2v-assembly1.cif.gz_C Crystal Structure of IRAK4 kinase in complex with the inhibitor CA-4948	0.119	297	246	7	303	1	280	4.145E-03	78
LOKIASV2_3899_ESMFold_N-A	4ks8-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4ks8-assembly1.cif.gz_A PAK6 kinase domain in complex with sunitinib	0.087	270	209	11	280	1	230	1.299E-02	78
LOKIASV2_3899_ESMFold_N-A	4c0t-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4c0t-assembly1.cif.gz_A Candida albicans PKh Kinase Domain	0.107	250	217	30	279	8	251	4.145E-03	78
LOKIASV2_3899_ESMFold_N-A	3eid-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3eid-assembly1.cif.gz_A CDK2/CyclinA complexed with a pyrazolopyridazine inhibitor	0.111	254	185	30	283	4	212	1.234E-02	78
LOKIASV2_3899_ESMFold_N-A	6lxy-assembly3.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	6lxy-assembly3.cif.gz_D IRAK4 in complex with inhibitor	0.119	305	255	7	311	3	292	1.056E-02	78
LOKIASV2_3899_ESMFold_N-A	4eoo-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4eoo-assembly1.cif.gz_A Thr 160 phosphorylated CDK2 Q131E - human cyclin A3 complex with ATP	0.121	254	185	30	283	6	216	1.002E-02	78
LOKIASV2_3899_ESMFold_N-A	1o6k-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	1o6k-assembly1.cif.gz_A Structure of activated form of PKB kinase domain S474D with GSK3 peptide and AMP-PNP	0.122	275	237	28	302	5	275	4.844E-03	78
LOKIASV2_3899_ESMFold_N-A	8p04-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	8p04-assembly1.cif.gz_A Crystal structure of human CLK1 in complex with Leucettinib-92	0.116	124	102	27	142	12	135	8.001E-02	78
LOKIASV2_3899_ESMFold_N-A	6una-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6una-assembly1.cif.gz_A Crystal structure of inactive p38gamma	0.111	253	180	31	283	20	222	1.518E-02	78
LOKIASV2_3899_ESMFold_N-A	6ytw-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6ytw-assembly1.cif.gz_A CLK3 bound with benzothiazole Tg003 (Cpd 2)	0.094	255	204	29	283	31	256	2.688E-02	78
LOKIASV2_3899_ESMFold_N-A	4wot-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	4wot-assembly2.cif.gz_B ROCK2 IN COMPLEX WITH 1426382-07-1	0.098	279	237	14	292	48	311	3.367E-03	78
LOKIASV2_3899_ESMFold_N-A	8ie5-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	8ie5-assembly1.cif.gz_A Crystal structure of DAPK1 in complex with oxyresveratrol	0.098	287	232	26	312	8	265	2.074E-02	77
LOKIASV2_3899_ESMFold_N-A	7jv1-assembly1.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	7jv1-assembly1.cif.gz_D Crystal Structure of KSR1:MEK1 in complex with AMP-PNP, and allosteric MEK inhibitor APS-9-95-1	0.122	274	228	28	301	12	272	9.033E-03	77
LOKIASV2_3899_ESMFold_N-A	8xfm-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	8xfm-assembly1.cif.gz_A The Crystal Structure of MNK2 from Biortus.	0.113	264	164	29	292	12	197	2.222E-03	77
LOKIASV2_3899_ESMFold_N-A	3orz-assembly4.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	3orz-assembly4.cif.gz_D PDK1 mutant bound to allosteric disulfide fragment activator 2A2	0.138	260	196	30	289	10	237	4.844E-03	77
LOKIASV2_3899_ESMFold_N-A	7qhg-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	7qhg-assembly2.cif.gz_B LIM domain kinase 2 (LIMK2) in complex with TH-470	0.124	262	165	30	291	4	192	3.736E-03	77
LOKIASV2_3899_ESMFold_N-A	6lvl-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6lvl-assembly2.cif.gz_B Crystal structure of FGFR2 in complex with 1,3,5-triazine derivative	0.097	282	246	28	309	12	284	5.102E-03	77
LOKIASV2_3899_ESMFold_N-A	1f3m-assembly1.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	1f3m-assembly1.cif.gz_C CRYSTAL STRUCTURE OF HUMAN SERINE/THREONINE KINASE PAK1	0.120	302	250	12	313	1	285	1.545E-03	77
LOKIASV2_3899_ESMFold_N-A	3kxx-assembly4.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	3kxx-assembly4.cif.gz_D Structure of the mutant Fibroblast Growth Factor receptor 1	0.106	282	237	28	309	21	286	1.171E-02	77
LOKIASV2_3899_ESMFold_N-A	4y73-assembly3.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	4y73-assembly3.cif.gz_C Crystal structure of IRAK4 kinase domain with inhibitor	0.123	278	231	33	310	27	290	6.967E-03	77
LOKIASV2_3899_ESMFold_N-A	2hak-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	2hak-assembly1.cif.gz_A Catalytic and ubiqutin-associated domains of MARK1/PAR-1	0.142	112	93	30	138	6	117	6.500E-02	77
LOKIASV2_3899_ESMFold_N-A	5r9j-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5r9j-assembly1.cif.gz_A PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N14231a in complex with MAP kinase p38-alpha	0.143	123	100	28	145	19	141	2.688E-02	77
LOKIASV2_3899_ESMFold_N-A	6yu1-assembly2.cif.gz_c	LOKIASV2_3899_ESMFold_N-A	6yu1-assembly2.cif.gz_c CLK3 bound with beta-carboline KH-CARB13 (Cpd 3)	0.136	133	106	29	152	31	163	7.596E-02	77
LOKIASV2_3899_ESMFold_N-A	2vd5-assembly1.cif.gz_A-2	LOKIASV2_3899_ESMFold_N-A	2vd5-assembly1.cif.gz_A-2 Structure of Human Myotonic Dystrophy Protein Kinase in Complex with the Bisindoylmaleide inhibitor BIM VIII	0.113	284	243	6	289	30	304	2.466E-03	77
LOKIASV2_3899_ESMFold_N-A	5otf-assembly1.cif.gz_A-2	LOKIASV2_3899_ESMFold_N-A	5otf-assembly1.cif.gz_A-2 MRCK beta in complex with BDP-00009066	0.101	279	227	2	280	44	296	3.197E-03	77
LOKIASV2_3899_ESMFold_N-A	4azw-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4azw-assembly1.cif.gz_A Crystal structure of monomeric WbdD.	0.121	229	162	39	267	229	413	1.234E-02	77
LOKIASV2_3899_ESMFold_N-A	4ax8-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4ax8-assembly1.cif.gz_A Medium resolution structure of the bifunctional kinase- methyltransferase WbdD	0.114	241	165	39	279	237	423	1.685E-02	77
LOKIASV2_3899_ESMFold_N-A	4jai-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4jai-assembly1.cif.gz_A Crystal Structure of Aurora Kinase A in complex with N-{4-[(6-oxo-5,6-dihydrobenzo[c][1,8]naphthyridin-1-yl)amino]phenyl}benzamide	0.116	281	210	30	310	8	245	1.112E-02	76
LOKIASV2_3899_ESMFold_N-A	4bic-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	4bic-assembly2.cif.gz_B Crystal Structures of Ask1-inhibitor Complexes	0.118	251	208	29	279	1	237	3.367E-03	76
LOKIASV2_3899_ESMFold_N-A	6oyw-assembly1.cif.gz_A-2	LOKIASV2_3899_ESMFold_N-A	6oyw-assembly1.cif.gz_A-2 ASK1 kinase domain in complex with Compound 11	0.126	249	209	31	279	2	241	1.056E-02	76
LOKIASV2_3899_ESMFold_N-A	8tb6-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	8tb6-assembly1.cif.gz_A TYK2 JH2 bound to Compound14	0.147	286	181	32	317	16	228	4.145E-03	76
LOKIASV2_3899_ESMFold_N-A	2v7a-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	2v7a-assembly1.cif.gz_A Crystal structure of the T315I Abl mutant in complex with the inhibitor PHA-739358	0.109	269	229	30	298	10	267	2.552E-02	76
LOKIASV2_3899_ESMFold_N-A	2xck-assembly1.cif.gz_A-2	LOKIASV2_3899_ESMFold_N-A	2xck-assembly1.cif.gz_A-2 Crystal structure of PDK1 in complex with a pyrazoloquinazoline inhibitor	0.140	260	195	30	289	7	234	1.685E-02	76
LOKIASV2_3899_ESMFold_N-A	7vdp-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	7vdp-assembly2.cif.gz_B The structure of cyclin-dependent kinase 5 (CDK5) in complex with p25 and Compound 1	0.110	253	184	31	283	1	208	1.969E-02	76
LOKIASV2_3899_ESMFold_N-A	4ypd-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4ypd-assembly1.cif.gz_A Crystal Structure of DAPK1 catalytic domain in complex with the hinge binding fragment 4-methylpyridazine	0.114	264	219	26	289	8	255	2.300E-02	76
LOKIASV2_3899_ESMFold_N-A	7eef-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7eef-assembly1.cif.gz_A Crystal structure of EphA7 mutant G656E	0.084	303	248	15	317	7	278	1.112E-02	76
LOKIASV2_3899_ESMFold_N-A	6thz-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6thz-assembly2.cif.gz_B IRAK4 IN COMPLEX WITH inhibitor	0.112	304	250	7	310	1	282	7.338E-03	76
LOKIASV2_3899_ESMFold_N-A	7atu-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	7atu-assembly2.cif.gz_B The LIMK1 Kinase Domain Bound To LIJTF500025	0.128	263	161	27	289	8	193	5.660E-03	76
LOKIASV2_3899_ESMFold_N-A	7s47-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7s47-assembly1.cif.gz_A Integrin beta5(743-774)-linker-PAK4cat(D440N/S474E)	0.093	278	229	12	289	1	254	6.614E-03	76
LOKIASV2_3899_ESMFold_N-A	7vds-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7vds-assembly1.cif.gz_A The structure of cyclin-dependent kinase 5 (CDK5) in complex with p25 and Compound 24	0.106	251	187	33	283	7	216	1.774E-02	76
LOKIASV2_3899_ESMFold_N-A	6bfn-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6bfn-assembly2.cif.gz_B Crystal structure of human IRAK1	0.124	256	154	34	289	24	200	1.056E-02	76
LOKIASV2_3899_ESMFold_N-A	4d2t-assembly4.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	4d2t-assembly4.cif.gz_D Structure of MELK in complex with inhibitors	0.098	273	208	20	292	2	233	3.935E-03	76
LOKIASV2_3899_ESMFold_N-A	4hys-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4hys-assembly1.cif.gz_A Crystal structure of JNK1 in complex with JIP1 peptide and 4-(4-Indazol-1-yl-pyrimidin-2-ylamino)-cyclohexan	0.125	248	172	28	275	17	214	1.774E-02	76
LOKIASV2_3899_ESMFold_N-A	8pqh-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	8pqh-assembly1.cif.gz_A PDGFRA T674I mutant kinase domain in complex with avapritinib	0.102	284	238	30	313	38	303	8.576E-03	76
LOKIASV2_3899_ESMFold_N-A	4dgm-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4dgm-assembly1.cif.gz_A Crystal Structure of maize CK2 in complex with the inhibitor apigenin	0.112	292	236	9	300	1	267	6.614E-03	76
LOKIASV2_3899_ESMFold_N-A	1uki-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	1uki-assembly1.cif.gz_A Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125	0.102	275	202	28	302	16	241	8.142E-03	76
LOKIASV2_3899_ESMFold_N-A	6q8p-assembly3.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	6q8p-assembly3.cif.gz_C Structure of CLK1 with bound N-methyl-10-nitropyrido[3,4-g]quinazolin-2-amine	0.108	124	103	27	142	12	135	6.171E-02	76
LOKIASV2_3899_ESMFold_N-A	4l8m-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4l8m-assembly1.cif.gz_A Human p38 MAP kinase in complex with a Dibenzoxepinone	0.138	252	176	30	281	20	224	7.338E-03	76
LOKIASV2_3899_ESMFold_N-A	1wfc-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	1wfc-assembly1.cif.gz_A STRUCTURE OF APO, UNPHOSPHORYLATED, P38 MITOGEN ACTIVATED PROTEIN KINASE P38 (P38 MAP KINASE) THE MAMMALIAN HOMOLOGUE OF THE YEAST HOG1 PROTEIN	0.155	205	121	31	235	20	163	1.442E-02	76
LOKIASV2_3899_ESMFold_N-A	5oat-assembly1.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	5oat-assembly1.cif.gz_D PINK1 structure	0.136	209	148	28	236	5	176	1.599E-02	76
LOKIASV2_3899_ESMFold_N-A	4uak-assembly1.cif.gz_A-2	LOKIASV2_3899_ESMFold_N-A	4uak-assembly1.cif.gz_A-2 MRCK beta in complex with ADP	0.106	271	219	10	280	51	296	4.145E-03	76
LOKIASV2_3899_ESMFold_N-A	5up3-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	5up3-assembly2.cif.gz_B Structure-Based Design of ASK1 Inhibitors as Potential First-in-Class Agents for Heart Failure	0.127	254	187	26	279	9	223	1.902E-03	75
LOKIASV2_3899_ESMFold_N-A	3zxt-assembly2.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	3zxt-assembly2.cif.gz_D Dimeric structure of DAPK-1 catalytic domain in complex with AMPPCP- Mg	0.105	264	158	26	289	3	179	1.869E-02	75
LOKIASV2_3899_ESMFold_N-A	5uor-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	5uor-assembly2.cif.gz_B Structure-Based Design of ASK1 Inhibitors as Potential First-in-Class Agents for Heart Failure	0.135	251	208	29	279	1	242	1.322E-03	75
LOKIASV2_3899_ESMFold_N-A	6e2o-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6e2o-assembly1.cif.gz_A ASK1 kinase domain complex with inhibitor	0.113	251	216	29	279	1	244	4.598E-03	75
LOKIASV2_3899_ESMFold_N-A	2j90-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	2j90-assembly1.cif.gz_B Crystal structure of human ZIP kinase in complex with a tetracyclic pyridone inhibitor (Pyridone 6)	0.126	261	209	29	289	1	240	4.290E-02	75
LOKIASV2_3899_ESMFold_N-A	5a6n-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5a6n-assembly1.cif.gz_A Crystal structure of human death associated protein kinase 3 (DAPK3) in complex with compound 2	0.108	264	179	26	289	2	203	8.576E-03	75
LOKIASV2_3899_ESMFold_N-A	4eor-assembly2.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	4eor-assembly2.cif.gz_C Thr 160 phosphorylated CDK2 WT - human cyclin A3 complex with the inhibitor NU6102	0.117	281	226	27	307	2	258	2.184E-02	75
LOKIASV2_3899_ESMFold_N-A	5kkr-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	5kkr-assembly1.cif.gz_B KSR2:MEK1 Complex Bound to the Small Molecule APS-2-79	0.103	275	229	28	302	15	270	1.234E-02	75
LOKIASV2_3899_ESMFold_N-A	4wnp-assembly3.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	4wnp-assembly3.cif.gz_C Structure of ULK1 bound to a potent inhibitor	0.126	250	214	30	279	7	252	1.299E-02	75
LOKIASV2_3899_ESMFold_N-A	5auw-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5auw-assembly1.cif.gz_A Crystal structure of DAPK1 in complex with quercetin.	0.112	264	218	26	289	8	253	3.485E-02	75
LOKIASV2_3899_ESMFold_N-A	3ion-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3ion-assembly1.cif.gz_A PDK1 in complex with Compound 8h	0.109	260	200	30	289	8	232	1.518E-02	75
LOKIASV2_3899_ESMFold_N-A	5lvp-assembly4.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	5lvp-assembly4.cif.gz_D Human PDK1 Kinase Domain in Complex with an HM-Peptide Bound to the PIF-Pocket	0.126	260	198	30	289	9	235	8.142E-03	75
LOKIASV2_3899_ESMFold_N-A	3orx-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	3orx-assembly2.cif.gz_B PDK1 mutant bound to allosteric disulfide fragment inhibitor 1F8	0.128	260	203	30	289	6	239	1.969E-02	75
LOKIASV2_3899_ESMFold_N-A	6thw-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6thw-assembly2.cif.gz_B IRAK4 in complex with inhibitor	0.121	304	245	7	310	1	280	1.171E-02	75
LOKIASV2_3899_ESMFold_N-A	8dks-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	8dks-assembly1.cif.gz_A IRAK4 IN COMPLEX WITH COMPOUND #3	0.120	287	230	25	311	21	282	1.171E-02	75
LOKIASV2_3899_ESMFold_N-A	7qhg-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7qhg-assembly1.cif.gz_A LIM domain kinase 2 (LIMK2) in complex with TH-470	0.115	261	203	29	289	2	231	7.730E-03	75
LOKIASV2_3899_ESMFold_N-A	6o8u-assembly4.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	6o8u-assembly4.cif.gz_D Crystal structure of IRAK4 in complex with compound 23	0.112	285	187	5	289	1	212	1.369E-02	75
LOKIASV2_3899_ESMFold_N-A	4d2t-assembly3.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	4d2t-assembly3.cif.gz_B Structure of MELK in complex with inhibitors	0.112	281	170	12	292	1	192	5.374E-03	75
LOKIASV2_3899_ESMFold_N-A	6qy8-assembly4.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	6qy8-assembly4.cif.gz_D Human CSNK2A2 bound to ERB-041	0.110	274	209	27	300	30	265	1.171E-02	75
LOKIASV2_3899_ESMFold_N-A	6l23-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6l23-assembly1.cif.gz_A Crystal structure of CK2a1 V116I with hematein	0.099	280	227	21	300	20	272	1.685E-02	75
LOKIASV2_3899_ESMFold_N-A	4zhx-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4zhx-assembly1.cif.gz_A Novel binding site for allosteric activation of AMPK	0.115	213	132	28	240	6	155	2.832E-02	75
LOKIASV2_3899_ESMFold_N-A	6qat-assembly1.cif.gz_B-2	LOKIASV2_3899_ESMFold_N-A	6qat-assembly1.cif.gz_B-2 Crystal structure of ULK2 in complexed with hesperadin	0.126	247	180	33	279	17	223	3.671E-02	74
LOKIASV2_3899_ESMFold_N-A	6xih-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6xih-assembly2.cif.gz_B Structure-guided optimization of a novel class of ASK1 inhibitors with increased sp3 character and an exquisite selectivity profile	0.127	249	196	31	279	2	226	1.685E-02	74
LOKIASV2_3899_ESMFold_N-A	4ztq-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4ztq-assembly1.cif.gz_A Human Aurora A catalytic domain bound to FK932	0.126	281	208	30	310	7	245	1.685E-02	74
LOKIASV2_3899_ESMFold_N-A	4l7s-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4l7s-assembly1.cif.gz_A Kinase domain mutant of human Itk in complex with an aminobenzothiazole inhibitor	0.107	277	206	32	308	12	243	1.969E-02	74
LOKIASV2_3899_ESMFold_N-A	5one-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5one-assembly1.cif.gz_A Crystal structure of Aurora-A in complex with FMF-03-145-1 (compound 2)	0.118	262	194	28	289	10	230	8.576E-03	74
LOKIASV2_3899_ESMFold_N-A	6xih-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6xih-assembly1.cif.gz_A Structure-guided optimization of a novel class of ASK1 inhibitors with increased sp3 character and an exquisite selectivity profile	0.140	249	202	31	279	2	237	1.234E-02	74
LOKIASV2_3899_ESMFold_N-A	4p2k-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4p2k-assembly1.cif.gz_A Structure of Ephrin type-A receptor 2	0.123	289	216	25	313	11	257	5.102E-03	74
LOKIASV2_3899_ESMFold_N-A	3dog-assembly1.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	3dog-assembly1.cif.gz_C Structure of Thr 160 phosphorylated CDK2/cyclin A in complex with the inhibitor N-&-N1	0.130	282	218	27	308	2	253	2.423E-02	74
LOKIASV2_3899_ESMFold_N-A	7jv0-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7jv0-assembly1.cif.gz_A Crystal Structure of KSR1:MEK1 in complex with AMP-PNP, and allosteric MEK inhibitor PD0325901	0.120	274	231	28	301	11	273	5.660E-03	74
LOKIASV2_3899_ESMFold_N-A	7eec-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7eec-assembly1.cif.gz_A Crystal structure of EphA7 mutant G656R	0.089	292	227	26	317	23	272	2.832E-02	74
LOKIASV2_3899_ESMFold_N-A	3kn6-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3kn6-assembly1.cif.gz_A Crystal structure of the C-terminal kinase domain of MSK1	0.095	255	196	25	279	4	221	5.660E-03	74
LOKIASV2_3899_ESMFold_N-A	5k76-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	5k76-assembly2.cif.gz_B IRAK4 in complex with Compound 28	0.119	256	156	34	289	28	205	1.112E-02	74
LOKIASV2_3899_ESMFold_N-A	3kfa-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3kfa-assembly1.cif.gz_A Structural analysis of DFG-in and DFG-out dual Src-Abl inhibitors sharing a common vinyl purine template	0.108	278	239	30	307	15	283	1.442E-02	74
LOKIASV2_3899_ESMFold_N-A	3we4-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3we4-assembly1.cif.gz_A Crystal structure of S6K1 kinase domain in complex with a pyrimidine derivative PF-4708671 2-{[4-(5-ethylpyrimidin-4-yl)piperazin-1-yl]methyl}-5-(trifluoromethyl)-1H-benzimidazole	0.131	250	203	30	279	7	241	1.056E-02	74
LOKIASV2_3899_ESMFold_N-A	1ung-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	1ung-assembly1.cif.gz_A Structural mechanism for the inhibition of CDK5-p25 by roscovitine, aloisine and indirubin.	0.101	254	188	30	283	4	213	2.074E-02	74
LOKIASV2_3899_ESMFold_N-A	2nru-assembly3.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	2nru-assembly3.cif.gz_C Crystal structure of IRAK-4	0.124	288	251	17	303	7	294	1.518E-02	74
LOKIASV2_3899_ESMFold_N-A	4mao-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4mao-assembly1.cif.gz_A RSK2 T493M C-Terminal Kinase Domain in Complex with RMM58	0.124	293	250	27	312	5	297	2.074E-02	74
LOKIASV2_3899_ESMFold_N-A	4nus-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4nus-assembly1.cif.gz_A Rsk2 N-terminal kinase in complex with LJH685	0.110	261	210	29	289	15	251	1.599E-02	74
LOKIASV2_3899_ESMFold_N-A	4d2v-assembly2.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	4d2v-assembly2.cif.gz_D Structure of MELK in complex with inhibitors	0.114	298	221	20	317	2	251	4.598E-03	74
LOKIASV2_3899_ESMFold_N-A	4ekk-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4ekk-assembly1.cif.gz_A Akt1 with AMP-PNP	0.115	275	240	28	302	5	276	5.374E-03	74
LOKIASV2_3899_ESMFold_N-A	3bv2-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3bv2-assembly1.cif.gz_A Morpholino pyrrolotriazine P38 Alpha map kinase inhibitor compound 30	0.139	252	175	30	281	20	223	1.774E-02	74
LOKIASV2_3899_ESMFold_N-A	3ptg-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3ptg-assembly1.cif.gz_A Design and Synthesis of a Novel, Orally Efficacious Tri-substituted Thiophene Based JNK Inhibitor	0.130	248	173	28	275	17	216	1.969E-02	74
LOKIASV2_3899_ESMFold_N-A	7o7i-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7o7i-assembly1.cif.gz_A Crystal structure of the human HIPK3 kinase domain	0.125	256	193	28	283	10	230	1.369E-02	74
LOKIASV2_3899_ESMFold_N-A	6c9j-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6c9j-assembly1.cif.gz_A AMP-activated protein kinase bound to pharmacological activator R734	0.112	213	132	28	240	6	155	2.983E-02	74
LOKIASV2_3899_ESMFold_N-A	6b2e-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6b2e-assembly1.cif.gz_A Structure of full length human AMPK (a2b2g1) in complex with a small molecule activator SC4.	0.112	252	209	28	279	6	241	1.112E-02	74
LOKIASV2_3899_ESMFold_N-A	7k7l-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7k7l-assembly1.cif.gz_A Structure of a hit for G Protein Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure	0.121	280	243	13	289	121	400	1.685E-02	74
LOKIASV2_3899_ESMFold_N-A	6yid-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6yid-assembly1.cif.gz_A Crystal structure of ULK2 in complex with SBI-0206965	0.141	253	198	28	280	6	237	2.688E-02	73
LOKIASV2_3899_ESMFold_N-A	6e2n-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6e2n-assembly1.cif.gz_A ASK1 kinase domain complex with inhibitor	0.116	251	215	29	279	1	244	4.366E-03	73
LOKIASV2_3899_ESMFold_N-A	6bl8-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6bl8-assembly2.cif.gz_B Predicting the Conformational Variability of Abl Tyrosine Kinase Using Molecular Dynamics Simulations and Markov State Models	0.107	268	225	30	297	10	262	2.552E-02	73
LOKIASV2_3899_ESMFold_N-A	5hu9-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5hu9-assembly1.cif.gz_A Crystal structure of ABL1 in complex with CHMFL-074	0.109	260	202	32	291	18	245	1.969E-02	73
LOKIASV2_3899_ESMFold_N-A	5nka-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5nka-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 2g	0.112	287	217	29	315	10	254	5.102E-03	73
LOKIASV2_3899_ESMFold_N-A	6iuo-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6iuo-assembly1.cif.gz_A Crystal structure of FGFR4 kinase domain in complex with a covalent inhibitor	0.113	281	223	28	308	22	273	1.369E-02	73
LOKIASV2_3899_ESMFold_N-A	5lvp-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	5lvp-assembly2.cif.gz_B Human PDK1 Kinase Domain in Complex with an HM-Peptide Bound to the PIF-Pocket	0.126	265	200	25	289	6	235	1.599E-02	73
LOKIASV2_3899_ESMFold_N-A	1h1w-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	1h1w-assembly1.cif.gz_A High resolution crystal structure of the human PDK1 catalytic domain	0.135	260	200	30	289	12	243	1.599E-02	73
LOKIASV2_3899_ESMFold_N-A	5k7g-assembly4.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	5k7g-assembly4.cif.gz_D IRAK4 in complex with AZ3862	0.126	274	220	37	310	32	284	1.056E-02	73
LOKIASV2_3899_ESMFold_N-A	2nry-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	2nry-assembly2.cif.gz_B Crystal structure of IRAK-4	0.103	304	256	7	310	1	286	1.518E-02	73
LOKIASV2_3899_ESMFold_N-A	3lq5-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3lq5-assembly1.cif.gz_A Structure of CDK9/CyclinT in complex with S-CR8	0.092	255	192	30	284	14	225	4.290E-02	73
LOKIASV2_3899_ESMFold_N-A	5mag-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5mag-assembly1.cif.gz_A Crystal structure of MELK in complex with an inhibitor	0.129	273	156	20	292	2	181	1.112E-02	73
LOKIASV2_3899_ESMFold_N-A	2xh5-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	2xh5-assembly1.cif.gz_A Structure of 4-(4-tert-Butylbenzyl)-1-(7H-pyrrolo(2,3-d)pyrimidin-4- yl)piperidin-4-amine bound to PKB	0.120	271	233	32	302	10	275	1.171E-02	73
LOKIASV2_3899_ESMFold_N-A	6qy8-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6qy8-assembly1.cif.gz_A Human CSNK2A2 bound to ERB-041	0.119	274	207	27	300	30	265	1.442E-02	73
LOKIASV2_3899_ESMFold_N-A	6qx9-assembly1.cif.gz_K	LOKIASV2_3899_ESMFold_N-A	6qx9-assembly1.cif.gz_K Structure of a human fully-assembled precatalytic spliceosome (pre-B complex).	0.117	253	164	38	290	22	208	2.341E-03	73
LOKIASV2_3899_ESMFold_N-A	3d0e-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3d0e-assembly1.cif.gz_A Crystal structure of human Akt2 in complex with GSK690693	0.125	275	236	28	302	5	275	1.234E-02	73
LOKIASV2_3899_ESMFold_N-A	6r6e-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6r6e-assembly1.cif.gz_A Crystal structure of di-phosphorylated human CLK1 in complex with 5-(6,7-dichloro-1-methyl-1H-indol-3-yl)pyrimidin-4-amine	0.111	117	100	27	139	6	122	6.847E-02	73
LOKIASV2_3899_ESMFold_N-A	6fyv-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6fyv-assembly1.cif.gz_A X-RAY STRUCTURE OF CLK4-KD(146-480)/CX-4945 AT 2.46A	0.125	121	98	29	141	11	131	1.212E-01	73
LOKIASV2_3899_ESMFold_N-A	4r3c-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4r3c-assembly1.cif.gz_A Crystal structure of p38 alpha MAP kinase in complex with a novel isoform selective drug candidate	0.137	254	173	30	283	21	221	6.967E-03	73
LOKIASV2_3899_ESMFold_N-A	4nif-assembly1.cif.gz_E	LOKIASV2_3899_ESMFold_N-A	4nif-assembly1.cif.gz_E Heterodimeric structure of ERK2 and RSK1	0.118	256	191	28	283	14	230	1.599E-02	73
LOKIASV2_3899_ESMFold_N-A	6ynb-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6ynb-assembly1.cif.gz_A Crystal structure of cAMP-dependent Protein Kinase (PKA) in complex with short-chain Fasudil-derivative N-(2-aminoethyl)isoquinoline-5-sulfonamide (soaked)	0.127	279	219	14	292	19	270	8.142E-03	73
LOKIASV2_3899_ESMFold_N-A	5t5t-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5t5t-assembly1.cif.gz_A AMPK bound to allosteric activator	0.104	255	223	28	282	6	255	1.518E-02	73
LOKIASV2_3899_ESMFold_N-A	3og7-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3og7-assembly1.cif.gz_A B-Raf Kinase V600E oncogenic mutant in complex with PLX4032	0.138	276	204	28	303	7	244	2.832E-02	72
LOKIASV2_3899_ESMFold_N-A	6e2o-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6e2o-assembly1.cif.gz_B ASK1 kinase domain complex with inhibitor	0.122	249	191	31	279	12	230	5.962E-03	72
LOKIASV2_3899_ESMFold_N-A	5jrs-assembly2.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5jrs-assembly2.cif.gz_A CRYSTAL STRUCTURE OF BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE COMPLEXED WITH 4-[2-FLUORO-3-(4-OXO -3,4-DIHYDROQUINAZOLIN-3-YL)PHENYL]-7-(2-HYDROXYPROPAN-2-Y L)-9H-CARBAZOLE-1-CARBOXAMIDE	0.109	283	223	26	308	4	254	1.518E-02	72
LOKIASV2_3899_ESMFold_N-A	4rlp-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4rlp-assembly1.cif.gz_A Human p70s6k1 with ruthenium-based inhibitor FL772	0.123	263	199	30	292	7	234	1.969E-02	72
LOKIASV2_3899_ESMFold_N-A	7cc2-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	7cc2-assembly2.cif.gz_B Strategic design of catalytic lysine-targeting reversible covalent BCR-ABL Inhibitors	0.098	269	228	30	298	11	264	2.184E-02	72
LOKIASV2_3899_ESMFold_N-A	3ma6-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3ma6-assembly1.cif.gz_A Crystal structure of kinase domain of TgCDPK1 in presence of 3BrB-PP1	0.107	281	227	27	307	3	257	1.234E-02	72
LOKIASV2_3899_ESMFold_N-A	1fpu-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	1fpu-assembly2.cif.gz_B CRYSTAL STRUCTURE OF ABL KINASE DOMAIN IN COMPLEX WITH A SMALL MOLECULE INHIBITOR	0.120	280	221	32	311	18	269	2.074E-02	72
LOKIASV2_3899_ESMFold_N-A	5o26-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5o26-assembly1.cif.gz_A Crystal structure of WNK3 kinase domain in a diphosphorylated state and in complex with AMP-PNP/Mg2+	0.104	252	202	34	285	18	244	1.369E-02	72
LOKIASV2_3899_ESMFold_N-A	5wax-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	5wax-assembly2.cif.gz_B Crystal Structure of Sugarcane SAPK10 (serine/threonine-protein kinase 10)	0.127	111	93	32	142	10	116	2.983E-02	72
LOKIASV2_3899_ESMFold_N-A	4l00-assembly3.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4l00-assembly3.cif.gz_A Crystal structure of the apo Jak1 pseudokinase domain	0.112	281	223	33	313	24	275	2.736E-03	72
LOKIASV2_3899_ESMFold_N-A	3ik3-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3ik3-assembly1.cif.gz_A AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance	0.108	281	224	32	312	15	266	2.074E-02	72
LOKIASV2_3899_ESMFold_N-A	2pzr-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	2pzr-assembly1.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K641R Mutation Responsible for Pfeiffer Syndrome	0.096	278	239	32	309	14	278	1.056E-02	72
LOKIASV2_3899_ESMFold_N-A	6f3i-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6f3i-assembly2.cif.gz_B IRAK4 IN COMPLEX WITH inhibitor	0.109	304	249	7	310	1	280	9.033E-03	72
LOKIASV2_3899_ESMFold_N-A	2qoh-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	2qoh-assembly2.cif.gz_B Crystal Structure of Abl kinase bound with PPY-A	0.107	276	237	32	307	15	280	1.171E-02	72
LOKIASV2_3899_ESMFold_N-A	5okt-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5okt-assembly1.cif.gz_A Crystal structure of human Casein Kinase I delta in complex with IWP-2	0.114	287	235	28	314	4	269	1.171E-02	72
LOKIASV2_3899_ESMFold_N-A	5say-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	5say-assembly2.cif.gz_B DDR1, N-[2-[3-(2-aminopyrimidin-5-yl)oxyphenyl]ethyl]-3-(trifluoromethoxy)benzamide, 2.190A, P1211, Rfree=27.7%	0.130	254	199	25	278	5	234	1.518E-02	72
LOKIASV2_3899_ESMFold_N-A	8g66-assembly1.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	8g66-assembly1.cif.gz_C Structure with SJ3149	0.090	289	246	29	317	7	277	3.935E-03	72
LOKIASV2_3899_ESMFold_N-A	5hvk-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5hvk-assembly1.cif.gz_A Crystal structure of LIMK1 mutant D460N in complex with full-length cofilin-1	0.126	265	169	25	289	13	206	1.969E-02	72
LOKIASV2_3899_ESMFold_N-A	6bfn-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6bfn-assembly1.cif.gz_A Crystal structure of human IRAK1	0.120	279	172	11	289	8	204	6.967E-03	72
LOKIASV2_3899_ESMFold_N-A	4nif-assembly1.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	4nif-assembly1.cif.gz_D Heterodimeric structure of ERK2 and RSK1	0.145	277	222	27	303	3	263	7.730E-03	72
LOKIASV2_3899_ESMFold_N-A	6cnh-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6cnh-assembly1.cif.gz_A Human PRPF4B in complex with Rebastinib	0.121	255	178	29	283	23	226	4.598E-03	72
LOKIASV2_3899_ESMFold_N-A	6yqk-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6yqk-assembly1.cif.gz_A Crystal structure of cAMP-dependent Protein Kinase (PKA) in complex with a methylisoquinoline Fasudil-derivative (soaked)	0.126	279	219	14	292	19	270	9.033E-03	72
LOKIASV2_3899_ESMFold_N-A	6yty-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6yty-assembly1.cif.gz_A CLK3 A319V mutant bound with benzothiazole Tg003 (Cpd 2)	0.122	133	108	29	152	29	161	7.596E-02	72
LOKIASV2_3899_ESMFold_N-A	6fad-assembly3.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	6fad-assembly3.cif.gz_C SR protein kinase 1 (SRPK1) in complex with the RGG-box of HSV1 ICP27	0.170	130	96	29	145	25	154	3.671E-02	72
LOKIASV2_3899_ESMFold_N-A	3tku-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	3tku-assembly1.cif.gz_B MRCK beta in complex with fasudil	0.098	272	222	14	285	52	298	2.881E-03	72
LOKIASV2_3899_ESMFold_N-A	7mp8-assembly1.cif.gz_A-2	LOKIASV2_3899_ESMFold_N-A	7mp8-assembly1.cif.gz_A-2 Crystal structure of the cytosolic domain of Tribolium castaneum PINK1 in the non-phosphorylated state	0.121	223	166	14	236	22	211	2.423E-02	72
LOKIASV2_3899_ESMFold_N-A	5t6i-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5t6i-assembly1.cif.gz_A CRYSTAL STRUCTURE OF TGCDPK1 FROM TOXOPLASMA GONDII COMPLEXED WITH 5GB	0.099	285	235	27	311	5	266	9.033E-03	72
LOKIASV2_3899_ESMFold_N-A	4ieb-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4ieb-assembly1.cif.gz_A Crystal Structure of a Gly128Met mutant of the toxoplasma CDPK, TGME49_101440	0.130	281	218	27	307	17	268	1.969E-02	72
LOKIASV2_3899_ESMFold_N-A	8jpd-assembly1.cif.gz_G	LOKIASV2_3899_ESMFold_N-A	8jpd-assembly1.cif.gz_G Focused refinement structure of GRK2 in NTSR1-GRK2-Galpha(q) complexes	0.130	275	228	28	290	188	462	5.962E-03	72
LOKIASV2_3899_ESMFold_N-A	6tu9-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6tu9-assembly2.cif.gz_B The ROR1 Pseudokinase Domain Bound To Ponatinib	0.098	306	232	8	313	1	258	1.685E-02	71
LOKIASV2_3899_ESMFold_N-A	7dt2-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7dt2-assembly1.cif.gz_A Strategic design of catalytic lysine-targeting reversible covalent BCR-ABL Inhibitors	0.106	281	227	32	312	10	264	2.184E-02	71
LOKIASV2_3899_ESMFold_N-A	2g2i-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	2g2i-assembly2.cif.gz_B A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domain	0.104	268	226	30	297	11	263	2.300E-02	71
LOKIASV2_3899_ESMFold_N-A	2x9f-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	2x9f-assembly1.cif.gz_A ephB4 kinase domain inhibitor complex	0.094	287	229	26	312	4	257	1.171E-02	71
LOKIASV2_3899_ESMFold_N-A	3dk3-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3dk3-assembly1.cif.gz_A Crystal structure of mutant ABL kinase domain in complex with small molecule fragment	0.111	267	225	32	298	10	263	1.774E-02	71
LOKIASV2_3899_ESMFold_N-A	7b8w-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	7b8w-assembly2.cif.gz_B Structure of LIMK1 Kinase domain with allosteric inhibitor TH-470	0.118	273	228	33	305	14	273	1.369E-02	71
LOKIASV2_3899_ESMFold_N-A	8fjz-assembly2.cif.gz_F-2	LOKIASV2_3899_ESMFold_N-A	8fjz-assembly2.cif.gz_F-2 Crystal structure of HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with 3-{4-[(3R,5S)-3-Amino-5-methylpiperidin-1-yl]-6-chloro-7H-pyrrolo[2,3-d]pyrimidin-5-yl}benzonitrile	0.118	264	165	26	289	5	192	2.423E-02	71
LOKIASV2_3899_ESMFold_N-A	5x1s-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5x1s-assembly1.cif.gz_A PpkA-294 with Amppcp	0.119	262	185	28	289	11	221	1.056E-02	71
LOKIASV2_3899_ESMFold_N-A	1oky-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	1oky-assembly1.cif.gz_A Structure of human PDK1 kinase domain in complex with staurosporine	0.127	260	200	30	289	11	240	6.967E-03	71
LOKIASV2_3899_ESMFold_N-A	4eoi-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4eoi-assembly1.cif.gz_A Thr 160 phosphorylated CDK2 K89D, Q131E - human cyclin A3 complex with the inhibitor RO3306	0.112	257	188	27	283	2	214	1.869E-02	71
LOKIASV2_3899_ESMFold_N-A	4uv0-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4uv0-assembly1.cif.gz_A Structure of a semisynthetic phosphorylated DAPK	0.105	292	236	26	317	7	271	9.514E-03	71
LOKIASV2_3899_ESMFold_N-A	6b3e-assembly2.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	6b3e-assembly2.cif.gz_C Crystal structure of human CDK12/CyclinK in complex with an inhibitor	0.145	256	184	28	283	7	222	1.599E-02	71
LOKIASV2_3899_ESMFold_N-A	4d2t-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4d2t-assembly1.cif.gz_A Structure of MELK in complex with inhibitors	0.125	271	160	22	292	2	185	9.514E-03	71
LOKIASV2_3899_ESMFold_N-A	4iir-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4iir-assembly1.cif.gz_A Crystal Structure of AMPPNP-bound Human PRPF4B kinase domain	0.116	256	191	28	283	18	234	4.145E-03	71
LOKIASV2_3899_ESMFold_N-A	7pvu-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7pvu-assembly1.cif.gz_A Crystal structure of p38alpha C162S in complex with CAS2094511-69-8, P 1 21 1	0.151	256	172	28	283	18	221	1.518E-02	71
LOKIASV2_3899_ESMFold_N-A	6xdf-assembly3.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6xdf-assembly3.cif.gz_B Crystal structure of IRE1a in complex with G-4100	0.098	273	219	28	300	6	249	2.423E-02	71
LOKIASV2_3899_ESMFold_N-A	7mp9-assembly1.cif.gz_A-2	LOKIASV2_3899_ESMFold_N-A	7mp9-assembly1.cif.gz_A-2 Crystal structure of the cytosolic domain of Tribolium castaneum PINK1 phosphorylated at Ser205 in complex with ADP analog	0.097	223	171	14	236	22	211	2.832E-02	71
LOKIASV2_3899_ESMFold_N-A	4rer-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4rer-assembly1.cif.gz_A Crystal structure of the phosphorylated human alpha1 beta2 gamma1 holo-AMPK complex bound to AMP and cyclodextrin	0.109	257	210	33	289	1	237	7.338E-03	71
LOKIASV2_3899_ESMFold_N-A	3qgw-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3qgw-assembly1.cif.gz_A Crystal Structure of ITK kinase bound to an inhibitor	0.091	281	214	28	308	4	239	5.014E-02	70
LOKIASV2_3899_ESMFold_N-A	6e2n-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6e2n-assembly1.cif.gz_B ASK1 kinase domain complex with inhibitor	0.127	264	200	29	292	1	230	8.576E-03	70
LOKIASV2_3899_ESMFold_N-A	7n9g-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7n9g-assembly1.cif.gz_A Crystal structure of the Abl 1b Kinase domain in complex with Dasatinib and Imatinib	0.098	265	216	32	296	10	249	2.552E-02	70
LOKIASV2_3899_ESMFold_N-A	3is5-assembly1.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	3is5-assembly1.cif.gz_C Crystal structure of CDPK kinase domain from toxoplasma Gondii, TGME49_018720	0.117	263	164	30	292	11	197	3.485E-02	70
LOKIASV2_3899_ESMFold_N-A	4xey-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4xey-assembly1.cif.gz_A Crystal structure of an SH2-kinase domain construct of c-Abl tyrosine kinase	0.097	269	228	30	298	12	265	4.290E-02	70
LOKIASV2_3899_ESMFold_N-A	4uya-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4uya-assembly1.cif.gz_A Structure of MLK4 kinase domain with ATPgammaS	0.121	278	231	29	306	9	272	3.197E-03	70
LOKIASV2_3899_ESMFold_N-A	2g2f-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	2g2f-assembly1.cif.gz_A A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domain	0.116	283	227	30	312	11	268	2.983E-02	70
LOKIASV2_3899_ESMFold_N-A	8fko-assembly3.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	8fko-assembly3.cif.gz_D Crystal structure of HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with 3-{4-[(2S,5R)-5-Amino-2-methylpiperidin-1-yl]-6-chloro-7H-pyrrolo[2,3-d]pyrimidin-5-yl}benzonitrile	0.120	266	164	24	289	9	195	2.552E-02	70
LOKIASV2_3899_ESMFold_N-A	3sc1-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3sc1-assembly1.cif.gz_A Novel Isoquinolone PDK1 Inhibitors Discovered through Fragment-Based Lead Discovery	0.107	260	203	30	289	10	237	1.869E-02	70
LOKIASV2_3899_ESMFold_N-A	3hrc-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3hrc-assembly1.cif.gz_A Crystal structure of a mutant of human PDK1 Kinase domain in complex with ATP	0.123	260	203	30	289	7	238	2.184E-02	70
LOKIASV2_3899_ESMFold_N-A	5i9u-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5i9u-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase	0.101	287	224	29	315	14	263	3.485E-02	70
LOKIASV2_3899_ESMFold_N-A	5w85-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5w85-assembly1.cif.gz_A CRYSTAL STRUCTURE OF IRAK-4 WITH A 4,6-DIAMINONICOTINAMIDE INHIBITOR (COMPOUND NUMBER 9)	0.116	277	223	34	310	28	280	1.685E-02	70
LOKIASV2_3899_ESMFold_N-A	5x18-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	5x18-assembly2.cif.gz_B Crystal structure of Casein kinase I homolog 1	0.107	288	246	30	317	8	284	1.299E-02	70
LOKIASV2_3899_ESMFold_N-A	2bdw-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	2bdw-assembly1.cif.gz_B Crystal Structure of the Auto-Inhibited Kinase Domain of Calcium/Calmodulin Activated Kinase II	0.100	263	217	27	289	2	243	2.832E-02	70
LOKIASV2_3899_ESMFold_N-A	1ukh-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	1ukh-assembly1.cif.gz_A Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125	0.110	251	174	28	278	16	211	8.576E-03	70
LOKIASV2_3899_ESMFold_N-A	3u87-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3u87-assembly1.cif.gz_A Structure of a chimeric construct of human CK2alpha and human CK2alpha' in complex with a non-hydrolysable ATP-analogue	0.097	274	214	27	300	35	272	2.423E-02	70
LOKIASV2_3899_ESMFold_N-A	6xx7-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6xx7-assembly1.cif.gz_A Arabidopsis thaliana Casein Kinase 2 (CK2) alpha-1 crystal in complex with ANP	0.116	298	219	3	300	20	268	1.969E-02	70
LOKIASV2_3899_ESMFold_N-A	6yqi-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6yqi-assembly1.cif.gz_A Crystal structure of cAMP-dependent Protein Kinase (PKA) in complex with long-chain Fasudil-derivative N-[2-(propylamino)ethyl]isoquinoline-5-sulfonamide (soaked)	0.130	279	218	14	292	19	269	1.234E-02	70
LOKIASV2_3899_ESMFold_N-A	3cd3-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3cd3-assembly1.cif.gz_A Crystal structure of phosphorylated human feline sarcoma viral oncogene homologue (v-FES) in complex with staurosporine and a consensus peptide	0.106	291	258	16	305	62	352	1.171E-02	70
LOKIASV2_3899_ESMFold_N-A	6fad-assembly4.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	6fad-assembly4.cif.gz_D SR protein kinase 1 (SRPK1) in complex with the RGG-box of HSV1 ICP27	0.123	250	214	29	278	25	269	3.309E-02	70
LOKIASV2_3899_ESMFold_N-A	7kpx-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7kpx-assembly1.cif.gz_A Structure of the yeast CKM	0.152	272	215	7	278	2	255	7.338E-03	70
LOKIASV2_3899_ESMFold_N-A	6c9f-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6c9f-assembly1.cif.gz_A AMP-activated protein kinase bound to pharmacological activator R734	0.127	246	203	34	279	8	241	7.338E-03	70
LOKIASV2_3899_ESMFold_N-A	8q61-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	8q61-assembly1.cif.gz_A Co-crystal structure of human AKT2 with compound 3	0.119	293	249	11	303	87	370	5.374E-03	70
LOKIASV2_3899_ESMFold_N-A	6c9h-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6c9h-assembly1.cif.gz_A non-phosphorylated AMP-activated protein kinase bound to pharmacological activator R734	0.114	308	254	28	315	6	313	1.112E-02	70
LOKIASV2_3899_ESMFold_N-A	5tkd-assembly3.cif.gz_A-2	LOKIASV2_3899_ESMFold_N-A	5tkd-assembly3.cif.gz_A-2 CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH 6-[(3,5-DIMETHYLPHE NYL)AMINO]-8- (METHYLAMINO)IMIDAZO[1,2-B]PYRIDAZINE-3-CARBO XAMIDE	0.122	247	178	32	278	9	212	5.660E-03	69
LOKIASV2_3899_ESMFold_N-A	6c2t-assembly1.cif.gz_A-2	LOKIASV2_3899_ESMFold_N-A	6c2t-assembly1.cif.gz_A-2 Aurora A ligand complex	0.120	281	216	30	310	6	251	3.671E-02	69
LOKIASV2_3899_ESMFold_N-A	3vw6-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3vw6-assembly1.cif.gz_A Crystal structure of human apoptosis signal-regulating kinase 1 (ASK1) with imidazopyridine inhibitor	0.116	251	206	29	279	2	235	9.033E-03	69
LOKIASV2_3899_ESMFold_N-A	4aoj-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4aoj-assembly1.cif.gz_A Human TrkA in complex with the inhibitor AZ-23	0.105	282	220	30	311	11	257	1.369E-02	69
LOKIASV2_3899_ESMFold_N-A	6oyw-assembly1.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	6oyw-assembly1.cif.gz_C ASK1 kinase domain in complex with Compound 11	0.104	259	204	31	289	12	240	7.338E-03	69
LOKIASV2_3899_ESMFold_N-A	3hmi-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3hmi-assembly1.cif.gz_A The crystal structure of human ABL2 in complex with 5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE	0.108	267	229	32	298	10	267	3.867E-02	69
LOKIASV2_3899_ESMFold_N-A	2vwi-assembly1.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	2vwi-assembly1.cif.gz_C Structure of the OSR1 kinase, a hypertension drug target	0.113	264	177	26	289	7	207	1.002E-02	69
LOKIASV2_3899_ESMFold_N-A	1uu9-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	1uu9-assembly1.cif.gz_A Structure of human PDK1 kinase domain in complex with BIM-3	0.137	260	195	30	289	11	237	1.518E-02	69
LOKIASV2_3899_ESMFold_N-A	2o8y-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	2o8y-assembly1.cif.gz_A Apo IRAK4 Kinase Domain	0.124	278	221	34	311	27	279	2.300E-02	69
LOKIASV2_3899_ESMFold_N-A	5ho7-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5ho7-assembly1.cif.gz_A DISCOVERY OF NOVEL 7-AZAINDOLES AS PDK1 INHIBITORS	0.115	260	201	30	289	12	239	2.688E-02	69
LOKIASV2_3899_ESMFold_N-A	3orx-assembly4.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	3orx-assembly4.cif.gz_D PDK1 mutant bound to allosteric disulfide fragment inhibitor 1F8	0.112	260	208	30	289	7	241	2.184E-02	69
LOKIASV2_3899_ESMFold_N-A	5mrd-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5mrd-assembly1.cif.gz_A Human PDK1-PKCiota Kinase Chimera in Complex with Allosteric Compound PS267 Bound to the PIF-Pocket	0.119	274	206	30	303	7	241	1.774E-02	69
LOKIASV2_3899_ESMFold_N-A	2iw6-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	2iw6-assembly1.cif.gz_A STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR	0.103	257	191	27	283	2	215	3.485E-02	69
LOKIASV2_3899_ESMFold_N-A	1zmu-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	1zmu-assembly1.cif.gz_A Catalytic and ubiqutin-associated domains of MARK2/PAR-1: Wild type	0.146	263	180	30	292	3	214	1.171E-02	69
LOKIASV2_3899_ESMFold_N-A	7ukz-assembly3.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	7ukz-assembly3.cif.gz_C CDK11 in complex with small molecule inhibitor OTS964	0.130	253	183	28	280	1	211	1.171E-02	69
LOKIASV2_3899_ESMFold_N-A	3ocb-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	3ocb-assembly2.cif.gz_B Akt1 kinase domain with pyrrolopyrimidine inhibitor	0.115	258	218	28	285	5	251	1.969E-02	69
LOKIASV2_3899_ESMFold_N-A	5r9t-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5r9t-assembly1.cif.gz_A PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13477a in complex with MAP kinase p38-alpha	0.139	208	125	28	235	18	163	2.832E-02	69
LOKIASV2_3899_ESMFold_N-A	5r9x-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5r9x-assembly1.cif.gz_A PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13611a in complex with MAP kinase p38-alpha	0.133	256	185	28	283	18	231	1.685E-02	69
LOKIASV2_3899_ESMFold_N-A	3v3v-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3v3v-assembly1.cif.gz_A Structural and functional analysis of quercetagetin, a natural JNK1 inhibitor	0.103	256	191	28	283	18	231	3.671E-02	69
LOKIASV2_3899_ESMFold_N-A	4aw2-assembly1.cif.gz_A-2	LOKIASV2_3899_ESMFold_N-A	4aw2-assembly1.cif.gz_A-2 Crystal structure of CDC42 binding protein kinase alpha (MRCK alpha)	0.100	277	229	4	280	40	294	8.576E-03	69
LOKIASV2_3899_ESMFold_N-A	4rew-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4rew-assembly1.cif.gz_A Crystal structure of the non-phosphorylated human alpha1 beta2 gamma1 holo-AMPK complex	0.108	208	137	33	240	1	155	1.518E-02	69
LOKIASV2_3899_ESMFold_N-A	4yga-assembly2.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	4yga-assembly2.cif.gz_C CDPK1, from Toxoplasma gondii, bound to inhibitory VHH-1B7	0.107	281	224	27	307	4	255	1.112E-02	69
LOKIASV2_3899_ESMFold_N-A	7dts-assembly1.cif.gz_a	LOKIASV2_3899_ESMFold_N-A	7dts-assembly1.cif.gz_a Crystal structure of RNase L in complex with AC40357	0.096	277	193	28	304	333	547	1.599E-02	69
LOKIASV2_3899_ESMFold_N-A	3pj1-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3pj1-assembly1.cif.gz_A Crystal structure of BTK kinase domain complexed with 3-(2,6-Dichloro-phenyl)-7-[4-(2-diethylamino-ethoxy)-phenylamino]-1-methyl-3,4-dihydro-1H-pyrimido[4,5-d]pyrimidin-2-one	0.130	281	197	32	312	12	238	2.300E-02	68
LOKIASV2_3899_ESMFold_N-A	6nze-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6nze-assembly1.cif.gz_A CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH Compound_5 AKA 4-[(2-CARBAMOYLPHEN YL)AMINO]-6-[(5-FLUOROPYRIDIN-2-YL)AMINO]-N-METHYLPYRIDINE -3-CARBOXAMIDE	0.113	265	185	32	296	9	218	1.518E-02	68
LOKIASV2_3899_ESMFold_N-A	2yn8-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	2yn8-assembly1.cif.gz_A ephB4 kinase domain inhibitor complex	0.090	292	220	26	317	4	246	1.869E-02	68
LOKIASV2_3899_ESMFold_N-A	2yza-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	2yza-assembly1.cif.gz_A Crystal structure of kinase domain of Human 5'-AMP-activated protein kinase alpha-2 subunit mutant (T172D)	0.106	250	198	30	279	7	229	4.073E-02	68
LOKIASV2_3899_ESMFold_N-A	6cz3-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6cz3-assembly1.cif.gz_A Structure of the PTK6 kinase domain bound to a type I inhibitor (3-fluoro-4-{[6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]amino}phenyl)(morpholin-4-yl)methanone	0.136	126	103	26	145	2	127	3.671E-02	68
LOKIASV2_3899_ESMFold_N-A	2e2b-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	2e2b-assembly2.cif.gz_B Crystal structure of the c-Abl kinase domain in complex with INNO-406	0.114	265	216	32	296	18	262	3.671E-02	68
LOKIASV2_3899_ESMFold_N-A	6hex-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6hex-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative ATMM006	0.101	286	215	30	315	9	248	4.760E-02	68
LOKIASV2_3899_ESMFold_N-A	6qav-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6qav-assembly1.cif.gz_B Crystal structure of ULK2 in complexed with MRT68921	0.108	263	175	29	291	1	197	1.518E-02	68
LOKIASV2_3899_ESMFold_N-A	7w7y-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7w7y-assembly1.cif.gz_A The crystal structure of human abl1 kinase domain in complex with ABL2-A5	0.115	275	217	38	312	23	268	4.073E-02	68
LOKIASV2_3899_ESMFold_N-A	6cje-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6cje-assembly1.cif.gz_A Crystal Structure of Mnk2-D228G in complex with Inhibitor	0.116	181	133	29	179	14	194	1.869E-02	68
LOKIASV2_3899_ESMFold_N-A	3udb-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	3udb-assembly2.cif.gz_B Crystal structure of SnRK2.6	0.137	125	105	26	150	6	128	2.074E-02	68
LOKIASV2_3899_ESMFold_N-A	3f5g-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3f5g-assembly1.cif.gz_A Crystal structure of death associated protein kinase in complex with ADP and Mg2+	0.118	264	217	26	289	8	254	6.847E-02	68
LOKIASV2_3899_ESMFold_N-A	3gu6-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3gu6-assembly1.cif.gz_A Crystal structure of DAPKQ23V-ADP	0.114	264	178	26	289	8	209	5.014E-02	68
LOKIASV2_3899_ESMFold_N-A	4aw1-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4aw1-assembly1.cif.gz_A Human PDK1 Kinase Domain in Complex with Allosteric Compound PS210 Bound to the PIF-Pocket	0.112	263	202	30	292	14	242	2.300E-02	68
LOKIASV2_3899_ESMFold_N-A	6ege-assembly1.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	6ege-assembly1.cif.gz_D Crystal structure of the unphosphorylated IRAK4 kinase domain Bound to a type I inhibitor	0.107	274	224	34	307	30	281	2.074E-02	68
LOKIASV2_3899_ESMFold_N-A	8fjz-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	8fjz-assembly2.cif.gz_B Crystal structure of HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with 3-{4-[(3R,5S)-3-Amino-5-methylpiperidin-1-yl]-6-chloro-7H-pyrrolo[2,3-d]pyrimidin-5-yl}benzonitrile	0.118	264	168	26	289	9	200	3.142E-02	68
LOKIASV2_3899_ESMFold_N-A	5okt-assembly3.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	5okt-assembly3.cif.gz_C Crystal structure of human Casein Kinase I delta in complex with IWP-2	0.110	287	235	28	314	4	268	1.969E-02	68
LOKIASV2_3899_ESMFold_N-A	2ivu-assembly1.cif.gz_A-2	LOKIASV2_3899_ESMFold_N-A	2ivu-assembly1.cif.gz_A-2 Crystal structure of phosphorylated RET tyrosine kinase domain complexed with the inhibitor ZD6474	0.101	276	237	30	305	24	288	2.184E-02	68
LOKIASV2_3899_ESMFold_N-A	5o1s-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5o1s-assembly1.cif.gz_A Dimethyl fumarate is an allosteric covalent inhibitor of the p90 ribosomal S6 kinases	0.128	248	201	32	279	8	238	1.869E-02	68
LOKIASV2_3899_ESMFold_N-A	2i0e-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	2i0e-assembly2.cif.gz_B Structure of catalytic domain of human protein kinase C beta II complexed with a bisindolylmaleimide inhibitor	0.095	251	192	30	280	4	216	2.074E-02	68
LOKIASV2_3899_ESMFold_N-A	3e88-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	3e88-assembly2.cif.gz_B Crystal structures of the kinase domain of AKT2 in complex with ATP-competitive inhibitors	0.119	275	238	28	302	5	275	2.074E-02	68
LOKIASV2_3899_ESMFold_N-A	2pvl-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	2pvl-assembly1.cif.gz_A Structure-Based Design of Pyrazolo[1,5-a][1,3,5]triazine Derivatives as Potent Inhibitors of Protein Kinase CK2	0.125	273	207	28	300	32	268	2.983E-02	68
LOKIASV2_3899_ESMFold_N-A	2eu9-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	2eu9-assembly1.cif.gz_A Crystal Structure of CLK3	0.096	115	99	29	139	20	134	1.037E-01	68
LOKIASV2_3899_ESMFold_N-A	5x3f-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	5x3f-assembly1.cif.gz_B Crystal structure of the YgjG-Protein A-Zpa963-PKA catalytic domain	0.109	272	209	15	286	50	285	1.056E-02	68
LOKIASV2_3899_ESMFold_N-A	8bzp-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	8bzp-assembly1.cif.gz_A JNK3 (Mitogen-activated protein kinase 10) in Complex with Compound 23 bearing a C(sp3)F2Br moiety	0.116	274	231	28	289	17	290	1.234E-02	68
LOKIASV2_3899_ESMFold_N-A	7m74-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7m74-assembly1.cif.gz_A ATP-bound AMP-activated protein kinase	0.117	263	169	30	292	6	197	6.967E-03	68
LOKIASV2_3899_ESMFold_N-A	7v3v-assembly1.cif.gz_H	LOKIASV2_3899_ESMFold_N-A	7v3v-assembly1.cif.gz_H Cryo-EM structure of MCM double hexamer bound with DDK in State I	0.128	228	150	14	241	6	178	3.142E-02	68
LOKIASV2_3899_ESMFold_N-A	6hhj-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6hhj-assembly1.cif.gz_A Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 24b	0.112	266	228	14	279	93	350	7.338E-03	68
LOKIASV2_3899_ESMFold_N-A	3cik-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3cik-assembly1.cif.gz_A Human GRK2 in Complex with Gbetagamma subunits	0.120	281	228	27	307	160	419	4.290E-02	68
LOKIASV2_3899_ESMFold_N-A	3kl8-assembly4.cif.gz_E	LOKIASV2_3899_ESMFold_N-A	3kl8-assembly4.cif.gz_E CaMKIINtide Inhibitor Complex	0.108	263	205	27	289	3	233	6.500E-02	67
LOKIASV2_3899_ESMFold_N-A	6npe-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6npe-assembly1.cif.gz_B C-abl Kinase domain with the activator(cmpd6), 2-cyano-N-(4-(3,4-dichlorophenyl)thiazol-2-yl)acetamide	0.119	276	216	32	307	10	255	2.983E-02	67
LOKIASV2_3899_ESMFold_N-A	2hyy-assembly3.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	2hyy-assembly3.cif.gz_C Human Abl kinase domain in complex with imatinib (STI571, Glivec)	0.112	280	224	32	311	10	262	3.485E-02	67
LOKIASV2_3899_ESMFold_N-A	3dk7-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	3dk7-assembly2.cif.gz_B Crystal structure of mutant ABL kinase domain in complex with small molecule fragment	0.102	280	226	32	311	10	262	4.760E-02	67
LOKIASV2_3899_ESMFold_N-A	7dua-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	7dua-assembly1.cif.gz_B Crystal structure of human Proto-oncogene tyrosine-protein kinase receptor Ret in complex with 4-amino-7-(1-methylcyclopropyl)-N-(5-methyl-1H-pyrazol-3-yl)pyrrolo[2,3-d]pyrimidine-5-carboxamide	0.101	293	238	15	307	2	267	2.688E-02	67
LOKIASV2_3899_ESMFold_N-A	4rt7-assembly1.cif.gz_A-2	LOKIASV2_3899_ESMFold_N-A	4rt7-assembly1.cif.gz_A-2 Crystal Structure of FLT3 with a small molecule inhibitor	0.106	282	235	27	308	9	272	4.290E-02	67
LOKIASV2_3899_ESMFold_N-A	7eed-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7eed-assembly1.cif.gz_A Crystal structure of EphA7 mutant D751H	0.090	292	227	26	317	23	273	2.688E-02	67
LOKIASV2_3899_ESMFold_N-A	3eh9-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3eh9-assembly1.cif.gz_A Crystal structure of death associated protein kinase complexed with ADP	0.119	264	175	26	289	8	207	5.281E-02	67
LOKIASV2_3899_ESMFold_N-A	8wsw-assembly4.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	8wsw-assembly4.cif.gz_D The Crystal Structure of LIMK2a from Biortus	0.108	263	169	29	291	1	190	2.074E-02	67
LOKIASV2_3899_ESMFold_N-A	3oy3-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	3oy3-assembly2.cif.gz_B Crystal structure of ABL T315I mutant kinase domain bound with a DFG-out inhibitor AP24589	0.120	276	236	32	307	15	283	2.983E-02	67
LOKIASV2_3899_ESMFold_N-A	8pyi-assembly7.cif.gz_GGG	LOKIASV2_3899_ESMFold_N-A	8pyi-assembly7.cif.gz_GGG Human IGF1R with inhibitor 6	0.112	261	206	30	290	13	245	1.774E-02	67
LOKIASV2_3899_ESMFold_N-A	7siu-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	7siu-assembly1.cif.gz_B Crystal structure of HPK1 (MAP4K1) complex with inhibitor A-745	0.126	114	98	30	142	7	120	8.001E-02	67
LOKIASV2_3899_ESMFold_N-A	4bkj-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4bkj-assembly1.cif.gz_A Crystal structure of the human DDR1 kinase domain in complex with imatinib	0.130	291	205	17	307	34	270	1.002E-02	67
LOKIASV2_3899_ESMFold_N-A	3zdu-assembly1.cif.gz_A-2	LOKIASV2_3899_ESMFold_N-A	3zdu-assembly1.cif.gz_A-2 Crystal structure of the human CDKL3 kinase domain	0.102	249	176	30	278	4	200	2.300E-02	67
LOKIASV2_3899_ESMFold_N-A	4d2t-assembly2.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	4d2t-assembly2.cif.gz_C Structure of MELK in complex with inhibitors	0.116	280	160	13	292	1	182	2.074E-02	67
LOKIASV2_3899_ESMFold_N-A	3qkl-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3qkl-assembly1.cif.gz_A Spirochromane Akt Inhibitors	0.115	275	240	28	302	5	276	1.869E-02	67
LOKIASV2_3899_ESMFold_N-A	5etf-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5etf-assembly1.cif.gz_A Structure of dead kinase MAPK14 with bound the KIM domain of MKK6	0.149	254	171	30	283	21	222	1.774E-02	67
LOKIASV2_3899_ESMFold_N-A	4kin-assembly3.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	4kin-assembly3.cif.gz_C Crystal structure of mitogen-activated protein kinase 14 (P38-H5) complex with 5-(2-CHLOROPHENYL)-N-(5-(CYCLOPROPYLCARBAMOYL)-2-METHYLPHENYL)-2-THIOPHENECARBOXAMIDE	0.122	254	179	28	281	19	223	1.685E-02	67
LOKIASV2_3899_ESMFold_N-A	5czo-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	5czo-assembly2.cif.gz_B Structure of S. cerevisiae Hrr25:Mam1 complex, form 2	0.104	332	275	8	315	1	332	1.869E-02	67
LOKIASV2_3899_ESMFold_N-A	5t6a-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5t6a-assembly1.cif.gz_A Crystal Structure of TgCDPK1 from toxoplasma gondii complexed with 5GA	0.119	334	251	27	312	4	337	1.442E-02	67
LOKIASV2_3899_ESMFold_N-A	6b1u-assembly2.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	6b1u-assembly2.cif.gz_C Structure of full-length human AMPK (a2b1g1) in complex with a small molecule activator SC4	0.109	208	137	33	240	1	155	2.184E-02	67
LOKIASV2_3899_ESMFold_N-A	4wbo-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4wbo-assembly1.cif.gz_A Bovine G Protein Coupled Receptor Kinase 1 in Complex with Amlexanox	0.133	268	228	12	279	138	401	1.234E-02	67
LOKIASV2_3899_ESMFold_N-A	4kio-assembly4.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	4kio-assembly4.cif.gz_D Kinase domain mutant of human Itk in complex with a covalently-binding inhibitor	0.083	277	215	27	303	6	240	5.281E-02	66
LOKIASV2_3899_ESMFold_N-A	4pp9-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4pp9-assembly1.cif.gz_A ITK kinase domain with compound 1 (N-[1-(3-CYANOBENZYL)-1H-PYRAZOL-4-YL]-2H-INDAZOLE-3-CARBOXAMIDE)	0.121	288	209	30	317	8	246	1.442E-02	66
LOKIASV2_3899_ESMFold_N-A	4b8l-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4b8l-assembly1.cif.gz_A Aurora B kinase P353G mutant	0.128	277	209	27	303	4	244	7.730E-03	66
LOKIASV2_3899_ESMFold_N-A	4bf2-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	4bf2-assembly2.cif.gz_B Crystal Structures of Ask1-inhibitor Complexes	0.124	249	201	31	279	2	231	6.280E-03	66
LOKIASV2_3899_ESMFold_N-A	4bhn-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4bhn-assembly1.cif.gz_A Crystal Structures of Ask1-inhibitor Complexes	0.122	251	205	29	279	1	235	3.367E-03	66
LOKIASV2_3899_ESMFold_N-A	3kl8-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3kl8-assembly1.cif.gz_A CaMKIINtide Inhibitor Complex	0.103	252	208	38	289	1	233	6.847E-02	66
LOKIASV2_3899_ESMFold_N-A	3kl8-assembly5.cif.gz_G	LOKIASV2_3899_ESMFold_N-A	3kl8-assembly5.cif.gz_G CaMKIINtide Inhibitor Complex	0.102	263	208	27	289	4	236	5.859E-02	66
LOKIASV2_3899_ESMFold_N-A	2hz4-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	2hz4-assembly2.cif.gz_B Abl kinase domain unligated and in complex with tetrahydrostaurosporine	0.098	283	226	32	314	10	260	4.760E-02	66
LOKIASV2_3899_ESMFold_N-A	5h2u-assembly4.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	5h2u-assembly4.cif.gz_D Crystal structure of PTK6 Kinase Domain complexed with Dasatinib	0.096	283	227	30	312	7	258	4.290E-02	66
LOKIASV2_3899_ESMFold_N-A	2vwi-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	2vwi-assembly1.cif.gz_B Structure of the OSR1 kinase, a hypertension drug target	0.130	260	204	30	289	9	244	3.142E-02	66
LOKIASV2_3899_ESMFold_N-A	6yid-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6yid-assembly1.cif.gz_B Crystal structure of ULK2 in complex with SBI-0206965	0.138	246	194	34	279	18	243	4.760E-02	66
LOKIASV2_3899_ESMFold_N-A	3oxz-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3oxz-assembly1.cif.gz_A Crystal structure of ABL kinase domain bound with a DFG-out inhibitor AP24534	0.123	278	221	30	307	15	267	3.671E-02	66
LOKIASV2_3899_ESMFold_N-A	1mry-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	1mry-assembly1.cif.gz_A crystal structure of an inactive akt2 kinase domain	0.116	275	217	28	302	5	250	1.518E-02	66
LOKIASV2_3899_ESMFold_N-A	2pe0-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	2pe0-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 (PDK1) 5-Hydroxy-3-[1-(1H-pyrrol-2-yl)-eth-(Z)-ylidene]-1,3-dihydro-indol-2-one COMPLEX	0.133	260	195	30	289	9	234	3.309E-02	66
LOKIASV2_3899_ESMFold_N-A	3dgk-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3dgk-assembly1.cif.gz_A Crystal structure of a glycine-rich loop mutant of the death associated protein kinase catalytic domain	0.105	264	221	26	289	8	255	6.500E-02	66
LOKIASV2_3899_ESMFold_N-A	5fm3-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5fm3-assembly1.cif.gz_A Crystal structure of hyper-phosphorylated RET kinase domain with (proximal) juxtamembrane segment	0.111	278	228	30	307	18	274	3.485E-02	66
LOKIASV2_3899_ESMFold_N-A	2wnt-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	2wnt-assembly1.cif.gz_A Crystal Structure of the Human Ribosomal protein S6 kinase	0.141	250	194	30	279	3	229	2.423E-02	66
LOKIASV2_3899_ESMFold_N-A	5nk6-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5nk6-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 2d	0.096	284	231	32	315	9	264	1.599E-02	66
LOKIASV2_3899_ESMFold_N-A	6tsz-assembly1.cif.gz_U	LOKIASV2_3899_ESMFold_N-A	6tsz-assembly1.cif.gz_U The ULK4 Pseudokinase Domain Bound To ATPgammaS	0.111	266	188	26	291	4	216	4.145E-03	66
LOKIASV2_3899_ESMFold_N-A	3o0g-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3o0g-assembly1.cif.gz_A Crystal Structure of Cdk5:p25 in complex with an ATP analogue	0.109	255	189	29	283	5	217	6.171E-02	66
LOKIASV2_3899_ESMFold_N-A	4tw9-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	4tw9-assembly1.cif.gz_B Difluoro-dioxolo-benzoimidazol-benzamides as potent inhibitors of CK1delta and epsilon with nanomolar inhibitory activity on cancer cell proliferation	0.112	287	234	28	314	7	271	1.599E-02	66
LOKIASV2_3899_ESMFold_N-A	6gro-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6gro-assembly1.cif.gz_A Human CSNK1G3 bound to SB-223133	0.092	288	247	28	315	5	277	8.142E-03	66
LOKIASV2_3899_ESMFold_N-A	7jv7-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7jv7-assembly1.cif.gz_A Crystal Structure of the yeast RNA Pol II CTD kinase CTDK-1 complex	0.130	256	184	28	283	7	219	2.423E-02	66
LOKIASV2_3899_ESMFold_N-A	4bky-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4bky-assembly1.cif.gz_A Crystal structure of unphosphorylated Maternal Embryonic Leucine zipper Kinase (MELK) in complex with pyrrolopyrazole inhibitor	0.108	273	195	20	292	2	221	2.184E-02	66
LOKIASV2_3899_ESMFold_N-A	6npz-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6npz-assembly1.cif.gz_A Crystal structure of Akt1 (aa 123-480) kinase with a bisubstrate	0.101	273	241	30	302	10	278	2.552E-02	66
LOKIASV2_3899_ESMFold_N-A	4d2w-assembly1.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	4d2w-assembly1.cif.gz_D Structure of MELK in complex with inhibitors	0.111	260	207	20	279	4	237	1.685E-02	66
LOKIASV2_3899_ESMFold_N-A	7axv-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7axv-assembly1.cif.gz_A Crystal structure of the cAMP-dependent protein kinase A cocrystallized with 5-isoquinolinesulfonic acid and PKI (5-24)	0.110	266	223	14	279	19	270	1.685E-02	66
LOKIASV2_3899_ESMFold_N-A	3beg-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3beg-assembly1.cif.gz_A Crystal structure of SR protein kinase 1 complexed to its substrate ASF/SF2	0.147	126	96	30	142	12	137	1.417E-01	66
LOKIASV2_3899_ESMFold_N-A	1opl-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	1opl-assembly2.cif.gz_B Structural basis for the auto-inhibition of c-Abl tyrosine kinase	0.096	114	99	32	141	108	221	1.277E-01	66
LOKIASV2_3899_ESMFold_N-A	6w39-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6w39-assembly1.cif.gz_A Structure of unphosphorylated IRE1 in complex with G-1749	0.087	262	203	28	289	5	227	1.369E-02	66
LOKIASV2_3899_ESMFold_N-A	6w3k-assembly1.cif.gz_A-2	LOKIASV2_3899_ESMFold_N-A	6w3k-assembly1.cif.gz_A-2 Structure of unphosphorylated human IRE1 bound to G-9807	0.109	274	220	34	307	15	262	4.290E-02	66
LOKIASV2_3899_ESMFold_N-A	4cfe-assembly1.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	4cfe-assembly1.cif.gz_C Structure of full length human AMPK in complex with a small molecule activator, a benzimidazole derivative (991)	0.144	118	97	28	141	5	122	9.350E-02	66
LOKIASV2_3899_ESMFold_N-A	6xdb-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6xdb-assembly1.cif.gz_A Crystal structure of IRE1a in complex with G-6904	0.093	274	228	34	307	16	267	3.671E-02	66
LOKIASV2_3899_ESMFold_N-A	3soa-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3soa-assembly1.cif.gz_A Full-length human CaMKII	0.148	118	99	25	141	2	119	9.350E-02	66
LOKIASV2_3899_ESMFold_N-A	4yga-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4yga-assembly1.cif.gz_A CDPK1, from Toxoplasma gondii, bound to inhibitory VHH-1B7	0.110	281	231	27	307	4	263	1.774E-02	66
LOKIASV2_3899_ESMFold_N-A	2bcj-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	2bcj-assembly1.cif.gz_A Crystal Structure of G Protein-Coupled Receptor Kinase 2 in Complex with Galpha-q and Gbetagamma Subunits	0.147	291	238	27	317	161	440	4.519E-02	66
LOKIASV2_3899_ESMFold_N-A	6m11-assembly1.cif.gz_a	LOKIASV2_3899_ESMFold_N-A	6m11-assembly1.cif.gz_a Crystal structure of Rnase L in complex with Sunitinib	0.095	275	188	28	302	342	550	3.485E-02	66
LOKIASV2_3899_ESMFold_N-A	3cs9-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	3cs9-assembly2.cif.gz_B Human ABL kinase in complex with nilotinib	0.110	284	209	32	315	10	245	4.519E-02	65
LOKIASV2_3899_ESMFold_N-A	5v24-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5v24-assembly1.cif.gz_A Structure-based drug design of novel ASK1 inhibitors using a fully integrated lead optimization strategy	0.116	250	201	31	280	2	229	1.112E-02	65
LOKIASV2_3899_ESMFold_N-A	3is5-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	3is5-assembly1.cif.gz_B Crystal structure of CDPK kinase domain from toxoplasma Gondii, TGME49_018720	0.112	266	168	27	292	8	197	3.309E-02	65
LOKIASV2_3899_ESMFold_N-A	3dk7-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3dk7-assembly1.cif.gz_A Crystal structure of mutant ABL kinase domain in complex with small molecule fragment	0.086	284	230	32	315	10	262	2.983E-02	65
LOKIASV2_3899_ESMFold_N-A	8h7f-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	8h7f-assembly1.cif.gz_A The crystal structure of human abl1 kinase domain in complex with abl1-B-EBA	0.111	267	227	32	298	11	266	5.281E-02	65
LOKIASV2_3899_ESMFold_N-A	5o49-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	5o49-assembly2.cif.gz_B Human FGF in complex with a covalent inhibitor	0.108	282	235	28	309	17	281	2.300E-02	65
LOKIASV2_3899_ESMFold_N-A	3uyt-assembly6.cif.gz_B-3	LOKIASV2_3899_ESMFold_N-A	3uyt-assembly6.cif.gz_B-3 crystal structure of ck1d with PF670462 from P1 crystal form	0.103	285	243	28	312	3	274	2.688E-02	65
LOKIASV2_3899_ESMFold_N-A	4twc-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	4twc-assembly2.cif.gz_B 2-Benzamido-N-(1H-benzo[d]imidazol-2-yl)thiazole-4- carboxamide derivatives as potent inhibitors of CK1d/e	0.109	285	241	28	312	7	278	1.969E-02	65
LOKIASV2_3899_ESMFold_N-A	1zmv-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	1zmv-assembly1.cif.gz_A Catalytic and ubiqutin-associated domains of MARK2/PAR-1: K82R mutant	0.117	265	188	28	292	1	214	1.969E-02	65
LOKIASV2_3899_ESMFold_N-A	1oi9-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	1oi9-assembly1.cif.gz_A Structure of human Thr160-phospho CDK2/cyclin A complexed with a 6-cyclohexylmethyloxy-2-anilino-purine inhibitor	0.114	254	190	27	280	2	216	1.037E-01	65
LOKIASV2_3899_ESMFold_N-A	1z9x-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	1z9x-assembly1.cif.gz_A Human DRP-1 kinase, W305S S308A D40 mutant, crystal form with 3 monomers in the asymmetric unit	0.119	288	234	30	317	12	278	4.290E-02	65
LOKIASV2_3899_ESMFold_N-A	5ywm-assembly1.cif.gz_X	LOKIASV2_3899_ESMFold_N-A	5ywm-assembly1.cif.gz_X Crystal structure of CK2a2 form-1	0.113	281	220	8	288	1	249	4.073E-02	65
LOKIASV2_3899_ESMFold_N-A	3ocb-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3ocb-assembly1.cif.gz_A Akt1 kinase domain with pyrrolopyrimidine inhibitor	0.111	265	209	28	292	5	240	2.688E-02	65
LOKIASV2_3899_ESMFold_N-A	5yf9-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	5yf9-assembly2.cif.gz_B Crystal structure of CK2a2 form-2	0.106	272	212	21	292	17	254	2.983E-02	65
LOKIASV2_3899_ESMFold_N-A	4d2v-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	4d2v-assembly1.cif.gz_B Structure of MELK in complex with inhibitors	0.117	297	218	21	317	3	250	4.598E-03	65
LOKIASV2_3899_ESMFold_N-A	6isj-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6isj-assembly1.cif.gz_A Crystal structure of CX-4945 bound CK2 alpha from C. neoformans	0.101	286	249	4	289	20	297	4.073E-02	65
LOKIASV2_3899_ESMFold_N-A	6khf-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6khf-assembly1.cif.gz_A Crystal structure of CLK3 in complex with CX-4945	0.099	255	197	30	284	15	234	3.309E-02	65
LOKIASV2_3899_ESMFold_N-A	3new-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3new-assembly1.cif.gz_A p38-alpha complexed with Compound 10	0.110	256	179	28	283	18	219	1.234E-02	65
LOKIASV2_3899_ESMFold_N-A	8ssn-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	8ssn-assembly1.cif.gz_A Abl kinase in complex with SKI and asciminib	0.104	275	220	23	297	166	411	1.969E-02	65
LOKIASV2_3899_ESMFold_N-A	3is5-assembly1.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	3is5-assembly1.cif.gz_D Crystal structure of CDPK kinase domain from toxoplasma Gondii, TGME49_018720	0.092	287	171	6	292	1	189	5.014E-02	64
LOKIASV2_3899_ESMFold_N-A	3vw6-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	3vw6-assembly1.cif.gz_B Crystal structure of human apoptosis signal-regulating kinase 1 (ASK1) with imidazopyridine inhibitor	0.117	286	186	31	316	2	213	1.002E-02	64
LOKIASV2_3899_ESMFold_N-A	3kl8-assembly2.cif.gz_I	LOKIASV2_3899_ESMFold_N-A	3kl8-assembly2.cif.gz_I CaMKIINtide Inhibitor Complex	0.099	263	206	27	289	4	233	7.596E-02	64
LOKIASV2_3899_ESMFold_N-A	6nzr-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6nzr-assembly1.cif.gz_B CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH Compound_12 AKA 4-[(2-methanesulfonylphenyl)amino]-N-(H3)methyl-6-[(pyridin-2- yl)amino]pyridazine-3-carboxamide	0.162	249	205	31	279	12	257	7.730E-03	64
LOKIASV2_3899_ESMFold_N-A	3zxt-assembly2.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	3zxt-assembly2.cif.gz_C Dimeric structure of DAPK-1 catalytic domain in complex with AMPPCP- Mg	0.122	260	202	30	289	9	239	3.142E-02	64
LOKIASV2_3899_ESMFold_N-A	1ung-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	1ung-assembly2.cif.gz_B Structural mechanism for the inhibition of CDK5-p25 by roscovitine, aloisine and indirubin.	0.109	253	176	31	283	2	200	8.427E-02	64
LOKIASV2_3899_ESMFold_N-A	5vo1-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5vo1-assembly1.cif.gz_A DLK in complex with compound 10 (5-(1-isopropyl-5-(3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl)-1H-pyrazol-3-yl)-3-(trifluoromethyl)pyridin-2-amine)	0.118	262	161	31	292	11	193	3.547E-03	64
LOKIASV2_3899_ESMFold_N-A	7vdq-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	7vdq-assembly2.cif.gz_B The structure of cyclin-dependent kinase 5 (CDK5) in complex with p25 and Compound 7	0.093	251	186	33	283	1	206	3.867E-02	64
LOKIASV2_3899_ESMFold_N-A	7qra-assembly4.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	7qra-assembly4.cif.gz_D Crystal structure of CK1 delta in complex with VN725	0.111	287	229	28	314	5	263	2.983E-02	64
LOKIASV2_3899_ESMFold_N-A	6n8g-assembly3.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	6n8g-assembly3.cif.gz_C IRAK4 bound to benzoxazole compound	0.116	304	253	7	310	1	287	4.760E-02	64
LOKIASV2_3899_ESMFold_N-A	4oh4-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	4oh4-assembly2.cif.gz_B Crystal structure of BRI1 in complex with BKI1	0.123	305	240	11	315	15	289	4.760E-02	64
LOKIASV2_3899_ESMFold_N-A	6w4p-assembly1.cif.gz_H	LOKIASV2_3899_ESMFold_N-A	6w4p-assembly1.cif.gz_H CaMKII alpha-30 Cryo-EM reconstruction - Class B	0.174	118	96	25	141	2	119	1.345E-01	64
LOKIASV2_3899_ESMFold_N-A	6wjg-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6wjg-assembly1.cif.gz_B PKA RIIbeta holoenzyme with DnaJB1-PKAc fusion in fibrolamellar hepatoceullar carcinoma	0.110	265	169	28	292	1	191	3.309E-02	64
LOKIASV2_3899_ESMFold_N-A	4dli-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4dli-assembly1.cif.gz_A Human p38 MAP kinase in complex with RL87	0.128	254	174	28	281	18	217	1.442E-02	64
LOKIASV2_3899_ESMFold_N-A	2rg6-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	2rg6-assembly1.cif.gz_A Phenylalanine pyrrolotriazine p38 alpha map kinase inhibitor compound 11J	0.128	256	175	28	283	19	220	1.774E-02	64
LOKIASV2_3899_ESMFold_N-A	6q8p-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6q8p-assembly1.cif.gz_A Structure of CLK1 with bound N-methyl-10-nitropyrido[3,4-g]quinazolin-2-amine	0.159	124	97	27	142	13	136	1.037E-01	64
LOKIASV2_3899_ESMFold_N-A	3oz6-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3oz6-assembly1.cif.gz_A Crystal structure of MapK from Cryptosporidium Parvum, cgd2_1960	0.103	289	248	25	313	3	280	3.867E-02	64
LOKIASV2_3899_ESMFold_N-A	5r9c-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5r9c-assembly1.cif.gz_A PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N14074a in complex with MAP kinase p38-alpha	0.136	256	185	28	283	18	232	2.300E-02	64
LOKIASV2_3899_ESMFold_N-A	7w5c-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7w5c-assembly1.cif.gz_A Crystal structure of Mitogen Activated Protein Kinase 4 (MPK4) from Arabidopsis thaliana	0.113	278	209	30	307	27	263	2.832E-02	64
LOKIASV2_3899_ESMFold_N-A	4z7h-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4z7h-assembly1.cif.gz_A Crystal structure of human IRE1 cytoplasmic kinase-RNase region - complex with imidazopyridine compound 3	0.106	257	204	33	289	14	242	6.171E-02	64
LOKIASV2_3899_ESMFold_N-A	3c4x-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	3c4x-assembly1.cif.gz_B Crystal Structure of G protein coupled receptor kinase 1 bound to ATP and magnesium chloride at 2.9A	0.106	299	249	8	286	93	391	1.171E-02	64
LOKIASV2_3899_ESMFold_N-A	4wbo-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	4wbo-assembly2.cif.gz_B Bovine G Protein Coupled Receptor Kinase 1 in Complex with Amlexanox	0.123	265	211	12	276	136	377	2.832E-02	64
LOKIASV2_3899_ESMFold_N-A	6oyw-assembly2.cif.gz_D-3	LOKIASV2_3899_ESMFold_N-A	6oyw-assembly2.cif.gz_D-3 ASK1 kinase domain in complex with Compound 11	0.112	249	211	31	279	2	240	1.112E-02	63
LOKIASV2_3899_ESMFold_N-A	3dk6-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3dk6-assembly1.cif.gz_A Crystal structure of mutant ABL kinase domain in complex with small molecule fragment	0.111	267	222	32	298	10	260	5.281E-02	63
LOKIASV2_3899_ESMFold_N-A	2wma-assembly2.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	2wma-assembly2.cif.gz_C Structural and thermodynamic consequences of cyclization of peptide ligands for the recruitment site of cyclin A	0.125	263	206	27	289	2	237	8.427E-02	63
LOKIASV2_3899_ESMFold_N-A	5a6n-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	5a6n-assembly1.cif.gz_B Crystal structure of human death associated protein kinase 3 (DAPK3) in complex with compound 2	0.107	264	216	26	289	3	245	3.142E-02	63
LOKIASV2_3899_ESMFold_N-A	6q7f-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6q7f-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative ATDL18	0.113	286	211	30	315	9	247	1.774E-02	63
LOKIASV2_3899_ESMFold_N-A	6het-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6het-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative AT055	0.118	291	213	25	315	6	248	1.774E-02	63
LOKIASV2_3899_ESMFold_N-A	4r6v-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4r6v-assembly1.cif.gz_A Crystal Structure of FGF Receptor (FGFR) 4 Kinase Harboring the V550L Gate-Keeper Mutation in Complex with FIIN-3, an Irreversible Tyrosine Kinase Inhibitor Capable of Overcoming FGFR kinase Gate-Keeper Mutations	0.107	281	221	28	308	23	271	2.184E-02	63
LOKIASV2_3899_ESMFold_N-A	3ztx-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	3ztx-assembly2.cif.gz_B Aurora kinase selective inhibitors identified using a Taxol-induced checkpoint sensitivity screen.	0.115	274	219	30	303	16	264	2.552E-02	63
LOKIASV2_3899_ESMFold_N-A	4fzd-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	4fzd-assembly1.cif.gz_B Crystal structure of MST4-MO25 complex with WSF motif	0.106	269	225	37	305	19	271	3.142E-02	63
LOKIASV2_3899_ESMFold_N-A	6rfj-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6rfj-assembly2.cif.gz_B IRAK4 IN COMPLEX WITH inhibitor	0.117	304	245	7	310	1	278	5.281E-02	63
LOKIASV2_3899_ESMFold_N-A	4ct1-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4ct1-assembly1.cif.gz_A Human PDK1-PKCzeta Kinase Chimera in Complex with Allosteric Compound PS315 Bound to the PIF-Pocket	0.126	274	205	30	303	7	241	3.142E-02	63
LOKIASV2_3899_ESMFold_N-A	7nzy-assembly4.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	7nzy-assembly4.cif.gz_D Crystal structure of human Casein Kinase I delta in complex with CGS-15943	0.112	287	234	28	314	5	268	2.832E-02	63
LOKIASV2_3899_ESMFold_N-A	4ytf-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4ytf-assembly1.cif.gz_A Discovery of VX-509 (Decernotinib): A Potent and Selective Janus kinase (JAK) 3 Inhibitor for the Treatment of Autoimmune Diseases	0.099	283	249	30	312	8	284	1.037E-01	63
LOKIASV2_3899_ESMFold_N-A	6p69-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6p69-assembly2.cif.gz_B Crystal structure of FGFR1-Y563C (FGFR4 surrogate) covalently bound to compound 11.	0.121	282	236	28	309	16	284	3.142E-02	63
LOKIASV2_3899_ESMFold_N-A	4hok-assembly13.cif.gz_E	LOKIASV2_3899_ESMFold_N-A	4hok-assembly13.cif.gz_E crystal structure of apo ck1e	0.113	285	240	28	312	7	278	1.969E-02	63
LOKIASV2_3899_ESMFold_N-A	2izr-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	2izr-assembly1.cif.gz_A Structure of casein kinase gamma 3 in complex with inhibitor	0.089	288	247	28	315	6	277	1.112E-02	63
LOKIASV2_3899_ESMFold_N-A	7enc-assembly1.cif.gz_8	LOKIASV2_3899_ESMFold_N-A	7enc-assembly1.cif.gz_8 TFIID-based PIC-Mediator holo-complex in fully-assembled state (hPIC-MED)	0.118	253	188	31	283	2	215	5.014E-02	63
LOKIASV2_3899_ESMFold_N-A	4ump-assembly2.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	4ump-assembly2.cif.gz_C Structure of MELK in complex with inhibitors	0.112	273	193	20	292	4	221	4.290E-02	63
LOKIASV2_3899_ESMFold_N-A	6l20-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6l20-assembly1.cif.gz_A Crystal structure of CK2a2 with hematein	0.104	263	196	26	288	21	240	6.847E-02	63
LOKIASV2_3899_ESMFold_N-A	4ump-assembly1.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	4ump-assembly1.cif.gz_D Structure of MELK in complex with inhibitors	0.108	273	170	20	292	3	194	2.074E-02	63
LOKIASV2_3899_ESMFold_N-A	6buu-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6buu-assembly1.cif.gz_A Crystal structure of AKT1 (aa 144-480) with a bisubstrate	0.115	258	218	28	285	5	251	4.290E-02	63
LOKIASV2_3899_ESMFold_N-A	2r9s-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	2r9s-assembly2.cif.gz_B c-Jun N-terminal Kinase 3 with 3,5-Disubstituted Quinoline inhibitor	0.114	253	171	31	283	21	214	4.760E-02	63
LOKIASV2_3899_ESMFold_N-A	6xx8-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6xx8-assembly1.cif.gz_A Arabidopsis thaliana Casein Kinase 2 (CK2) alpha-1 crystal form II	0.128	273	206	28	300	24	260	6.171E-02	63
LOKIASV2_3899_ESMFold_N-A	3oht-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	3oht-assembly1.cif.gz_B Crystal Structure of Salmo Salar p38alpha	0.136	254	171	28	281	19	217	2.074E-02	63
LOKIASV2_3899_ESMFold_N-A	3iw4-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3iw4-assembly1.cif.gz_A Crystal structure of PKC alpha in complex with NVP-AEB071	0.105	263	209	30	292	9	242	5.281E-02	63
LOKIASV2_3899_ESMFold_N-A	3o8u-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3o8u-assembly1.cif.gz_A Conformational plasticity of p38 MAP kinase DFG motif mutants in response to inhibitor binding	0.132	256	173	28	283	18	217	8.142E-03	63
LOKIASV2_3899_ESMFold_N-A	5ts8-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5ts8-assembly1.cif.gz_A Z. MAYS CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 5,6-DIBROMOBENZOTRIAZOLE	0.121	273	207	28	300	31	267	3.142E-02	63
LOKIASV2_3899_ESMFold_N-A	5r92-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5r92-assembly1.cif.gz_A PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment KCL063 in complex with MAP kinase p38-alpha	0.136	256	182	28	283	19	230	2.184E-02	63
LOKIASV2_3899_ESMFold_N-A	8efj-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	8efj-assembly1.cif.gz_A A structural study of selectivity mechanisms for JNK3 and p38 alpha with indazole scaffold probing compounds	0.115	256	183	28	283	18	225	2.983E-02	63
LOKIASV2_3899_ESMFold_N-A	6e4t-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6e4t-assembly1.cif.gz_A Structure of AMPK bound to activator	0.110	251	188	34	284	8	219	3.142E-02	63
LOKIASV2_3899_ESMFold_N-A	6w3a-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6w3a-assembly1.cif.gz_A Structure of unphosphorylated IRE1 in complex with G-7658	0.104	110	87	33	142	14	111	8.427E-02	63
LOKIASV2_3899_ESMFold_N-A	2f2u-assembly2.cif.gz_B-3	LOKIASV2_3899_ESMFold_N-A	2f2u-assembly2.cif.gz_B-3 crystal structure of the Rho-kinase kinase domain	0.106	314	226	4	317	37	290	1.685E-02	63
LOKIASV2_3899_ESMFold_N-A	4z7h-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	4z7h-assembly2.cif.gz_B Crystal structure of human IRE1 cytoplasmic kinase-RNase region - complex with imidazopyridine compound 3	0.120	260	197	33	292	14	238	6.171E-02	63
LOKIASV2_3899_ESMFold_N-A	6s9w-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6s9w-assembly1.cif.gz_A Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 16a	0.126	266	224	14	279	95	351	1.599E-02	63
LOKIASV2_3899_ESMFold_N-A	5iso-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5iso-assembly1.cif.gz_A STRUCTURE OF FULL LENGTH HUMAN AMPK (NON-PHOSPHORYLATED AT T-LOOP) IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR, A BENZIMIDAZOLE DERIVATIVE (991)	0.121	208	135	33	240	1	155	2.300E-02	63
LOKIASV2_3899_ESMFold_N-A	6nyh-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6nyh-assembly2.cif.gz_B Structure of human RIPK1 kinase domain in complex with GNE684	0.102	258	151	34	291	7	175	3.485E-02	62
LOKIASV2_3899_ESMFold_N-A	8s9f-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	8s9f-assembly1.cif.gz_A Crystal structure of the kinase domain of Bruton's Tyrosine Kinase bound to dasatinib	0.113	281	213	32	312	11	251	5.859E-02	62
LOKIASV2_3899_ESMFold_N-A	3udb-assembly5.cif.gz_E	LOKIASV2_3899_ESMFold_N-A	3udb-assembly5.cif.gz_E Crystal structure of SnRK2.6	0.164	127	105	26	152	5	131	4.519E-02	62
LOKIASV2_3899_ESMFold_N-A	3h9f-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3h9f-assembly1.cif.gz_A Crystal Structure of Human Dual Specificity Protein Kinase (TTK) in complex with a pyrimido-diazepin ligand	0.125	251	198	29	279	15	241	1.774E-02	62
LOKIASV2_3899_ESMFold_N-A	8bof-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	8bof-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 12	0.107	251	171	27	277	6	198	2.184E-02	62
LOKIASV2_3899_ESMFold_N-A	8bzi-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	8bzi-assembly1.cif.gz_A Human MST3 (STK24) kinase in complex with inhibitor MR39	0.112	288	228	25	312	7	264	5.562E-02	62
LOKIASV2_3899_ESMFold_N-A	6fnh-assembly3.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	6fnh-assembly3.cif.gz_C Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with a pyrazolo[3,4-d]pyrimidine fragment of NVP-BHG712	0.116	291	217	25	315	11	256	2.074E-02	62
LOKIASV2_3899_ESMFold_N-A	2hiw-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	2hiw-assembly2.cif.gz_B Crystal Structure of Inactive Conformation Abl Kinase Catalytic Domain Complexed with Type II Inhibitor	0.109	280	228	32	311	17	273	6.500E-02	62
LOKIASV2_3899_ESMFold_N-A	4tpt-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	4tpt-assembly1.cif.gz_B Crystal Structure of the Human LIMK2 Kinase Domain In Complex With a Non-ATP Competitive Inhibitor	0.107	279	212	31	309	15	252	1.969E-02	62
LOKIASV2_3899_ESMFold_N-A	6f1w-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6f1w-assembly1.cif.gz_A Crystal structure of human Casein Kinase I delta in complex with compound 31a	0.108	290	244	28	317	5	278	3.485E-02	62
LOKIASV2_3899_ESMFold_N-A	3mvh-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3mvh-assembly1.cif.gz_A Crystal structure of Akt-1-inhibitor complexes	0.120	265	207	28	292	4	239	4.760E-02	62
LOKIASV2_3899_ESMFold_N-A	4d2v-assembly1.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	4d2v-assembly1.cif.gz_C Structure of MELK in complex with inhibitors	0.112	292	214	26	317	3	244	5.660E-03	62
LOKIASV2_3899_ESMFold_N-A	6khd-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6khd-assembly1.cif.gz_A Crystal structure of CLK1 in complex with CX-4945	0.112	257	199	27	283	10	234	2.552E-02	62
LOKIASV2_3899_ESMFold_N-A	6yu1-assembly1.cif.gz_a	LOKIASV2_3899_ESMFold_N-A	6yu1-assembly1.cif.gz_a CLK3 bound with beta-carboline KH-CARB13 (Cpd 3)	0.089	255	206	29	283	21	247	6.500E-02	62
LOKIASV2_3899_ESMFold_N-A	5r8y-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5r8y-assembly1.cif.gz_A PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N08078b in complex with MAP kinase p38-alpha	0.143	256	182	28	283	19	231	3.142E-02	62
LOKIASV2_3899_ESMFold_N-A	1pmv-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	1pmv-assembly1.cif.gz_A The structure of JNK3 in complex with a dihydroanthrapyrazole inhibitor	0.108	249	183	30	278	20	225	6.847E-02	62
LOKIASV2_3899_ESMFold_N-A	7dd1-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7dd1-assembly1.cif.gz_A Crystal structure of SRPK1 in complex with a peptide inhibitor	0.137	255	219	29	283	13	267	1.369E-02	62
LOKIASV2_3899_ESMFold_N-A	4xhg-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4xhg-assembly1.cif.gz_A Structure of C. glabrata Hrr25 bound to ADP (formate condition)	0.104	287	237	28	314	11	276	3.309E-02	62
LOKIASV2_3899_ESMFold_N-A	6xdf-assembly2.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6xdf-assembly2.cif.gz_A Crystal structure of IRE1a in complex with G-4100	0.098	267	209	34	300	17	249	8.877E-02	62
LOKIASV2_3899_ESMFold_N-A	4wbo-assembly3.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	4wbo-assembly3.cif.gz_C Bovine G Protein Coupled Receptor Kinase 1 in Complex with Amlexanox	0.133	268	228	12	279	135	398	2.184E-02	62
LOKIASV2_3899_ESMFold_N-A	6m13-assembly1.cif.gz_b	LOKIASV2_3899_ESMFold_N-A	6m13-assembly1.cif.gz_b Crystal structure of Rnase L in complex with Toceranib	0.109	266	178	37	302	351	551	2.983E-02	62
LOKIASV2_3899_ESMFold_N-A	6cpg-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6cpg-assembly1.cif.gz_A Structure of dephosphorylated Aurora A (122-403) in complex with inhibiting monobody and AT9283 in an inactive conformation	0.116	281	213	30	310	7	248	3.867E-02	61
LOKIASV2_3899_ESMFold_N-A	3kl8-assembly3.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	3kl8-assembly3.cif.gz_C CaMKIINtide Inhibitor Complex	0.105	264	207	27	290	3	234	1.093E-01	61
LOKIASV2_3899_ESMFold_N-A	2hzi-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	2hzi-assembly2.cif.gz_B Abl kinase domain in complex with PD180970	0.089	284	230	32	315	10	262	5.859E-02	61
LOKIASV2_3899_ESMFold_N-A	8bk0-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	8bk0-assembly1.cif.gz_A Crystal structure of human Ephrin type-A receptor 2 (EPHA2) Kinase domain in complex with LDN-211904	0.117	291	220	25	315	6	255	2.983E-02	61
LOKIASV2_3899_ESMFold_N-A	5vja-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	5vja-assembly1.cif.gz_B Crystal Structure of human zipper-interacting protein kinase (ZIPK, alias DAPK3) in complex with a pyrazolo[3,4-d]pyrimidinone ligand (HS38)	0.108	263	214	27	289	4	244	3.309E-02	61
LOKIASV2_3899_ESMFold_N-A	3ue4-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	3ue4-assembly2.cif.gz_B Structural and spectroscopic analysis of the kinase inhibitor bosutinib binding to the Abl tyrosine kinase domain	0.103	283	229	30	312	10	265	8.427E-02	61
LOKIASV2_3899_ESMFold_N-A	4zog-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	4zog-assembly2.cif.gz_B VX-680/MK-0457 binds to human ABL1 also in inactive DFG conformations.	0.099	269	230	30	298	9	264	5.859E-02	61
LOKIASV2_3899_ESMFold_N-A	5auu-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5auu-assembly1.cif.gz_A Crystal structure of DAPK1 in complex with luteolin.	0.105	264	219	26	289	8	253	1.151E-01	61
LOKIASV2_3899_ESMFold_N-A	2oib-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	2oib-assembly2.cif.gz_B Crystal structure of IRAK4 kinase domain apo form	0.116	278	224	34	311	26	279	3.867E-02	61
LOKIASV2_3899_ESMFold_N-A	1xjd-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	1xjd-assembly1.cif.gz_A Crystal Structure of PKC-theta complexed with Staurosporine at 2A resolution	0.105	252	207	28	279	7	238	5.562E-02	61
LOKIASV2_3899_ESMFold_N-A	8fjz-assembly3.cif.gz_E-2	LOKIASV2_3899_ESMFold_N-A	8fjz-assembly3.cif.gz_E-2 Crystal structure of HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with 3-{4-[(3R,5S)-3-Amino-5-methylpiperidin-1-yl]-6-chloro-7H-pyrrolo[2,3-d]pyrimidin-5-yl}benzonitrile	0.110	264	170	26	289	8	199	5.562E-02	61
LOKIASV2_3899_ESMFold_N-A	5lvl-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5lvl-assembly1.cif.gz_A Human PDK1 Kinase Domain in Complex with Compound PS653 Bound to the ATP-Binding Site	0.134	260	167	30	289	9	202	2.983E-02	61
LOKIASV2_3899_ESMFold_N-A	6qhr-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6qhr-assembly1.cif.gz_A Structure of the mitogen activated kinase kinase 7 in complex with pyrazolopyrimidine 1m	0.137	252	175	28	279	18	221	3.309E-02	61
LOKIASV2_3899_ESMFold_N-A	2vz6-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	2vz6-assembly1.cif.gz_A Structure of human calcium calmodulin dependent protein kinase type II alpha (CAMK2A) in complex with Indirubin E804	0.099	258	214	32	289	7	244	1.869E-02	61
LOKIASV2_3899_ESMFold_N-A	4btj-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	4btj-assembly2.cif.gz_B TTBK1 in complex with ATP	0.094	280	243	27	306	11	279	2.552E-02	61
LOKIASV2_3899_ESMFold_N-A	6gue-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6gue-assembly1.cif.gz_A CDK2/CyclinA in complex with AZD5438	0.104	257	189	27	283	2	213	9.350E-02	61
LOKIASV2_3899_ESMFold_N-A	2hak-assembly5.cif.gz_E	LOKIASV2_3899_ESMFold_N-A	2hak-assembly5.cif.gz_E Catalytic and ubiqutin-associated domains of MARK1/PAR-1	0.115	260	205	30	289	7	239	5.562E-02	61
LOKIASV2_3899_ESMFold_N-A	2r7i-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	2r7i-assembly1.cif.gz_A Crystal structure of catalytic subunit of protein kinase CK2	0.103	257	183	27	283	35	239	6.847E-02	61
LOKIASV2_3899_ESMFold_N-A	3s4q-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3s4q-assembly1.cif.gz_A P38 alpha kinase complexed with a pyrazolo-triazine based inhibitor	0.129	256	183	28	283	1	211	1.969E-02	61
LOKIASV2_3899_ESMFold_N-A	3qkm-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3qkm-assembly1.cif.gz_A Spirocyclic sulfonamides as AKT inhibitors	0.122	252	207	28	279	5	241	5.859E-02	61
LOKIASV2_3899_ESMFold_N-A	7zkx-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7zkx-assembly1.cif.gz_A SRPK2 IN COMPLEX WITH INHIBITOR	0.113	255	217	29	283	11	256	2.423E-02	61
LOKIASV2_3899_ESMFold_N-A	7mt9-assembly1.cif.gz_G	LOKIASV2_3899_ESMFold_N-A	7mt9-assembly1.cif.gz_G Rhodopsin kinase (GRK1) in complex with rhodopsin	0.116	266	229	14	279	7	266	4.760E-02	61
LOKIASV2_3899_ESMFold_N-A	5mxx-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5mxx-assembly1.cif.gz_A Crystal structure of human SR protein kinase 1 (SRPK1) in complex with compound 1	0.157	128	96	29	143	24	151	1.212E-01	61
LOKIASV2_3899_ESMFold_N-A	7jhh-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7jhh-assembly1.cif.gz_A Cryo-EM structure of ATP-bound fully inactive AMPK in complex with Fab and nanobody	0.108	263	170	30	292	6	197	1.442E-02	61
LOKIASV2_3899_ESMFold_N-A	6b1u-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6b1u-assembly1.cif.gz_A Structure of full-length human AMPK (a2b1g1) in complex with a small molecule activator SC4	0.119	252	207	28	279	7	242	2.074E-02	61
LOKIASV2_3899_ESMFold_N-A	3c50-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3c50-assembly1.cif.gz_A Crystal Structure of G protein coupled receptor kinase 1 bound to ADP and magnesium chloride at 2.6A	0.117	293	247	9	289	107	399	1.869E-02	61
LOKIASV2_3899_ESMFold_N-A	7elw-assembly1.cif.gz_b	LOKIASV2_3899_ESMFold_N-A	7elw-assembly1.cif.gz_b Crystal structure of RNase L in complex with Myricetin	0.096	274	191	28	301	332	543	1.969E-02	61
LOKIASV2_3899_ESMFold_N-A	1snu-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	1snu-assembly2.cif.gz_B CRYSTAL STRUCTURE OF THE UNPHOSPHORYLATED INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN	0.103	272	210	32	303	6	240	3.309E-02	60
LOKIASV2_3899_ESMFold_N-A	4af3-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4af3-assembly1.cif.gz_A Human Aurora B Kinase in complex with INCENP and VX-680	0.119	249	161	38	286	20	203	5.014E-02	60
LOKIASV2_3899_ESMFold_N-A	3qri-assembly3.cif.gz_B-2	LOKIASV2_3899_ESMFold_N-A	3qri-assembly3.cif.gz_B-2 The crystal structure of human abl1 kinase domain in complex with DCC-2036	0.110	265	223	32	296	11	261	1.037E-01	60
LOKIASV2_3899_ESMFold_N-A	6npv-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6npv-assembly1.cif.gz_A C-abl Kinase domain with the activator(cmpd51), N-(1-(3,4-dichlorophenyl)-4-(2-hydroxyethyl)-4,5-dihydro-1H-pyrazol-3-yl)isonicotinamide	0.102	267	226	32	298	11	263	8.427E-02	60
LOKIASV2_3899_ESMFold_N-A	5l6o-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5l6o-assembly1.cif.gz_A EphB3 kinase domain covalently bound to an irreversible inhibitor (compound 3)	0.088	287	235	29	315	1	259	8.427E-02	60
LOKIASV2_3899_ESMFold_N-A	5o2b-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5o2b-assembly1.cif.gz_A Crystal structure of WNK3 kinase domain in a diphosphorylated state and in a complex with the inhibitor PP-121	0.115	256	154	34	289	22	196	2.074E-02	60
LOKIASV2_3899_ESMFold_N-A	4nka-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4nka-assembly1.cif.gz_A Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with pyrazolaminopyrimidine 2	0.120	282	230	28	309	13	274	2.074E-02	60
LOKIASV2_3899_ESMFold_N-A	4a07-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4a07-assembly1.cif.gz_A Human PDK1 Kinase Domain in Complex with Allosteric Activator PS171 Bound to the PIF-Pocket	0.114	263	206	30	292	7	240	5.014E-02	60
LOKIASV2_3899_ESMFold_N-A	5j5t-assembly1.cif.gz_A-2	LOKIASV2_3899_ESMFold_N-A	5j5t-assembly1.cif.gz_A-2 GLK co-crystal structure with aminopyrrolopyrimidine inhibitor	0.125	260	165	30	289	5	193	1.093E-01	60
LOKIASV2_3899_ESMFold_N-A	5g6v-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5g6v-assembly1.cif.gz_A Crystal structure of the PCTAIRE1 kinase in complex with inhibitor	0.113	253	185	31	283	1	210	3.309E-02	60
LOKIASV2_3899_ESMFold_N-A	4imy-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4imy-assembly1.cif.gz_A The AFF4 scaffold binds human P-TEFb adjacent to HIV Tat	0.093	257	199	27	283	9	228	1.345E-01	60
LOKIASV2_3899_ESMFold_N-A	4ae6-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	4ae6-assembly2.cif.gz_B Structure and Function of the Human Sperm-Specific Isoform of Protein Kinase A (PKA) Catalytic Subunit Calpha 2	0.120	278	224	15	292	2	257	2.832E-02	60
LOKIASV2_3899_ESMFold_N-A	4ump-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	4ump-assembly2.cif.gz_B Structure of MELK in complex with inhibitors	0.118	297	219	21	317	4	252	3.867E-02	60
LOKIASV2_3899_ESMFold_N-A	3pze-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3pze-assembly1.cif.gz_A JNK1 in complex with inhibitor	0.108	256	184	28	283	18	224	7.596E-02	60
LOKIASV2_3899_ESMFold_N-A	5lw1-assembly3.cif.gz_H	LOKIASV2_3899_ESMFold_N-A	5lw1-assembly3.cif.gz_H Crystal structure of DARPin-DARPin rigid fusion, variant DD_232_11_D12 in complex JNK1a1 and JIP1 peptide	0.125	120	99	28	141	17	136	1.277E-01	60
LOKIASV2_3899_ESMFold_N-A	6z55-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6z55-assembly2.cif.gz_B Crystal structure of CLK3 in complex with macrocycle ODS2004070	0.090	255	212	29	283	28	261	4.760E-02	60
LOKIASV2_3899_ESMFold_N-A	6w3c-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6w3c-assembly2.cif.gz_B Structure of phosphorylated apo IRE1	0.111	133	109	29	152	1	133	9.848E-02	60
LOKIASV2_3899_ESMFold_N-A	3q5i-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3q5i-assembly1.cif.gz_A Crystal Structure of PBANKA_031420	0.125	304	229	7	310	19	281	6.171E-02	60
LOKIASV2_3899_ESMFold_N-A	3uqc-assembly1.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	3uqc-assembly1.cif.gz_C Structure of the Intracellular Kinase Homology Domain of Rv3910 at 2.2 A resolution	0.093	264	196	40	303	31	247	3.671E-02	59
LOKIASV2_3899_ESMFold_N-A	3dk6-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	3dk6-assembly2.cif.gz_B Crystal structure of mutant ABL kinase domain in complex with small molecule fragment	0.105	267	219	32	298	9	254	1.345E-01	59
LOKIASV2_3899_ESMFold_N-A	5tx5-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	5tx5-assembly1.cif.gz_B Rip1 Kinase ( flag 1-294, C34A, C127A, C233A, C240A) with GSK772	0.098	258	165	34	291	9	192	3.309E-02	59
LOKIASV2_3899_ESMFold_N-A	2g2f-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	2g2f-assembly2.cif.gz_B A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domain	0.095	272	231	27	298	6	261	7.596E-02	59
LOKIASV2_3899_ESMFold_N-A	5vja-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5vja-assembly1.cif.gz_A Crystal Structure of human zipper-interacting protein kinase (ZIPK, alias DAPK3) in complex with a pyrazolo[3,4-d]pyrimidinone ligand (HS38)	0.107	263	215	27	289	4	245	3.671E-02	59
LOKIASV2_3899_ESMFold_N-A	6vrf-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6vrf-assembly2.cif.gz_B ADP bound TTBK2 kinase domain	0.138	124	105	29	152	12	134	2.931E-01	59
LOKIASV2_3899_ESMFold_N-A	7jxy-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	7jxy-assembly2.cif.gz_B Structure of TTBK1 kinase domain in complex with Compound 18	0.088	287	203	27	313	12	235	2.184E-02	59
LOKIASV2_3899_ESMFold_N-A	4twc-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4twc-assembly1.cif.gz_A 2-Benzamido-N-(1H-benzo[d]imidazol-2-yl)thiazole-4- carboxamide derivatives as potent inhibitors of CK1d/e	0.113	287	239	28	314	6	275	3.142E-02	59
LOKIASV2_3899_ESMFold_N-A	2iw9-assembly2.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	2iw9-assembly2.cif.gz_A STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR	0.117	257	187	27	283	2	214	1.037E-01	59
LOKIASV2_3899_ESMFold_N-A	2cci-assembly2.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	2cci-assembly2.cif.gz_C Crystal structure of phospho-CDK2 Cyclin A in complex with a peptide containing both the substrate and recruitment sites of CDC6	0.125	254	188	27	280	2	217	1.655E-01	59
LOKIASV2_3899_ESMFold_N-A	4eom-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4eom-assembly1.cif.gz_A Thr 160 phosphorylated CDK2 H84S, Q85M, Q131E - human cyclin A3 complex with ATP	0.111	255	187	29	283	7	217	1.037E-01	59
LOKIASV2_3899_ESMFold_N-A	4d2p-assembly2.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	4d2p-assembly2.cif.gz_D Structure of MELK in complex with inhibitors	0.105	260	209	20	279	4	237	1.442E-02	59
LOKIASV2_3899_ESMFold_N-A	3txo-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3txo-assembly1.cif.gz_A PKC eta kinase in complex with a naphthyridine	0.121	265	163	28	292	1	186	5.014E-02	59
LOKIASV2_3899_ESMFold_N-A	6khd-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6khd-assembly2.cif.gz_B Crystal structure of CLK1 in complex with CX-4945	0.100	258	210	27	284	10	243	7.212E-02	59
LOKIASV2_3899_ESMFold_N-A	6so1-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6so1-assembly1.cif.gz_A Fragment N13569a in complex with MAP kinase p38-alpha	0.127	256	183	28	283	18	228	3.485E-02	59
LOKIASV2_3899_ESMFold_N-A	6w39-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6w39-assembly1.cif.gz_B Structure of unphosphorylated IRE1 in complex with G-1749	0.093	262	200	28	289	5	226	3.671E-02	59
LOKIASV2_3899_ESMFold_N-A	3upx-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3upx-assembly1.cif.gz_A Calcium-Dependent Protein Kinase 1 from Toxoplasma gondii (TgCDPK1) in complex with inhibitor UW1300	0.123	335	246	27	308	5	339	3.671E-02	59
LOKIASV2_3899_ESMFold_N-A	2acx-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	2acx-assembly1.cif.gz_B Crystal Structure of G protein coupled receptor kinase 6 bound to AMPPNP	0.133	283	228	29	311	167	430	3.142E-02	59
LOKIASV2_3899_ESMFold_N-A	4oav-assembly1.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	4oav-assembly1.cif.gz_D Complete human RNase L in complex with 2-5A (5'-ppp heptamer), AMPPCP and RNA substrate.	0.093	275	186	28	302	334	539	9.848E-02	59
LOKIASV2_3899_ESMFold_N-A	3w10-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3w10-assembly1.cif.gz_A Aurora kinase A complexed to pyrazole aminoquinoline I	0.103	262	171	28	289	6	197	5.562E-02	58
LOKIASV2_3899_ESMFold_N-A	2y4p-assembly1.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	2y4p-assembly1.cif.gz_C Dimeric structure of DAPK-1 catalytic domain	0.116	254	209	26	279	8	244	1.151E-01	58
LOKIASV2_3899_ESMFold_N-A	3bqr-assembly1.cif.gz_A-2	LOKIASV2_3899_ESMFold_N-A	3bqr-assembly1.cif.gz_A-2 Crystal structure of human death associated protein kinase 3 (DAPK3) in complex with an imidazo-pyridazine ligand	0.099	264	220	26	289	3	247	1.935E-01	58
LOKIASV2_3899_ESMFold_N-A	3wf6-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3wf6-assembly1.cif.gz_A Crystal structure of S6K1 kinase domain in complex with a pyrazolopyrimidine derivative 4-[4-(1H-indol-3-yl)-3,6-dihydropyridin-1(2H)-yl]-1H-pyrazolo[3,4-d]pyrimidine	0.125	250	197	30	279	7	232	1.037E-01	58
LOKIASV2_3899_ESMFold_N-A	6vpj-assembly1.cif.gz_A-2	LOKIASV2_3899_ESMFold_N-A	6vpj-assembly1.cif.gz_A-2 TPX2 residues 7-20 fused to Aurora A residues 116-389 C247V + C319V double mutant dephosphorylated, and in complex with AMP-PNP	0.106	310	246	1	310	1	276	2.552E-02	58
LOKIASV2_3899_ESMFold_N-A	7ovm-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7ovm-assembly1.cif.gz_A Protein kinase MKK7 in complex with cyclobutyl-substituted indazole	0.124	250	173	28	277	17	214	5.859E-02	58
LOKIASV2_3899_ESMFold_N-A	7r9t-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	7r9t-assembly1.cif.gz_B Crystal structure of HPK1 in complex with compound 17	0.114	266	167	24	289	10	199	7.212E-02	58
LOKIASV2_3899_ESMFold_N-A	6tia-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6tia-assembly2.cif.gz_B IRAK4 IN COMPLEX WITH inhibitor	0.118	272	220	40	311	37	286	6.847E-02	58
LOKIASV2_3899_ESMFold_N-A	6cqd-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6cqd-assembly1.cif.gz_A Crystal structure of HPK1 in complex with ATP analogue (AMPPNP)	0.115	262	167	28	289	14	203	4.290E-02	58
LOKIASV2_3899_ESMFold_N-A	6fex-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6fex-assembly1.cif.gz_A DDR1, 2-[4-bromo-2-oxo-1'-(1H-pyrazolo[4,3-b]pyridine-5-carbonyl)spiro[indole-3,4'-piperidine]-1-yl]-N-(2,2,2-trifluoroethyl)acetamide, 1.291A, P212121, Rfree=17.4%	0.124	249	201	30	278	9	238	8.001E-02	58
LOKIASV2_3899_ESMFold_N-A	5twy-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	5twy-assembly2.cif.gz_B Structure of Maternal Embryonic Leucine Zipper Kinase	0.124	309	205	9	317	1	235	4.073E-02	58
LOKIASV2_3899_ESMFold_N-A	4ra5-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	4ra5-assembly1.cif.gz_B Human Protein Kinase C THETA IN COMPLEX WITH LIGAND COMPOUND 11a (6-[(1,3-Dimethyl-azetidin-3-yl)-methyl-amino]-4(R)-methyl-7-phenyl-2,10-dihydro-9-oxa-1,2,4a-triaza-phenanthren-3-one)	0.098	266	213	27	292	3	239	1.151E-01	58
LOKIASV2_3899_ESMFold_N-A	6ise-assembly2.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6ise-assembly2.cif.gz_A Crystal structure of AMPPNP bound CK2 alpha from C. neoformans	0.102	273	222	4	276	21	268	1.345E-01	58
LOKIASV2_3899_ESMFold_N-A	3qkk-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3qkk-assembly1.cif.gz_A Spirochromane Akt Inhibitors	0.115	275	240	28	302	5	276	6.500E-02	58
LOKIASV2_3899_ESMFold_N-A	4xhl-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4xhl-assembly1.cif.gz_A Structure of S. cerevisiae Hrr25 1-394 (K38R mutant)	0.105	302	257	28	315	3	304	3.309E-02	58
LOKIASV2_3899_ESMFold_N-A	6q2a-assembly13.cif.gz_M	LOKIASV2_3899_ESMFold_N-A	6q2a-assembly13.cif.gz_M Trypanosoma brucei CLK1 kinase domain in complex with a covalent aminobenzimidazole inhibitor AB1	0.087	328	262	28	315	1	328	6.500E-02	58
LOKIASV2_3899_ESMFold_N-A	2x7g-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	2x7g-assembly1.cif.gz_A Structure of human serine-arginine-rich protein-specific kinase 2 (SRPK2) bound to purvalanol B	0.129	128	99	29	143	11	138	3.608E-01	58
LOKIASV2_3899_ESMFold_N-A	5myv-assembly3.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	5myv-assembly3.cif.gz_C Crystal structure of SRPK2 in complex with compound 1	0.150	128	97	29	143	13	140	3.252E-01	58
LOKIASV2_3899_ESMFold_N-A	6fyk-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6fyk-assembly2.cif.gz_B X-Ray structure of CLK2-KD(136-496)/Indazole1 at 2.39A	0.096	261	192	29	289	26	238	8.427E-02	58
LOKIASV2_3899_ESMFold_N-A	4qfg-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4qfg-assembly1.cif.gz_A Structure of AMPK in complex with STAUROSPORINE inhibitor and in the absence of a synthetic activator	0.113	252	208	28	279	6	241	5.859E-02	58
LOKIASV2_3899_ESMFold_N-A	4z7g-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4z7g-assembly1.cif.gz_A Crystal structure of human IRE1 cytoplasmic kinase-RNase region - apo	0.105	260	189	33	292	14	225	7.212E-02	58
LOKIASV2_3899_ESMFold_N-A	5cyz-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5cyz-assembly1.cif.gz_A Structure of S. cerevisiae Hrr25:Mam1 complex, form 1	0.104	307	248	8	314	1	278	2.983E-02	58
LOKIASV2_3899_ESMFold_N-A	5w80-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5w80-assembly1.cif.gz_A Toxoplasma Gondii CDPK1 in complex with inhibitor GXJ-237	0.111	289	251	27	315	5	287	4.519E-02	58
LOKIASV2_3899_ESMFold_N-A	4wbo-assembly4.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	4wbo-assembly4.cif.gz_D Bovine G Protein Coupled Receptor Kinase 1 in Complex with Amlexanox	0.123	265	211	12	276	131	372	5.281E-02	58
LOKIASV2_3899_ESMFold_N-A	4pni-assembly1.cif.gz_A-2	LOKIASV2_3899_ESMFold_N-A	4pni-assembly1.cif.gz_A-2 Bovine G protein-coupled receptor kinase 1 in complex with GSK2163632A	0.115	278	233	12	289	136	399	3.309E-02	58
LOKIASV2_3899_ESMFold_N-A	4l9i-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	4l9i-assembly1.cif.gz_B Bovine G Protein Coupled Receptor Kinase 1 in Complex with Paroxetine	0.124	264	208	12	275	135	372	4.290E-02	58
LOKIASV2_3899_ESMFold_N-A	3pvw-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3pvw-assembly1.cif.gz_A Bovine GRK2 in complex with Gbetagamma subunits and a selective kinase inhibitor (CMPD103A)	0.124	289	218	4	292	151	400	3.142E-02	58
LOKIASV2_3899_ESMFold_N-A	8em8-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	8em8-assembly1.cif.gz_A Co-crystal structure of the cGMP-dependent protein kinase PKG from Plasmodium falciparum in complex with RY-1-165	0.122	269	223	11	279	482	736	1.774E-02	58
LOKIASV2_3899_ESMFold_N-A	3hyh-assembly3.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	3hyh-assembly3.cif.gz_B Crystal structure of the protein kinase domain of yeast AMP-activated protein kinase Snf1	0.113	249	172	31	279	11	205	5.014E-02	57
LOKIASV2_3899_ESMFold_N-A	2hyy-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	2hyy-assembly1.cif.gz_A Human Abl kinase domain in complex with imatinib (STI571, Glivec)	0.112	264	225	32	295	8	261	8.001E-02	57
LOKIASV2_3899_ESMFold_N-A	3rny-assembly3.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	3rny-assembly3.cif.gz_B Crystal structure of human RSK1 C-terminal kinase domain	0.151	258	194	46	303	13	241	8.001E-02	57
LOKIASV2_3899_ESMFold_N-A	6qg4-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6qg4-assembly1.cif.gz_A Structure of the mitogen activated kinase kinase 7 in complex with pyrazolopyrimidine inhibitor 1h	0.125	246	164	32	277	18	205	4.519E-02	57
LOKIASV2_3899_ESMFold_N-A	5l6p-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5l6p-assembly1.cif.gz_A EphB3 kinase domain covalently bound to an irreversible inhibitor (compound 6)	0.094	286	227	30	315	16	266	1.037E-01	57
LOKIASV2_3899_ESMFold_N-A	4ct2-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4ct2-assembly1.cif.gz_A Human PDK1-PKCzeta Kinase Chimera	0.135	260	162	30	289	7	194	8.001E-02	57
LOKIASV2_3899_ESMFold_N-A	7qr9-assembly4.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	7qr9-assembly4.cif.gz_D Crystal structure of CK1 delta in complex with PK-09-82	0.116	287	231	28	314	5	266	3.485E-02	57
LOKIASV2_3899_ESMFold_N-A	6rcg-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6rcg-assembly1.cif.gz_A Crystal structure of Casein kinase 1 delta (CK1 delta) complexed with SR3029 inhibitor	0.115	287	239	28	314	9	279	5.859E-02	57
LOKIASV2_3899_ESMFold_N-A	3uc4-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3uc4-assembly1.cif.gz_A The crystal structure of Snf1-related kinase 2.6	0.131	259	216	26	274	6	264	3.367E-03	57
LOKIASV2_3899_ESMFold_N-A	7egb-assembly1.cif.gz_8	LOKIASV2_3899_ESMFold_N-A	7egb-assembly1.cif.gz_8 TFIID-based holo PIC on SCP promoter	0.108	256	189	28	283	1	213	1.744E-01	57
LOKIASV2_3899_ESMFold_N-A	2yaa-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	2yaa-assembly1.cif.gz_B Crystal structure of the autoinhibited form of mouse DAPK2 in complex with ATP	0.104	292	242	26	317	7	277	3.142E-02	57
LOKIASV2_3899_ESMFold_N-A	1fot-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	1fot-assembly1.cif.gz_A STRUCTURE OF THE UNLIGANDED CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT FROM SACCHAROMYCES CEREVISIAE	0.137	271	198	30	300	6	236	2.074E-02	57
LOKIASV2_3899_ESMFold_N-A	2r7i-assembly3.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	2r7i-assembly3.cif.gz_C Crystal structure of catalytic subunit of protein kinase CK2	0.092	263	198	21	283	20	238	8.877E-02	57
LOKIASV2_3899_ESMFold_N-A	1cm8-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	1cm8-assembly2.cif.gz_B PHOSPHORYLATED MAP KINASE P38-GAMMA	0.087	277	227	29	305	1	250	5.859E-02	57
LOKIASV2_3899_ESMFold_N-A	2i0e-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	2i0e-assembly1.cif.gz_A Structure of catalytic domain of human protein kinase C beta II complexed with a bisindolylmaleimide inhibitor	0.104	278	239	30	307	4	271	4.073E-02	57
LOKIASV2_3899_ESMFold_N-A	3mgy-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3mgy-assembly1.cif.gz_A Mutagenesis of p38 MAP Kinase eshtablishes key roles of Phe169 in function and structural dynamics and reveals a novel DFG-out state	0.134	255	184	29	283	1	214	3.867E-02	57
LOKIASV2_3899_ESMFold_N-A	4loq-assembly3.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	4loq-assembly3.cif.gz_C Structural basis of autoactivation of p38 alpha induced by TAB1 (Tetragonal crystal form with bound sulphate)	0.127	264	172	28	291	19	216	3.485E-02	57
LOKIASV2_3899_ESMFold_N-A	4lop-assembly3.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	4lop-assembly3.cif.gz_C Structural basis of autoactivation of p38 alpha induced by TAB1 (Tetragonal crystal form)	0.130	254	185	30	283	22	235	2.184E-02	57
LOKIASV2_3899_ESMFold_N-A	6c9g-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6c9g-assembly1.cif.gz_A AMP-activated protein kinase bound to pharmacological activator R739	0.122	247	211	33	279	1	241	3.485E-02	57
LOKIASV2_3899_ESMFold_N-A	6w3e-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6w3e-assembly1.cif.gz_B Structure of phosphorylated IRE1 in complex with G-0701	0.110	262	208	28	289	5	239	1.417E-01	57
LOKIASV2_3899_ESMFold_N-A	5iso-assembly2.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	5iso-assembly2.cif.gz_C STRUCTURE OF FULL LENGTH HUMAN AMPK (NON-PHOSPHORYLATED AT T-LOOP) IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR, A BENZIMIDAZOLE DERIVATIVE (991)	0.121	208	135	33	240	1	155	6.500E-02	57
LOKIASV2_3899_ESMFold_N-A	4uw0-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4uw0-assembly1.cif.gz_A Low resolution structure of WbdD with C-terminal bundle ordered to residue 505	0.115	285	247	29	313	216	495	9.350E-02	57
LOKIASV2_3899_ESMFold_N-A	1u4d-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	1u4d-assembly2.cif.gz_B Structure of the ACK1 Kinase Domain bound to Debromohymenialdisine	0.103	212	125	30	241	10	149	2.381E-01	56
LOKIASV2_3899_ESMFold_N-A	6yg3-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6yg3-assembly1.cif.gz_A Crystal structure of MKK7 (MAP2K7) covalently bound with CPT1-70-1	0.119	289	219	28	316	16	265	4.519E-02	56
LOKIASV2_3899_ESMFold_N-A	3fme-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3fme-assembly1.cif.gz_A Crystal Structure of Human Mitogen-Activated Protein Kinase Kinase 6 (MEK6) Activated Mutant (S207D, T211D)	0.099	257	198	29	285	9	229	6.171E-02	56
LOKIASV2_3899_ESMFold_N-A	3dk3-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	3dk3-assembly2.cif.gz_B Crystal structure of mutant ABL kinase domain in complex with small molecule fragment	0.103	280	226	32	311	10	262	1.093E-01	56
LOKIASV2_3899_ESMFold_N-A	7t1t-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7t1t-assembly1.cif.gz_A JAK2 JH2 IN COMPLEX WITH JAK292	0.111	283	235	32	314	10	274	3.485E-02	56
LOKIASV2_3899_ESMFold_N-A	7nzy-assembly3.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	7nzy-assembly3.cif.gz_C Crystal structure of human Casein Kinase I delta in complex with CGS-15943	0.109	287	233	28	314	5	266	6.500E-02	56
LOKIASV2_3899_ESMFold_N-A	2x2m-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	2x2m-assembly1.cif.gz_A Crystal Structure of phosphorylated RET tyrosine kinase domain with inhibitor	0.098	289	256	18	306	2	286	1.212E-01	56
LOKIASV2_3899_ESMFold_N-A	6bp0-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6bp0-assembly2.cif.gz_B Crystal Structure of the Human vaccinia-related kinase 1 bound to (R)-2-phenylaminopteridinone inhibitor	0.107	266	206	40	305	23	254	6.500E-02	56
LOKIASV2_3899_ESMFold_N-A	3juh-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	3juh-assembly2.cif.gz_B Crystal structure of a mutant of human protein kinase CK2alpha with altered cosubstrate specificity	0.115	259	194	30	288	38	257	1.492E-01	56
LOKIASV2_3899_ESMFold_N-A	5awm-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5awm-assembly1.cif.gz_A The Crystal Structure of JNK from Drosophila melanogaster Reveals an Evolutionarily Conserved Topology with that of Mammalian JNK Proteins.	0.120	207	138	29	235	1	158	6.171E-02	56
LOKIASV2_3899_ESMFold_N-A	6w3e-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6w3e-assembly1.cif.gz_A Structure of phosphorylated IRE1 in complex with G-0701	0.095	257	187	33	289	14	221	8.427E-02	56
LOKIASV2_3899_ESMFold_N-A	3lj0-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3lj0-assembly1.cif.gz_A IRE1 complexed with ADP and Quercetin	0.157	125	99	28	152	7	124	2.146E-01	56
LOKIASV2_3899_ESMFold_N-A	5w9e-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5w9e-assembly1.cif.gz_A Toxoplasma Gondii CDPK1 in complex with inhibitor GXJ-186	0.108	289	251	27	315	5	286	6.500E-02	56
LOKIASV2_3899_ESMFold_N-A	3t8o-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3t8o-assembly1.cif.gz_A Rhodopsin kinase (GRK1) L166K mutant at 2.5A resolution	0.123	283	247	1	283	94	376	4.519E-02	56
LOKIASV2_3899_ESMFold_N-A	3zzw-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	3zzw-assembly1.cif.gz_B Crystal structure of the kinase domain of ROR2	0.131	116	96	32	142	8	123	2.261E-01	55
LOKIASV2_3899_ESMFold_N-A	3com-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3com-assembly1.cif.gz_A Crystal structure of Mst1 kinase	0.104	273	237	31	303	1	265	1.655E-01	55
LOKIASV2_3899_ESMFold_N-A	6cpy-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6cpy-assembly1.cif.gz_A Structure of apo GRMZM2G135359 pseudokinase	0.126	284	237	7	290	3	274	2.184E-02	55
LOKIASV2_3899_ESMFold_N-A	3alo-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3alo-assembly1.cif.gz_A Crystal structure of human non-phosphorylated MKK4 kinase domain ternary complex with AMP-PNP and p38 peptide	0.122	263	169	30	292	8	200	2.074E-02	55
LOKIASV2_3899_ESMFold_N-A	7qra-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	7qra-assembly2.cif.gz_B Crystal structure of CK1 delta in complex with VN725	0.112	287	237	28	314	5	272	5.014E-02	55
LOKIASV2_3899_ESMFold_N-A	7qr9-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	7qr9-assembly2.cif.gz_B Crystal structure of CK1 delta in complex with PK-09-82	0.111	287	238	28	314	6	274	5.281E-02	55
LOKIASV2_3899_ESMFold_N-A	4u6r-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4u6r-assembly1.cif.gz_A Crystal structure of human IRE1 cytoplasmic domains in complex with a sulfonamide inhibitor.	0.103	259	212	34	292	16	252	1.492E-01	55
LOKIASV2_3899_ESMFold_N-A	4qox-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4qox-assembly1.cif.gz_A Crystal Structure of CDPK4 from Plasmodium Falciparum, PF3D7_0717500	0.128	274	218	34	307	25	275	7.212E-02	55
LOKIASV2_3899_ESMFold_N-A	6m12-assembly1.cif.gz_b	LOKIASV2_3899_ESMFold_N-A	6m12-assembly1.cif.gz_b Crystal Structure of Rnase L in complex with SU11652	0.110	281	184	37	317	350	557	6.847E-02	55
LOKIASV2_3899_ESMFold_N-A	5ezr-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5ezr-assembly1.cif.gz_A Crystal Structure of PVX_084705 bound to compound	0.124	282	186	11	292	498	710	6.500E-02	55
LOKIASV2_3899_ESMFold_N-A	5f0a-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5f0a-assembly1.cif.gz_A CRYSTAL STRUCTURE OF PVX_084705 WITH BOUND 1-tert-butyl-3-(3-chlorophenoxy)-1H-pyrazolo[3,4-d]pyrimidin-4-amine INHIBITOR	0.119	275	231	11	285	503	765	3.485E-02	55
LOKIASV2_3899_ESMFold_N-A	1snx-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	1snx-assembly2.cif.gz_B CRYSTAL STRUCTURE OF APO INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN	0.101	286	211	32	317	10	245	1.151E-01	54
LOKIASV2_3899_ESMFold_N-A	7kx6-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	7kx6-assembly2.cif.gz_B Crystal structure of DCLK1-KD in complex with XMD8-85	0.103	261	205	25	285	4	233	6.847E-02	54
LOKIASV2_3899_ESMFold_N-A	5vd9-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5vd9-assembly1.cif.gz_A Crystal structure of human WEE1 kinase domain in complex with RAC-IV-097, a MK1775 analogue	0.128	253	205	27	279	5	240	1.093E-01	54
LOKIASV2_3899_ESMFold_N-A	7b32-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7b32-assembly1.cif.gz_A MST3 in complex with MRIA7	0.115	288	226	25	312	7	262	1.655E-01	54
LOKIASV2_3899_ESMFold_N-A	5nk8-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5nk8-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 2f	0.099	242	172	32	273	9	200	9.848E-02	54
LOKIASV2_3899_ESMFold_N-A	7b36-assembly2.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	7b36-assembly2.cif.gz_C MST4 in complex with compound G-5555	0.121	259	226	24	282	4	261	3.485E-02	54
LOKIASV2_3899_ESMFold_N-A	2jam-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	2jam-assembly1.cif.gz_A Crystal structure of human calmodulin-dependent protein kinase I G	0.139	112	91	30	141	6	112	1.837E-01	54
LOKIASV2_3899_ESMFold_N-A	6cqh-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6cqh-assembly2.cif.gz_B Crystal Structure of the Human vaccinia-related kinase bound to a N-propynyl-N-ethyl-dihydropteridine inhibitor	0.120	276	220	30	305	16	266	8.877E-02	54
LOKIASV2_3899_ESMFold_N-A	3l8x-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3l8x-assembly1.cif.gz_A P38 alpha kinase complexed with a pyrazolo-pyrimidine based inhibitor	0.113	254	186	28	281	1	211	6.847E-02	54
LOKIASV2_3899_ESMFold_N-A	8fp1-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	8fp1-assembly1.cif.gz_A PKCeta kinase domain in complex with compound 2	0.120	260	199	40	299	21	247	6.500E-02	54
LOKIASV2_3899_ESMFold_N-A	6z4z-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6z4z-assembly2.cif.gz_B Crystal structure of CLK1 in complex with macrocycle ODS2004070	0.103	258	211	27	284	13	248	9.848E-02	54
LOKIASV2_3899_ESMFold_N-A	4qp1-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4qp1-assembly1.cif.gz_A Crystal structure of ERK2 in complex with N-cyclohexyl-9H-purin-6-amine	0.113	283	202	1	283	2	230	1.417E-01	54
LOKIASV2_3899_ESMFold_N-A	3fko-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3fko-assembly1.cif.gz_A P38 kinase crystal structure in complex with RO3668	0.145	256	180	28	283	18	228	9.350E-02	54
LOKIASV2_3899_ESMFold_N-A	5myv-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	5myv-assembly2.cif.gz_B Crystal structure of SRPK2 in complex with compound 1	0.143	128	98	29	143	13	140	2.508E-01	54
LOKIASV2_3899_ESMFold_N-A	4fr4-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4fr4-assembly1.cif.gz_A Crystal structure of human serine/threonine-protein kinase 32A (YANK1)	0.111	262	219	28	289	2	248	5.562E-02	54
LOKIASV2_3899_ESMFold_N-A	4z7g-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	4z7g-assembly2.cif.gz_B Crystal structure of human IRE1 cytoplasmic kinase-RNase region - apo	0.099	275	205	33	307	14	242	1.345E-01	54
LOKIASV2_3899_ESMFold_N-A	5dzc-assembly1.cif.gz_A-2	LOKIASV2_3899_ESMFold_N-A	5dzc-assembly1.cif.gz_A-2 Crystal structure of the cGMP-dependent protein kinase PKG from Plasmodium Vivax - AMPPNP bound	0.127	275	229	11	285	503	765	4.519E-02	54
LOKIASV2_3899_ESMFold_N-A	4qd6-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	4qd6-assembly2.cif.gz_B ITK kinase domain in complex with inhibitor compound	0.092	278	213	26	303	5	240	1.093E-01	53
LOKIASV2_3899_ESMFold_N-A	2pk9-assembly3.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	2pk9-assembly3.cif.gz_C Structure of the Pho85-Pho80 CDK-cyclin Complex of the Phosphate-responsive Signal Transduction Pathway	0.110	199	101	42	240	10	123	4.216E-01	53
LOKIASV2_3899_ESMFold_N-A	5uq3-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5uq3-assembly1.cif.gz_A Crystal structure of human Cdk2-Spy1-P27 ternary complex	0.098	209	116	33	241	1	130	2.038E-01	53
LOKIASV2_3899_ESMFold_N-A	7l26-assembly4.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	7l26-assembly4.cif.gz_D HPK1 IN COMPLEX WITH COMPOUND 38	0.122	276	230	32	307	10	272	1.212E-01	53
LOKIASV2_3899_ESMFold_N-A	5okt-assembly4.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	5okt-assembly4.cif.gz_D Crystal structure of human Casein Kinase I delta in complex with IWP-2	0.099	283	232	32	314	7	265	6.171E-02	53
LOKIASV2_3899_ESMFold_N-A	2q0b-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	2q0b-assembly1.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic E565A Mutation Responsible for Pfeiffer Syndrome	0.111	273	238	39	311	13	281	5.859E-02	53
LOKIASV2_3899_ESMFold_N-A	1s9i-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	1s9i-assembly1.cif.gz_B X-ray structure of the human mitogen-activated protein kinase kinase 2 (MEK2)in a complex with ligand and MgATP	0.102	307	254	6	312	4	287	7.596E-02	53
LOKIASV2_3899_ESMFold_N-A	5r9n-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5r9n-assembly1.cif.gz_A PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13421a in complex with MAP kinase p38-alpha	0.138	126	107	28	152	19	144	1.277E-01	53
LOKIASV2_3899_ESMFold_N-A	1wbp-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	1wbp-assembly1.cif.gz_A SRPK1 bound to 9mer docking motif peptide	0.141	251	214	29	278	13	263	8.877E-02	53
LOKIASV2_3899_ESMFold_N-A	3c50-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	3c50-assembly1.cif.gz_B Crystal Structure of G protein coupled receptor kinase 1 bound to ADP and magnesium chloride at 2.6A	0.109	269	212	16	284	139	377	1.417E-01	53
LOKIASV2_3899_ESMFold_N-A	5ukk-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5ukk-assembly1.cif.gz_A Human GRK2 in complex with human G-beta-gamma subunits and CCG211998 (14ak)	0.129	290	242	28	317	151	429	3.867E-02	53
LOKIASV2_3899_ESMFold_N-A	4yc8-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4yc8-assembly1.cif.gz_A C-Helix-Out Binding of Dasatinib Analog to c-Abl Kinase	0.081	284	226	32	315	10	256	1.345E-01	52
LOKIASV2_3899_ESMFold_N-A	3otu-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3otu-assembly1.cif.gz_A PDK1 mutant bound to allosteric disulfide fragment activator JS30	0.117	257	199	33	289	10	235	6.847E-02	52
LOKIASV2_3899_ESMFold_N-A	4qp2-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	4qp2-assembly2.cif.gz_B Crystal Structure of ERKs in complex with 5-chlorobenzo[d]oxazol-2-amine	0.114	256	190	28	283	12	227	1.572E-01	52
LOKIASV2_3899_ESMFold_N-A	6sfo-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6sfo-assembly1.cif.gz_A MAPK14 with bound inhibitor SR-318	0.119	255	192	29	283	1	219	5.859E-02	52
LOKIASV2_3899_ESMFold_N-A	4xey-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	4xey-assembly2.cif.gz_B Crystal structure of an SH2-kinase domain construct of c-Abl tyrosine kinase	0.079	296	240	12	307	70	331	1.417E-01	52
LOKIASV2_3899_ESMFold_N-A	4ih8-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4ih8-assembly1.cif.gz_A Crystal structure of TgCDPK1 with inhibitor bound	0.111	285	233	27	311	4	266	1.492E-01	52
LOKIASV2_3899_ESMFold_N-A	3qrj-assembly3.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3qrj-assembly3.cif.gz_A The crystal structure of human abl1 kinase domain T315I mutant in complex with DCC-2036	0.105	248	183	32	279	9	214	3.608E-01	51
LOKIASV2_3899_ESMFold_N-A	5oop-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5oop-assembly1.cif.gz_A Structure of CHK1 10-pt. mutant complex with AMP-PNP	0.111	209	121	32	240	8	144	2.146E-01	51
LOKIASV2_3899_ESMFold_N-A	8c0a-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	8c0a-assembly2.cif.gz_B Crystal structure of JAK2 JH2-R683S	0.101	281	236	32	312	10	272	5.562E-02	51
LOKIASV2_3899_ESMFold_N-A	7ovj-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7ovj-assembly1.cif.gz_A Protein kinase MKK7 in complex with difluoro-phenethyltriazole-substituted pyrazolopyrimidine	0.120	245	161	33	277	23	206	1.151E-01	51
LOKIASV2_3899_ESMFold_N-A	6f26-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6f26-assembly1.cif.gz_A Crystal structure of human Casein Kinase I delta in complex with compound 31b	0.103	287	232	28	314	5	264	1.093E-01	51
LOKIASV2_3899_ESMFold_N-A	2ivv-assembly1.cif.gz_A-2	LOKIASV2_3899_ESMFold_N-A	2ivv-assembly1.cif.gz_A-2 Crystal structure of phosphorylated RET tyrosine kinase domain complexed with the inhibitor PP1	0.106	290	246	18	307	2	277	5.859E-02	51
LOKIASV2_3899_ESMFold_N-A	7ovn-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7ovn-assembly1.cif.gz_A Protein kinase MKK7 in complex with tolyl-substituted indazole	0.132	253	174	27	279	16	217	1.345E-01	51
LOKIASV2_3899_ESMFold_N-A	6ib0-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6ib0-assembly1.cif.gz_A The structure of MKK7 in complex with the covalent 4-amino-pyrazolopyrimidine 3a	0.105	284	238	33	316	24	290	6.847E-02	51
LOKIASV2_3899_ESMFold_N-A	6u0k-assembly2.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6u0k-assembly2.cif.gz_A TTBK2 kinase domain in complex with Compound 1	0.083	291	249	27	317	11	282	2.642E-01	51
LOKIASV2_3899_ESMFold_N-A	4lmn-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4lmn-assembly1.cif.gz_A Crystal Structure of MEK1 kinase bound to GDC0973	0.105	285	251	33	317	12	292	1.345E-01	51
LOKIASV2_3899_ESMFold_N-A	4aaa-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4aaa-assembly1.cif.gz_A Crystal structure of the human CDKL2 kinase domain	0.100	206	131	32	237	9	154	3.800E-01	51
LOKIASV2_3899_ESMFold_N-A	4fr4-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	4fr4-assembly2.cif.gz_B Crystal structure of human serine/threonine-protein kinase 32A (YANK1)	0.109	293	225	7	299	1	254	1.345E-01	51
LOKIASV2_3899_ESMFold_N-A	7bmk-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	7bmk-assembly1.cif.gz_B ATP-Competitive Partial Antagonists-'PAIR's-Rheostatically Modulate IRE1alpha's Kinase Helix-alphaC to Segregate its RNase-Mediated Biological Outputs	0.112	259	175	33	291	1	198	1.417E-01	51
LOKIASV2_3899_ESMFold_N-A	2rio-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	2rio-assembly1.cif.gz_A Structure of the dual enzyme Ire1 reveals the basis for catalysis and regulation of non-conventional splicing	0.171	123	96	30	152	9	125	2.783E-01	51
LOKIASV2_3899_ESMFold_N-A	4m97-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4m97-assembly1.cif.gz_A Calcium-Dependent Protein Kinase 1 from Neospora caninum	0.104	278	237	26	303	5	269	9.350E-02	51
LOKIASV2_3899_ESMFold_N-A	3qc9-assembly2.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	3qc9-assembly2.cif.gz_C Crystal structure of cross-linked bovine GRK1 T8C/N480C double mutant complexed with ADP and Mg	0.120	264	209	12	275	130	367	1.345E-01	51
LOKIASV2_3899_ESMFold_N-A	3c51-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3c51-assembly1.cif.gz_A Crystal structure of G protein coupled receptor kinase 1 bound to ADP and magnesium chloride at 3.55A	0.122	291	248	7	289	105	395	9.848E-02	51
LOKIASV2_3899_ESMFold_N-A	2yn8-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	2yn8-assembly2.cif.gz_B ephB4 kinase domain inhibitor complex	0.099	292	223	26	317	6	253	2.832E-02	50
LOKIASV2_3899_ESMFold_N-A	3ujg-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3ujg-assembly1.cif.gz_A Crystal structure of SnRK2.6 in complex with HAB1	0.114	287	243	29	303	1	287	1.599E-02	50
LOKIASV2_3899_ESMFold_N-A	2jed-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	2jed-assembly2.cif.gz_B The crystal structure of the kinase domain of the protein kinase C theta in complex with NVP-XAA228 at 2.32A resolution.	0.093	263	211	30	292	6	239	1.572E-01	50
LOKIASV2_3899_ESMFold_N-A	3lfb-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3lfb-assembly1.cif.gz_A Human p38 MAP Kinase in Complex with RL98	0.126	256	173	28	283	19	217	8.877E-02	50
LOKIASV2_3899_ESMFold_N-A	7myj-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7myj-assembly1.cif.gz_A Structure of full length human AMPK (a2b1g1) in complex with a small molecule activator MSG011	0.119	252	192	33	284	3	221	1.151E-01	50
LOKIASV2_3899_ESMFold_N-A	3n51-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3n51-assembly1.cif.gz_A Calcium-Dependent Protein Kinase 1 from Toxoplasma gondii (TgCDPK1) in complex with bumped kinase inhibitor RM-1-95	0.122	341	247	27	308	4	344	1.171E-02	50
LOKIASV2_3899_ESMFold_N-A	4l9i-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4l9i-assembly1.cif.gz_A Bovine G Protein Coupled Receptor Kinase 1 in Complex with Paroxetine	0.115	259	210	31	289	162	399	1.492E-01	50
LOKIASV2_3899_ESMFold_N-A	5vja-assembly1.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	5vja-assembly1.cif.gz_D Crystal Structure of human zipper-interacting protein kinase (ZIPK, alias DAPK3) in complex with a pyrazolo[3,4-d]pyrimidinone ligand (HS38)	0.105	263	211	27	289	4	240	1.492E-01	49
LOKIASV2_3899_ESMFold_N-A	7l26-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	7l26-assembly2.cif.gz_B HPK1 IN COMPLEX WITH COMPOUND 38	0.113	258	159	32	289	10	189	1.212E-01	49
LOKIASV2_3899_ESMFold_N-A	7ovl-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7ovl-assembly1.cif.gz_A Protein kinase MKK7 in complex with methoxycyclohexyl-substituted indazole	0.112	279	229	32	310	19	277	1.037E-01	49
LOKIASV2_3899_ESMFold_N-A	6bru-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6bru-assembly2.cif.gz_B Crystal Structure of the Human vaccinia-related kinase bound to a (S)-2-phenylaminopteridinone inhibitor	0.115	266	202	40	305	23	251	8.427E-02	49
LOKIASV2_3899_ESMFold_N-A	6bu6-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6bu6-assembly2.cif.gz_B Crystal Structure of the Human vaccinia-related kinase bound to a bis-difluorophenol-aminopyridine inhibitor	0.115	275	213	30	304	15	256	1.277E-01	49
LOKIASV2_3899_ESMFold_N-A	4yr8-assembly3.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	4yr8-assembly3.cif.gz_C Crystal structure of JNK in complex with a regulator protein	0.112	279	242	28	306	12	285	3.485E-02	49
LOKIASV2_3899_ESMFold_N-A	4xhh-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4xhh-assembly1.cif.gz_A Structure of C. glabrata Hrr25, Apo state	0.110	252	193	28	279	6	223	1.345E-01	49
LOKIASV2_3899_ESMFold_N-A	3i7b-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3i7b-assembly1.cif.gz_A Calcium-Dependent Protein Kinase 1 from Toxoplasma gondii (TgCDPK1) in complex with bumped kinase inhibitor NM-PP1	0.123	346	251	26	312	2	347	1.234E-02	49
LOKIASV2_3899_ESMFold_N-A	3qc9-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	3qc9-assembly2.cif.gz_B Crystal structure of cross-linked bovine GRK1 T8C/N480C double mutant complexed with ADP and Mg	0.114	282	236	13	279	117	398	1.417E-01	49
LOKIASV2_3899_ESMFold_N-A	3qc9-assembly1.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	3qc9-assembly1.cif.gz_D Crystal structure of cross-linked bovine GRK1 T8C/N480C double mutant complexed with ADP and Mg	0.116	282	235	13	279	117	398	1.345E-01	49
LOKIASV2_3899_ESMFold_N-A	8boi-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	8boi-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 9	0.119	287	210	29	315	11	249	1.572E-01	48
LOKIASV2_3899_ESMFold_N-A	6qft-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6qft-assembly1.cif.gz_A Structure of the mitogen activated kinase kinase 7 in complex with pyrazolopyrimidin 1b	0.142	250	166	28	277	16	210	5.281E-02	48
LOKIASV2_3899_ESMFold_N-A	4fzf-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	4fzf-assembly1.cif.gz_B Crystal structure of MST4-MO25 complex with DKI	0.108	267	226	40	306	20	273	2.783E-01	48
LOKIASV2_3899_ESMFold_N-A	7l26-assembly3.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	7l26-assembly3.cif.gz_C HPK1 IN COMPLEX WITH COMPOUND 38	0.113	266	167	24	289	6	194	2.508E-01	48
LOKIASV2_3899_ESMFold_N-A	5amn-assembly1.cif.gz_A-2	LOKIASV2_3899_ESMFold_N-A	5amn-assembly1.cif.gz_A-2 The Discovery of 2-Substituted Phenol Quinazolines as Potent and Selective RET Kinase Inhibitors	0.105	292	252	16	307	2	284	8.001E-02	48
LOKIASV2_3899_ESMFold_N-A	5myv-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5myv-assembly1.cif.gz_A Crystal structure of SRPK2 in complex with compound 1	0.114	268	230	29	289	13	280	1.212E-01	48
LOKIASV2_3899_ESMFold_N-A	5toe-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5toe-assembly1.cif.gz_A Pim-1 kinase in complex with a 7-azaindole	0.086	263	215	27	289	2	237	3.800E-01	47
LOKIASV2_3899_ESMFold_N-A	5nk5-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5nk5-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 1m	0.108	239	184	32	270	9	215	1.572E-01	47
LOKIASV2_3899_ESMFold_N-A	5f9e-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	5f9e-assembly2.cif.gz_B Structure of Protein Kinase C theta with compound 10: 2,2-dimethyl-7-(2-oxidanylidene-3~{H}-imidazo[4,5-b]pyridin-1-yl)-1-(phenylmethyl)-3~{H}-quinazolin-4-one	0.079	263	215	30	292	6	239	2.783E-01	47
LOKIASV2_3899_ESMFold_N-A	6dd4-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6dd4-assembly2.cif.gz_B Crystal Structure of the Human vaccinia-related kinase bound to a N,N-dipropyl-dihydropteridine inhibitor	0.114	272	212	34	305	20	259	2.038E-01	47
LOKIASV2_3899_ESMFold_N-A	3c4w-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	3c4w-assembly1.cif.gz_B Crystal Structure of G protein coupled receptor kinase 1 bound to ATP and magnesium chloride at 2.7A	0.118	282	235	13	279	141	422	2.146E-01	47
LOKIASV2_3899_ESMFold_N-A	6zwo-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6zwo-assembly1.cif.gz_B cryo-EM structure of human mTOR complex 2, focused on one half	0.116	283	245	28	310	1248	1525	2.300E-02	47
LOKIASV2_3899_ESMFold_N-A	7nfe-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7nfe-assembly1.cif.gz_A Cryo-EM structure of NHEJ super-complex (monomer)	0.095	287	253	31	311	3166	3452	1.774E-02	47
LOKIASV2_3899_ESMFold_N-A	3dy7-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3dy7-assembly1.cif.gz_A X-ray structure of the human mitogen-activated protein kinase kinase 1 (MEK1) in a complex with ligand and MgATP	0.139	255	159	31	285	9	194	6.171E-02	46
LOKIASV2_3899_ESMFold_N-A	8ex2-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	8ex2-assembly1.cif.gz_A Crystal structure of JAK2 JH2 (pseudokinase domain) in complex with HTSA3	0.122	258	220	28	279	13	270	6.171E-02	46
LOKIASV2_3899_ESMFold_N-A	4q9z-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	4q9z-assembly1.cif.gz_B Human Protein Kinase C Theta in Complex with Compound35 ((1R)-9-(AZETIDIN-3-YLAMINO)-1,8-DIMETHYL-3,5-DIHYDRO[1,2,4]TRIAZINO[3,4-C][1,4]BENZOXAZIN-2(1H)-ONE)	0.094	263	215	27	289	4	241	3.252E-01	46
LOKIASV2_3899_ESMFold_N-A	6ohd-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6ohd-assembly1.cif.gz_A P38 in complex with T-3220137	0.120	256	188	28	283	1	215	1.037E-01	46
LOKIASV2_3899_ESMFold_N-A	3c4w-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3c4w-assembly1.cif.gz_A Crystal Structure of G protein coupled receptor kinase 1 bound to ATP and magnesium chloride at 2.7A	0.125	268	230	12	279	135	398	3.087E-01	46
LOKIASV2_3899_ESMFold_N-A	4ppc-assembly3.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4ppc-assembly3.cif.gz_A ITK kinase domain with compound 27 (N-{1-[(1R)-3-(DIMETHYLAMINO)-1-PHENYLPROPYL]-1H-PYRAZOL-4-YL}-6-(1H-PYRAZOL-4-YL)-1H-INDAZOLE-3-CARBOXAMIDE)	0.091	272	202	32	303	8	230	4.216E-01	45
LOKIASV2_3899_ESMFold_N-A	7l24-assembly4.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	7l24-assembly4.cif.gz_D HPK1 IN COMPLEX WITH COMPOUND 11	0.104	261	161	32	292	10	190	4.003E-01	45
LOKIASV2_3899_ESMFold_N-A	3e92-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3e92-assembly1.cif.gz_A Crystal Structure of P38 Kinase in Complex with A Biaryl Amide Inhibitor	0.131	256	186	28	283	20	234	1.837E-01	45
LOKIASV2_3899_ESMFold_N-A	5jms-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5jms-assembly1.cif.gz_A Crystal structure of TgCDPK1 bound to CGP060476	0.117	335	248	27	308	5	339	2.983E-02	45
LOKIASV2_3899_ESMFold_N-A	3c4z-assembly1.cif.gz_A-2	LOKIASV2_3899_ESMFold_N-A	3c4z-assembly1.cif.gz_A-2 Crystal structure of G protein coupled receptor kinase 1 bound to ADP and magnesium chloride at 1.84A	0.125	243	203	37	279	163	395	5.562E-02	45
LOKIASV2_3899_ESMFold_N-A	5dyk-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5dyk-assembly1.cif.gz_A Crystal structure of the cGMP-dependent protein kinase PKG from Plasmodium falciparum - Apo form	0.116	269	225	11	279	500	755	1.093E-01	45
LOKIASV2_3899_ESMFold_N-A	6ib2-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6ib2-assembly1.cif.gz_A The structure of MKK7 in complex with the covalent 4-amino-pyrazolopyrimidine 4a	0.117	244	158	32	275	19	198	2.642E-01	44
LOKIASV2_3899_ESMFold_N-A	2hzn-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	2hzn-assembly1.cif.gz_A Abl kinase domain in complex with NVP-AFG210	0.108	140	111	1	140	1	125	6.388E-01	44
LOKIASV2_3899_ESMFold_N-A	6ath-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6ath-assembly1.cif.gz_A Cdk2/cyclin A/p27-KID-deltaC	0.100	234	166	50	283	13	197	4.216E-01	44
LOKIASV2_3899_ESMFold_N-A	7be5-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7be5-assembly1.cif.gz_A Crystal structure of MAP kinase p38 alpha in complex with inhibitor SR276	0.139	271	189	30	300	21	240	1.093E-01	44
LOKIASV2_3899_ESMFold_N-A	3t3u-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3t3u-assembly1.cif.gz_A Calcium-Dependent Protein Kinase 1 from Toxoplasma gondii (TgCDPK1) in complex with Bumped Kinase Inhibitor, RM-1-130	0.122	341	247	27	308	4	344	3.485E-02	44
LOKIASV2_3899_ESMFold_N-A	4ebw-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4ebw-assembly1.cif.gz_A Structure of Focal Adhesion Kinase catalytic domain in complex with novel allosteric inhibitor	0.121	114	97	30	140	12	125	9.678E-01	43
LOKIASV2_3899_ESMFold_N-A	3uc4-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	3uc4-assembly2.cif.gz_B The crystal structure of Snf1-related kinase 2.6	0.119	268	221	28	279	5	272	5.014E-02	43
LOKIASV2_3899_ESMFold_N-A	7r9p-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7r9p-assembly1.cif.gz_A Crystal structure of HPK1 in complex with compound 14	0.115	258	166	32	289	13	201	4.678E-01	43
LOKIASV2_3899_ESMFold_N-A	3hv6-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3hv6-assembly1.cif.gz_A Human p38 MAP Kinase in Complex with RL39	0.128	256	172	28	283	19	216	2.038E-01	43
LOKIASV2_3899_ESMFold_N-A	4pl5-assembly2.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	4pl5-assembly2.cif.gz_C Crystal structure of murine IRE1 in complex with OICR573 inhibitor	0.122	118	103	28	145	6	123	8.282E-01	43
LOKIASV2_3899_ESMFold_N-A	5w8r-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5w8r-assembly1.cif.gz_A Toxoplasma Gondii CDPK1 in complex with inhibitor 3CIB-PPI	0.125	339	246	27	308	5	343	3.671E-02	43
LOKIASV2_3899_ESMFold_N-A	3o0g-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	3o0g-assembly2.cif.gz_B Crystal Structure of Cdk5:p25 in complex with an ATP analogue	0.094	243	169	41	283	7	193	7.087E-01	42
LOKIASV2_3899_ESMFold_N-A	4yzd-assembly3.cif.gz_C	LOKIASV2_3899_ESMFold_N-A	4yzd-assembly3.cif.gz_C Crystal Structure of human phosphorylated IRE1alpha in complex with ADP-Mg	0.095	273	204	28	300	5	230	6.065E-01	42
LOKIASV2_3899_ESMFold_N-A	6zha-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6zha-assembly1.cif.gz_A Cryo-EM structure of DNA-PK monomer	0.117	295	215	31	275	3276	3570	4.760E-02	42
LOKIASV2_3899_ESMFold_N-A	4ihp-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4ihp-assembly1.cif.gz_A Crystal structure of TgCDPK1 with inhibitor bound	0.124	345	254	27	317	5	349	6.171E-02	41
LOKIASV2_3899_ESMFold_N-A	7k10-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7k10-assembly1.cif.gz_A CryoEM structure of activated-form FATKIN domain of DNA-PK	0.126	291	212	31	274	856	1146	1.969E-02	41
LOKIASV2_3899_ESMFold_N-A	7khj-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	7khj-assembly2.cif.gz_B Crystal structure of KIT kinase domain with a small molecule inhibitor, PLX8512 in the DFG-in state	0.103	277	218	27	303	16	259	5.466E-01	40
LOKIASV2_3899_ESMFold_N-A	7khk-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	7khk-assembly2.cif.gz_B Crystal structure of KIT kinase domain with a small molecule inhibitor, PLX9486 (bezuclastinib) in the DFG-in state	0.109	276	217	27	302	20	264	9.188E-01	40
LOKIASV2_3899_ESMFold_N-A	2dyl-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	2dyl-assembly1.cif.gz_A Crystal structure of human mitogen-activated protein kinase kinase 7 activated mutant (S287D, T291D)	0.120	280	223	32	311	18	271	4.003E-01	40
LOKIASV2_3899_ESMFold_N-A	6yg6-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6yg6-assembly2.cif.gz_B Crystal structure of MKK7 (MAP2K7) covalently bound with type-II inhibitor TL10-105	0.124	249	174	28	276	15	214	8.282E-01	40
LOKIASV2_3899_ESMFold_N-A	4btk-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4btk-assembly1.cif.gz_A TTBK1 in complex with inhibitor	0.088	285	243	28	312	11	277	4.927E-01	40
LOKIASV2_3899_ESMFold_N-A	4bbm-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4bbm-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE HUMAN CDKL2 KINASE DOMAIN WITH BOUND TCS 2312	0.071	301	263	27	310	9	309	1.212E-01	40
LOKIASV2_3899_ESMFold_N-A	5f9e-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5f9e-assembly1.cif.gz_A Structure of Protein Kinase C theta with compound 10: 2,2-dimethyl-7-(2-oxidanylidene-3~{H}-imidazo[4,5-b]pyridin-1-yl)-1-(phenylmethyl)-3~{H}-quinazolin-4-one	0.089	263	212	30	292	7	240	5.466E-01	40
LOKIASV2_3899_ESMFold_N-A	5myv-assembly4.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	5myv-assembly4.cif.gz_D Crystal structure of SRPK2 in complex with compound 1	0.108	252	222	29	278	13	264	5.190E-01	40
LOKIASV2_3899_ESMFold_N-A	6hv0-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6hv0-assembly1.cif.gz_A IRE1 kinase/RNase in complex with imidazo[1,2-b]pyridazin-8-amine compound 33	0.102	110	81	33	142	14	104	9.188E-01	40
LOKIASV2_3899_ESMFold_N-A	4pl3-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4pl3-assembly1.cif.gz_A Crystal structure of murine IRE1 in complex with MKC9989 inhibitor	0.119	109	93	34	142	17	122	1.714E+00	40
LOKIASV2_3899_ESMFold_N-A	3i79-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3i79-assembly1.cif.gz_A Calcium-Dependent Protein Kinase 1 from Toxoplasma gondii (TgCDPK1)	0.116	341	248	27	308	4	344	6.500E-02	40
LOKIASV2_3899_ESMFold_N-A	3upz-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3upz-assembly1.cif.gz_A Calcium-Dependent Protein Kinase 1 from Toxoplasma gondii (TgCDPK1) in complex with bumpless BKI analog UW1243	0.134	339	247	27	312	5	343	6.847E-02	40
LOKIASV2_3899_ESMFold_N-A	4yjn-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4yjn-assembly1.cif.gz_A Calcium-Dependent Protein Kinase 1 from Toxoplasma gondii (TgCDPK1) in complex with inhibitor UW1639	0.142	340	245	27	312	6	345	6.847E-02	40
LOKIASV2_3899_ESMFold_N-A	4lqq-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4lqq-assembly1.cif.gz_A Crystal structure of the Cbk1(T743E)-Mob2 kinase-coactivator complex in crystal form B	0.094	228	176	8	235	4	198	1.417E-01	39
LOKIASV2_3899_ESMFold_N-A	4ifg-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4ifg-assembly1.cif.gz_A Crystal structure of TgCDPK1 with inhibitor bound	0.131	336	244	27	308	5	340	8.427E-02	39
LOKIASV2_3899_ESMFold_N-A	3c4x-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	3c4x-assembly1.cif.gz_A Crystal Structure of G protein coupled receptor kinase 1 bound to ATP and magnesium chloride at 2.9A	0.167	142	107	12	141	136	277	6.388E-01	39
LOKIASV2_3899_ESMFold_N-A	7ovk-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	7ovk-assembly1.cif.gz_A Protein kinase MKK7 in complex with 5-bromo-2-hydroxyphenyl-substituted pyrazolopyrimidine	0.130	239	143	32	270	19	183	5.466E-01	38
LOKIASV2_3899_ESMFold_N-A	3vut-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	3vut-assembly2.cif.gz_B Crystal structures of non-phosphorylated MAP2K4	0.130	125	106	31	153	22	146	1.074E+00	38
LOKIASV2_3899_ESMFold_N-A	6p8g-assembly1.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	6p8g-assembly1.cif.gz_B Crystal structure of CDK4 in complex with CyclinD1 and P27	0.120	188	107	49	236	12	134	1.714E+00	34
LOKIASV2_3899_ESMFold_N-A	8a66-assembly2.cif.gz_B	LOKIASV2_3899_ESMFold_N-A	8a66-assembly2.cif.gz_B Crystal structure of MST2 in complex with XMU-MP-1	0.096	281	243	32	312	12	281	1.191E+00	34
LOKIASV2_3899_ESMFold_N-A	6zh2-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6zh2-assembly1.cif.gz_A Cryo-EM structure of DNA-PKcs (State 1)	0.099	358	252	31	311	3273	3630	1.345E-01	34
LOKIASV2_3899_ESMFold_N-A	4jpd-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	4jpd-assembly1.cif.gz_A The structure of CyaY from Burkholderia cenocepacia	0.090	44	37	14	55	12	55	2.880E+00	33
LOKIASV2_3899_ESMFold_N-A	4o2z-assembly1.cif.gz_A-2	LOKIASV2_3899_ESMFold_N-A	4o2z-assembly1.cif.gz_A-2 Crystal Structure of MPK3 from Leishmania donovani, LdBPK_100540 in the presence of NVP-BBT594	0.086	295	229	28	279	7	301	2.261E-01	31
LOKIASV2_3899_ESMFold_N-A	1soy-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	1soy-assembly1.cif.gz_A Solution structure of the bacterial frataxin orthologue, CyaY	0.071	42	37	14	54	11	52	5.658E+00	29
LOKIASV2_3899_ESMFold_N-A	1ew4-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	1ew4-assembly1.cif.gz_A CRYSTAL STRUCTURE OF ESCHERICHIA COLI CYAY PROTEIN REVEALS A NOVEL FOLD FOR THE FRATAXIN FAMILY	0.071	42	37	14	54	11	52	5.960E+00	28
LOKIASV2_3899_ESMFold_N-A	4lqq-assembly2.cif.gz_D	LOKIASV2_3899_ESMFold_N-A	4lqq-assembly2.cif.gz_D Crystal structure of the Cbk1(T743E)-Mob2 kinase-coactivator complex in crystal form B	0.117	289	152	1	289	44	216	1.019E+00	28
LOKIASV2_3899_ESMFold_N-A	5mwm-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	5mwm-assembly1.cif.gz_A INOSITOL 1,3,4,5,6-PENTAKISPHOSPHATE 2-KINASE FROM M. MUSCULUS IN COMPLEX WITH IP6	0.109	188	106	31	150	1	188	2.222E+00	25
LOKIASV2_3899_ESMFold_N-A	6syt-assembly1.cif.gz_A	LOKIASV2_3899_ESMFold_N-A	6syt-assembly1.cif.gz_A Structure of the SMG1-SMG8-SMG9 complex	0.058	313	284	14	316	1522	1834	1.191E+00	22
